Metabolic engineering and bio-electrochemical synthesis in Pseudomonas putida KT2440 for the production of p-hydroxybenzoate and 2-ketogluconate by Yu, Shiqin
IMetabolic engineering and bio-electrochemical synthesis in
Pseudomonas putida KT2440 for the production of p-hydroxybenzoate
and 2-ketogluconate
Shiqin Yu
Master of Science
A thesis submitted for the degree of Doctor of Philosophy at
The University of Queensland in 2017
School of Chemical Engineering
II
Abstract
Bio-based chemicals have drawn research interests due to the need for sustainable
development. Aromatics and the derived compounds are an important class of chemicals
that are mostly derived from fossil resources. Microbial bio-production can produce many
compounds from renewable feedstocks to reduce the current heavy dependency on fossil
resources. The aromatic compound para-hydroxybenzoate (PHBA) is used to make
parabens and high-value polymers (liquid crystal polymer). Biologically, this chemical can
be derived from the shikimate pathway, the central pathway for the biosynthesis of
aromatic amino acids in bacteria, plants and fungi and some protozoa. In recent years, the
gram-negative soil bacterium Pseudomonas putida is becoming an interesting chassis for
industrial biotechnology. The production of PHBA in recombinant P. putida KT2440 was
engineered by overexpressing the chorismate lyase Ubic from Escherichia coli and a
feedback resistant 3-Deoxy-D-arabinoheptulosonate 7-phosphate synthase (AroGD146N).
Additionally, the pathways competing for the substrate chorismate (trpE and pheA) and the
PHBA degradation pathway (pobA) were eliminated. Finally, deletion of the glucose
metabolism repressor hexR led to an increase in erythrose-4-phosphate and NADPH
supply. This resulted in a maximum titre of 1.73 g L-1 and a carbon yield of 18.1 % (C-mol
C-mol-1) in a non-optimized fed-batch fermentation. This is to date the highest PHBA
concentration produced by P. putida using a chorismate lyase route.
Large-scale aerobic fermentations are more expensive due to the limiting gas transfer and
lead to substrate loss in the form of CO2, whereas anaerobic processes are easier to scale
up and achieve high carbon yield. In the case of aromatics, anaerobic production could be
beneficial. Microbial electrosynthesis is an emerging technology for biosynthesis of
chemicals and fuels by microorganisms in an anaerobic bio-electrochemical system (BES).
These systems can provide electrons to electroactive microbes for reductive production
processes in the cathode or drain excessive electrons in oxidative production processes in
the anode. P. putida was tested for the first time for its ability to perform anoxic metabolism
in BES with ferricyanide as the mediator and anode as the electron sink. A dual-phase
fermentation was employed, where the cells grew aerobically in the first phase and then
performed an anaerobic oxidation process in the second phase. In this way, P. putida
KT2440 could electrochemically produce 2-ketogluconate, a sugar acid used for
biosynthesis of antioxidant E315 for the food industry under anaerobic conditions from
glucose. This would have been impossible without the use of BES. The parental strain
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obtained a carbon yield of around 65% (C-mol C-mol-1) and a productivity of 0.56 ± 0.01
mmolproduct gCDW-1 day-1.
Two genetic engineering targets were identified as potential targets for improvement of the
productivity, pointing towards the key enzymes in the electron transport chain coupled
catalytic reactions: the glucose dehydrogenase (mGCD) and gluconate dehydrogenase
(GADH, enzyme complex). Strains were constructed to evaluate their performances in
BES. Surprisingly, the double overexpression dehydrogenases strain did not lead to best
performance in BES. Real-time RT-qPCR revealed the intrinsic regulation system of
mGCD and GADH, in which mGCD was regulated by glucose and gluconate while GADH
only regulated by gluconate. By utilizing the self-regulation, the single overexpression
mutant (mGCD) achieved a 2-ketogluconate productivity of 1.59 ± 0.01 mmolproduct gCDW-1
day-1, a 300 % increase compared to the wildtype. This work demonstrated that expression
of dehydrogenases coupled with the electron transfer chain can significantly improve
productivity, and controlled expression level is necessary for the well-being of BES
biocatalyst as well as productivity improvement.
Different media and carbon sources were investigated for the production of the biomass
prior to the BES experiments. Cells grown in terrific broth (TB) or minimal medium with
glycerol as sole carbon source showed outstanding performance, and glucose-grown cells
gave the worst performance in terms of carbon yield, electron transfer rate or productivity.
The TB-grown cells achieved a carbon yield of 91 % (C-mol C-mol-1) with a productivity of
2.53 ± 0.09 mmolproduct gCDW-1 day-1, while the glycerol-grown cells achieved highest carbon
yield of 98 % (C-mol C-mol-1) with a 9 % lower productivity than that in TB-grown cells. The
proteomics analysis suggested the GADH enzyme complex (PP_3382, PP_3383, and
PP_3384) overexpression was limited by the subunit PP_3382 biosynthesis. The slight
upregulation of PP_3382 in glycerol-grown cells may contribute to its better performance in
this condition, suggesting that the aerobic growth condition can be optimized for a better
performance in bio-electrochemical production.
In summary, using a chorismate lyase route in P. putida is a suitable strategy to produce
aromatics. The use of a bio-electrochemical system in combination with metabolic
engineering can be used to enable and accelerate anaerobic production with P. putida. In
a first attempt, the two approaches showed promising results, paving the way for future
application.
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1Chapter 1 Introduction
1.1 General introduction
The need for economic, social, and environmental sustainability is prompting the
development of a bio-based economy, and expected to substantially reduce the current
heavy dependency on fossil fuels in a distant future. Currently, most of the chemicals are
derived from petroleum, gas and coal, and the current bio-production processes,
especially for the production of low-value, bulk chemicals is still struggling with high
production costs and low efficiency which makes it less cost competitive comparing with
chemical manufacturing processes. Confronting such challenges, a number of well-
understood microorganisms have been developed as cell factories, with an improved
production competitiveness achieved by upgraded biotechnology including the integration
of advanced techniques from multiple disciplines research areas. Aromatics and its
derived chemicals are one important class of chemicals. In microorganisms these
compounds are mainly generated from the shikimate pathway and its expanded pathways
including the aromatic amino acids biosynthesis branches. The shikimate pathway starts
from the condensation of phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P),
and ends with the formation of universal precursor chorismate after seven enzymatic
reactions. Chorismate serves as the precursor for the production of a wealth of value-
added chemicals such as aromatic amino acids, p-hydroxybenzoate and p-amino
benzoate (Figure 1-1 shows the industrially interesting chemicals derived from shikimate
pathway and its expanded pathways). The metabolites generated from shikimate pathway
and its expanded pathways have important biotechnological value in the food and
pharmaceutical industries as well as used as building blocks for bioplastics and polymers
(Amaratunga et al., 2000; Curran et al., 2013; Gosset, 2009; Karpf and Trussardi, 2009;
Koma et al., 2012; Zhang and Stephanopoulos, 2013). The microbial bio-production of
these value-added compounds for the chemical industry has attracted strong research
interest from metabolic engineering community. In this work I focus on the development of
a platform production host for shikimate pathway derived compounds using the
approaches of metabolic engineering and microbial electrosynthesis. Specifically, a
Pseudomonas putida KT2440 strain was engineered for the production of para-
hydroxybenzoate (PHBA). PHBA production was explored in both aerobic fermentation
system and anaerobically, using a bio-electrochemical system. The proof of principle for
bio-electrochemical production by P. putida KT2440 was firstly tested, and the potential
2targets were identified and engineered for productivity and yield improvement. In addition,
optimization was conducted for a better performance in electrochemical production.
1.2 The importance of bio-production of aromatics and derived compounds from
renewable resources
Resource push, market pull and environmental concerns motivate the establishment of a
renewable chemical industry featuring renewable resources as the main feedstock to
reduce the current heavy dependency on the fossil resources. The global market demand
for bio-based products is vigorously growing and expected to grow over the next several
decades. According to a report from the US Department of Agriculture, the market for bio-
based chemicals estimated to reach $19.7 billion in 2016, and the market share for the
bio-based chemicals could strongly grow, increasing from 2% of market size in 2008 to
22% in 2025 (Mary J. Biddy, 2016). Due to the low yield, low titre and low productivity, a
few compounds have achieved industrial-scale bio-production (Chubukov et al., 2016) and
these compounds are still struggling to become profitable when competing with chemical
production process or the isolation from natural sources. Take the production of high value
compounds as an example. The semi-synthetic artemisinin for producing malaria drug was
hailed as a triumph for metabolic engineering community since pharmaceutical giant
Sanofi started to sell it in 2014. But the return is lagging partly due to the glut from
agricultural artemisinin, consequently the selling price for past two years was less than
$250/kg, under Sanofi’s ‘no profit–no loss’ margin of around $350–400/kg (Peplow, 2016).
Regarding to bulk chemical bio-production, there are hardly any cost competiveness in the
comparison with fossil fuel based chemicals production. For the large-scale production of
bulk chemicals such as biofuels and bio-based monomers, the cost for feedstock accounts
for highest part of the overall production cost, representing of more than 50 % of the total
cost (Noorman, 2015). Therefore, the use of cheaper and renewable substrates in the bio-
production process is the key factor to reduce the overall production cost.
In sum, the industrial bio-production of chemicals especially low value, bulk chemicals is
considerably influenced by the efficiency of production host, cheaper substrates, market
demand and fossil fuel price. This requires more efforts to improve production host’s yield,
titre and productivity, but also favors the use of cheaper, abundant and renewable
feedstock for the decrease of production cost.
3Figure 1–1 Production of aromatic compounds via shikimate pathway in microbes.
Red framed box indicates central metabolism and green framed box indicates shikimate
pathway. Compounds have industrial interest are highlighted in red colour. Dashed arrows
indicate multi-enzymatic synthesis. 2,3-CHD, S,S-2,3-dihydroxy-2,3-dihydrobenzoate; 3,4-
CHD S,S-3,4-dihydroxy-3,4-dihydrobenzoate. aroZ, 3-DHS dehydratase; aroY, PCA
decarboxylase; catA, catechol 1,2-dioxygenase; feaB, phenylacetaldehyde dehydrogenase;
tpl, Tyr phenol lyase from Pantoea agglomerans; tyrDC, tyramine decarboxylase gene
from Lactobacillus brevis; pdc, 4HCA decarboxylase from L. plantarum; tyrB, tyrosine
aminotransferase; hpaBC, an endogenous hydroxylase from E. coli; ldh, lactate
dehydrogenase from L. pentosus; pal, Phe-ammonia lyase/Tyr-ammonia lyase from
Rhodosporidium toruloides; kivD, phenylpyruvate decarboxylase tyrA, biofunctional
chorismate mutase/prephenate dehydrogenase; entB, isochorismatase; entC,
isochorismate synthase; melA, tyrosinase; fcs, p-coumaroyl-CoA synthetase; ech, p-
coumaroyl-CoA hydratase/lyase; vdh, p-hydroxybenzaldehyde dehydrogenase; ipl,
isochorismate pyruvate lyase; SMO, salicylate 1-monoxygenase; pheA, bifunctional
chorismate mutase/prephenate dehydratase; tal, tyrosine ammonia lyase; Coum3H, 4-
coumarate hydroxylase; ubiC, chorismate.
41.2.1 PHBA as preservative precursor and a building block for bio-based polymers
Para-hydroxybenzoate (PHBA) is commercially produced from petroleum-derived
materials, and primarily used to prepare preservatives in cosmetics, food and
pharmaceuticals. In recent years, there is an increasing interest in the production of bio-
based building blocks for the production of bioplastic and polymers, and PHBA is the key
monomer for the production of high value thermoplastics such as liquid crystal polymers
(LCP) (Dodds and Humphreys, 2013). Figure 1-2 shows the application of PHBA derived
products. LCPs have a number of applications, e.g. endoscopic surgical instruments,
electro-optical displays, barrier films and high stiffness and high strength fibers (Fink,
2014), and have raised the interest in the application of producing the next generation
connectors, antennas and flexible printed circuit boards due to the excellent moldability in
thin sections, outstanding chemical resistance and good heat resistance (Schottek, 2007).
The global LCP market strongly increased since 2003, mainly driven by telecommunication
market in China and India, with significant growth rates in electric and electronic industry
and automotive manufacture in the future (Schottek, 2007). Even though the production
capacity was a little higher than global consumption during the period of 2002 to 2006
(Schottek, 2007), there is still a keen interest in bio-production, not only because of high
demand for LCPs, but also due to the rising price of raw material and energy.
Figure 1–2 PHBA derived products: parabens and liquid crystal polymers
applications
51.2.2 The shikimate pathway and its expanded pathway
The shikimate pathway is the key pathway for the synthesis of the aromatic amino acids
(AAA) L-tryptophan (Trp), L-phenylalanine (Phe), and L-tyrosine (Tyr), quinones, folates,
secondary metabolites and derived compounds including many commercially valuable
compounds (Figure 1-1) (Curran et al., 2013; Gosset, 2009; Karpf and Trussardi, 2009;
Koma et al., 2012; Zhang and Stephanopoulos, 2013). The pathway links carbohydrate
metabolism to aromatic compound biosynthesis by converting phosphoenolpyruvate (PEP)
and D-erythrose 4-phosphate (E4P) from the central carbon metabolism into 3-Deoxy-D-
arabinoheptulosonate 7-phosphate (DAHP). After a sequence of seven reactions,
chorismate, a universal precursor for aromatic amino acids and other aromatic compounds,
is formed (Bentley, 1990). Chorismate is the initial metabolic branch point for the
biosynthesis of aromatic amino acids, further catabolized into various metabolites which
can serve as precursors for commercially interesting chemicals (Figure 1-1). The
production of PHBA has two major metabolic routes, one is the direct synthesis from
chorismate by the action of chorismate lyase UbiC; the other is through the coumarate
pathway converting tyrosine into PHBA via a multistep pathway (Figure 1-1). Under
aerobic conditions, the PHBA production via UbiC conversion shows a higher theoretical
yield, about 6.1 % higher in Escherichia coli and 18.4 % higher in Saccharomyces
cerevisiae compared to coumarate route (Kromer et al., 2013). In P. putida, the
coumarate pathway is one of the downstream branches in aromatic amino acid
biosynthesis pathway showed in Figure 1-1, therefore the PHBA production via stem
pathway (shikimate pathway, Ubic conversion) has a higher theoretical yield than that
using a branch pathway (coumarate pathway).
1.2.3 The regulation of Pseudomonas shikimate pathway
The regulation of the shikimate pathway is well known in E. coli, and the bacteria regulate
carbon flux toward amino acid biosynthesis at the transcriptional and posttranscriptional
levels. An overview of shikimate pathway and its regulation in P. putida is shown in Figure
1-3. The first enzyme DAHP synthase is the key regulatory point regulated by feedback
inhibition, which controls carbon flux into the shikimate pathway in response to
concentrations of the aromatic amino acids. E. coli has three types of DAHP synthase,
Tyr-sensitive encoded by aroF, Phe-sensitive encoded by aroG and Trp-sensitive encoded
by aroH, are subjected to feedback inhibition by Tyr, Phe and Trp, respectively (Bentley,
61990; Herrmann and Weaver, 1999). In E. coli, AroG contributes around total 80 % DAHP
synthase activity (Herrmann and Weaver, 1999); while in Pseudomonas, there are two
isoforms of DAHP synthase and the major isoenzyme (tyrosine-sensitive) comprises about
90% of overall activity (Ramos, 2004). In Pseudomonas aeruginosa, the feedback
inhibition is cumulative and concerted, for example, the aroF-like isoenzyme was also
inhibited by PPY, and the aroH-like DHAP synthase can be inhibited by chorismate as well
(Whitaker et al., 1982). In P. putida KT2440, KEGG (http://www.kegg.jp/kegg/) indicates
three putative isoforms of DAHP synthase (AroF-1, AroF-2 and PP_1866), but enzyme
characteristics are not fully known yet (Figure 1-4). Additionally, E. coli AroF and AroG are
transcriptionally repressed by TyrR regulon in the presence of tyrosine or phenylalanine
(Brown and Somerville, 1971), while the repression of aroH is mediated by TrpR repressor
in the presence of tryptophan (Muday et al., 1991). P. putida global regulator PhhR can
repress AroF-2 DAHP synthase and shikimate dehydrogenase (PP_2608) and it can also
activate genes for Phe and Tyr degradation in Pseudomonas and support the cell growth
using the Phe or Tyr as the sole carbon source (Herrera et al., 2010). In addition,
anthranilate synthase and chorismate mutase compete for chorsimate as a substrate,
regulating the flux to Trp and Phe/Tyr. Both enzymes are inhibited by the end product, Trp
or Phe in P. aeruginosa (Calhoun et al., 1973; Queener and Gunsalus, 1970).
7Figure 1–3 Overview of shikimate pathway regulation in Pseudomonas putida. Blue
dash lines indicate the repression by the global regulator PhhR; red arrows indicate the
activation; black dash lines indicate feedback inhibition.
1.3 Pseudomonas putida as an industrial production host for aromatics and the
derived chemicals production
The selection of a suitable microbial host for an industrial production process mainly
depends on the strain’s potential for the efficient production of interesting targets (Rumbold
et al., 2009). A suitable production host could strongly affect the yield, titre and productivity.
Pseudomonas putida is a gram-negative, flagellated, obligate aerobic bacterium. Its
physiological and metabolic robustness highlights its advantages in biotechnology and
environmental applications (Fernández et al., 2012b; Verhoef et al., 2009; Wierckx et al.,
2005; Wittgens et al., 2011), and also provokes an increasing interest in developing
electrochemical production processes (Hintermayer et al., 2016; Lai et al., 2016; Schmitz
8et al., 2015). Recently, Pseudomonas putida was recommended as the next generation
synthetic biology chassis (Adams, 2016). P. putida has versatile metabolism for the
generation of various metabolites that can serve as building blocks for the production of a
wide range of compounds including many high value natural products (e.g. rhamnolipids,
terpenoids, polyketides, non-ribosomal peptides and other amino acid-derived compounds)
(Loeschcke and Thies, 2015). Due to the remarkable tolerance, Pseudomonas putida
strains have been used to produce very toxic chemicals such as phenol (Wierckx et al.,
2005) and styrene (Verhoef et al., 2009) to a higher titre without provoking the harmful
effect. Many aromatics and its derived compounds can cause toxicity to cells leading to
growth inhibition, and some of them even can be used as preservatives (e.g. PHBA) and
disinfectants (e.g. phenol). The aim to produce these chemicals in a high titre could
exacerbate inhibition and toxicity effects to the production cells. Therefore, P. putida have
a particular advantage in the bio-production of aromatics and the derived compounds.
As discussed in the section 1.2, since the cost for feedstock is the major part of the overall
production cost for the bio-based chemicals production, the use of the cheaper, abundant
and renewable feedstocks, especially from agricultural industry waste and by-products
from industrial production processes, are highly recommended. The non-food feedstocks
include lignocellulosic lysates of straw (Wi et al., 2015), bagasse (Pereira et al., 2015) or
by-products from industrial manufacturing processes such as crude glycerol (by-product of
biodiesel industry), etc. However, these feedstocks generally contain many substances
that could cause growth inhibition or toxicity to production cells (Nguyen et al., 2013;
Palmqvist and Hahn-Hägerdal, 2000a; Palmqvist and Hahn-Hägerdal, 2000b). This
requires a production host that can still efficiently perform production tasks in such harsh
conditions. Although there are several means to counteract this problem, for examples,
strain engineering for a better tolerance (Chen et al., 2013; Chin et al., 2013; Mingardon et
al., 2015; Mukhopadhyay), the optimization of fermentation (Warnecke and Gill, 2005) and
feedstock pre-treatment (e.g. detoxification) (Cavka and Jönsson, 2013; Jönsson and
Martín, 2016). Pseudomonas putida strains are less affected by the inhibition or toxicity
effects from substrates like lignocellulosic hydrolysates (Lopez et al., 2004; Meijnen et al.,
2011a) even growing better using crude glycerol as a carbon source, which caused toxicity
to E. coli (Verhoef et al., 2014). Additionally, solvent-tolerant strains can be used in two-
phase fermentation systems to prevent accumulation of products to inhibitory level
(Meijnen et al., 2011a). The use of cheaper and renewable feedstock allows economically
9feasible production processes for bulk chemicals, and thereby P. putida species are
suitable for industrial production of bulk chemicals.
P. putida KT2440 utilizes a variant version of the ED pathway for glycolysis (Figure 1-4),
and slightly overproduces NADPH from glucose catabolism (Nikel et al., 2015a). The
important role of NADPH is not only to prevent oxidative stress, but also to drive the most
of biosynthetic enzymatic reactions including the synthesis of important cell components
such as DNA and lipids (Spaans et al., 2015). The efficient supply of NADPH reducing
power is a limiting factor in NADPH-dependent biosynthesis pathways, while the increase
of NADPH availability has been shown to improve the yield and titre for the target products
(Chemler et al., 2010; Ng et al., 2015; Qiao et al., 2017). In shikimate pathway, the
reduction of 3-dehydroshikimate (3-DHS) to produce shikimate (SHIK) by the enzyme
shikimate dehydrogenase needs the reducing power NADPH (Figure 1-3), suggesting the
biosynthesis of many shikimate pathway derived compounds could be limited by
insufficient supply. The slight overproduction of NADPH by P. putida could offer cofactor
NADPH for the production pathway, suggesting this feature can benefit the production
strain for the biosynthesis of aromatics and the derived compounds. Generally, cells can
gain two ATP and two NADH if one molecule of glucose is metabolized via Embden-
Meyerhof-Parnas Pathway (EMP pathway), but only gain one ATP, one NADH and one
NADPH for each glucose molecule that is metabolized via Entner–Doudoroff pathway (ED
pathway) (Figure 1-4) (Singh et al., 2016a). Although P. putida cells gain less ATP but
more NADPH from the variant version of ED pathway, the glycolytic strategy can be
explained by the trade-off between energy yield and protein cost (Flamholz et al., 2013).
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Figure 1–4 Glucose metabolism by P. putida KT2440. Pathways are indicated with
different colors shown in the figure. Bold lines suggest over 50% of flux go through the
pathways based on carbon flux analysis (Nikel et al., 2015a). Pseudomonas putida lacks
the enzyme of 6-phosphofructokinase in the EMP pathway (indicated *Pfk), and almost
exclusively uses ED pathway for glycolysis.
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P. putida has additional features which are also beneficial for industrial bio-production
processes. It can grow fast with a simple nutrient requirement and only forms a few by-
products that can simplify the downstream processes and reduced the drain of precursors
towards by-product biosynthesis. The genome-scale metabolic network (e.g. KEGG,
http://www.kegg.jp/kegg/; MicroCyc, http://www.genoscope.cns.fr/agc/microcyc) (Belda et
al., 2016; Nelson et al., 2002), and as well as the genetic information (e.g. Pseudomonas
genome database, http://pseudomonas.com/) and metabolic engineering tools are
available for P. putida (Martínez-García et al., 2014; Martínez-García et al., 2011;
Martinez-Garcia and de Lorenzo, 2011; Silva-Rocha et al., 2013), thereby P. putida strain
development for industrial applications should be achievable, and facilitated by more
convenient and advanced tools and techniques in the near future. Numerous genetic tools
and well-established gene expression systems are available for the model microorganism
E. coli, but are much less for P. putida (Table 1-1). Many commercial expression vectors
with different N- and C-terminal tags were developed to meet different application
purposes. Several groups have developed broad-host vectors for P. putida, such as SEVA
plasmids (Silva-Rocha et al., 2013). These plasmids can be further modified for special
application purposes. Note that there are some differences in carbon catabolism
repression (CCR) between E. coli and P. putida (Deutscher, 2008; Rojo, 2010). For
example, when some well-studied expression systems from E. coli such as lac
promoter/regulation system (Plac, Ptrc and Ptac) are employed in P. putida, a higher basal
expression can be observed in P. putida than that in E. coli (Table 1-1).
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Table 1-1 Some common used metabolic engineering tools for Pseudomonas.
Genetic manipulation
tools
References comments
Genome editions (Gene knock-in/ knock-out)
pEMG/pSW-2 (Martinez-Garcia
and de Lorenzo,
2011)
Markerless and scarless; two steps
recombination.
pBAM1 (Martínez-García et
al., 2011)
Tn5-based mini-transposon vector.
Upp-based
counterselective method
(Graf and
Altenbuchner,
2011)
Markerless and scarless; two steps
recombination; convenient selection
λ red recombineering
and Cre/loxP site-
specific recombination
(Luo et al., 2016) The left scars may lead to chromosomal
deletions or inversions.
Inducible promoter systems (corresponding inducer)
Ptac, Ptrc, Plac /lacIq
(IPTG)
(Bagdasarian et al.,
1983; Baumberg et
al., 1980; Silva-
Rocha et al., 2013)
Negative regulation; very high basal
expression (higher than E. coli), Ptac, Ptrc
are medium higher promoters, Plac is
weak promoter.
Pm/XylS (m-toluate) (Herrero et al.,
1993)
Positive regulation; low basal expression
but very narrow induction range (Zwick et
al., 2013); Pm mutant (Bakke et al., 2009)
and XylS mutant (Vee Aune et al., 2010)
can significantly improve stimulation of
expression under induced condition.
PalkB/AlkS (short-chain
alkanes)
(Panke et al., 1999) Carbon-source dependent promoter
(Yuste et al., 1998);
rhaPBAD/rhaSR
(Rhamnose)
(Jeske and
Altenbuchner,
2010)
Positive regulation; very low basal
expression and broader inducible range in
Pseudomonas (Meisner and Goldberg,
2016)
ParaBAD/araC (Meisner and
Goldberg, 2016)
High basal expression in Pseudomonas
than in E. coli.
PT7 (IPTG via Plac)
PT7(m-toluate via
Pm/XylS)
(Herrero et al.,
1993; Troeschel et
al., 2012)
Gene encoding T7 RNA polymerase
needs to introduce into the genome
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1.4 Bio-electrochemical production
As discussed in the above section, Pseudomonas putida has a number of advantages as
an industrial production host, however, this obligate aerobic bacteria also encounter some
common aerobic fermentation issues when it comes to industrial-scale production. Due to
the low solubility of oxygen in aqueous media, the insufficient dissolved oxygen become
problematic for the large-scale aerobic fermentation. The insufficient supply of dissolved
oxygen has been showed adverse influences in cell growth, metabolism and product yield
(Liu et al., 2006; Utagawa, 2004; Yamane et al., 1997). Therefore, a considerable amount
of efforts have been made to provide adequate oxygen during the fermentation, including
optimization of the feeding strategy (Salehmin et al., 2013), using oxygen-enriched air,
using perfluorocarbon oxygen carrier (Rols et al., 1990), etc. However, these efforts do not
fully satisfy the industrial demands as they involve complicated and toilsome work for
optimization of specific microbes to produce specific product; using oxygen-enriched air
may cause oxidative stress to cell that would lead to impaired cell growth and the
decrease productivity (Baez and Shiloach, 2014); the perfluorocarbon emulsion is
relatively expensive limited its application in large scale production (Pilarek et al., 2011).
For a highly aerobic fermentation system, more investment is needed in large scale
production to install the expensive equipment and additional utility (e.g. equipment for
aeration and agitation) for providing sufficient dissolved oxygen during fermentation
(Noorman, 2015). Biomass production accounts for a substantial percentage of substrate
consumption in aerobic conditions. Take succinate production as an example. E. coli has
high biomass yield and high growth rates, but achieve a maximal theoretical succinate acid
yield of 1 molproduct molgluose-1, which is lower than the 1.71 molproduct molgluose-1 reached
under anaerobic conditions (Smolke, 2010). It was reported that the engineered E. coli has
almost reached 100% of the theoretical carbon yield under anaerobic conditions (Jantama
et al., 2008). Regarding to the slow production process under anaerobic conditions , two-
phase fermentation strategy was applied to for facultative production host E. coli,
specifically, aerobically growing the production host and anaerobically producing succinate
to achieve higher carbon yield and speed up fermentation (Jiang et al., 2010; Thakker et
al., 2012). Additionally, aerobic production processes have an inevitable substrate lost in
the form of CO2 produced during respiration. To broaden the application for the obligate
aerobe P. putida, the metabolic regime was engineered for the re-balance the redox and
resulted in a strain that can perform a sustainable degradation in anaerobic condition
though cell death was not completely stopped (Nikel and de Lorenzo, 2013). The
This section incorporates the review paper submitted in Metab.Eng (under revision)
14
technique of microbial electrosynthesis is suggested as a new means to balance the redox
via a bio-electrochemical system (Harnisch et al., 2015; Rabaey and Rozendal, 2010). The
following sections will introduce this technique and its potential application.
1.4.1 A brief introduction of the MES technology
Microbial electrosynthesis (MES) refers to the chemical compound synthesis driven by
electricity in a bio-electrochemical system (BES, Figure 1-5), which consists of an anode, a
cathode and an ion membrane separating the electrodes. Electroactive microorganism can
gain electrons from cathodes for reductive production processes, and microbes may also
benefit from anodic oxidation reactions to achieve redox balance during the fermentation
via discharge of excessive electrons (Pandit, 2012; Rosenbaum and Henrich, 2014).
Another advantage of the MES technique is that electrons (electricity) can be generated
from renewable sources such as wind, wave and solar, and this potentially become an
alternative solution to the issues of energy storage and transportation (Rabaey et al.,
2011). There are two ways for electron transfer between microbes and electrode, direct
electron transfer and mediated electron transfer. The natural electroactive microbes such
as Geobacter sulfurreducens and Shewanella oneidensis can directly transfer electrons to
extracellular electrode surface via the conductive pili or the so-called nanowires (Gorby et
al., 2006; Reguera et al., 2005). Microbes like P. aeruginosa can use self-synthesized
electron shuttle (e.g. pyocyanin) to support electrochemical activity (Rabaey et al., 2004),
but Shewanella also can secrete endogenous as the mediator for extracellular electron
transfer (Marsili et al., 2008). While the microbes like P. putida KT2440 do not possess the
ability for electrochemical activities. But these strain was able to use some artificial redox
mediators such as ferricyanide to perform anoxic metabolism in anodic chamber (Lai et al.,
2016). Endogenous mediators like phenzine from P. aeruginosa can mediate the electron
transfer to the anode (Venkataraman et al., 2010). Expression of phenzine biosynthesis
genes in P. putida KT2440 enables the electro-activity in this bacterium (Schmitz et al.,
2015). These cases suggest that the non-electrochemically active microbes like P. putida
KT2440 can become electroactive if the bacteria could be assisted with mediated electron
transfer either by adding the artificial redox chemicals or engineering the strains to
synthesized redox mediators. Another interesting case study is that E. coli was
implemented with a portion of the extracellular electron transfer chain (MtrCAB) from S.
oneidensis MR-1, and the engineered strain showed reduction of metal ions and solid
metal oxides several folds higher than the parental strain (Jensen et al., 2010). This hints
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that a well-studied production host like E. coli can be implemented with heterologous
electron transfer chain to support electrochemical production in BES system.
By reviewing most of the reported microbial electrosynthesis case studies, low substrate
conversion rate and/or low productivity are the common issues during electrochemical
production processes which limits industrial applications. The best performance of using
electrons to reduce carbon dioxide to produce acetate by Sporomusa ovata in cathode
achieved 85% electron recovery in the main product of acetate that accounted for around
95% in total products (Nevin et al., 2010). But productivity of 0.75 mmol acetate/L/day is
rather low, rendering this long electrochemical process lose its cost-effectiveness in the
practical application. More recently, mediated electrochemical production by P. putida was
reported to achieve around 90% carbon yield to sugar acid 2-ketogluconate, but the
productivity was around 2.27 mmolproduct/gCDW /day (the calculation based on the
assumption of no biomass formation formed during the electrochemical production process,
and biomass amount used the initial inoculum biomass) (Lai et al., 2016). Similar low
productivity was observed in PHBA production in anodic batch production by P. putida
KT2440 (Hintermayer et al., 2016). These case studies suggests the low productivity
needs to significantly improve, which requires the significant improvement of electron
transfer rate in the bio-electrochemical system. For the past decades, the improvement of
bio-electrochemical production mainly focused on electrode design (Liu et al., 2004; Park
and Zeikus, 2003; Zoski Cynthia, 2007), surface and material modification (Cornejo et al.,
2015; Rice and McCreery, 1989). There are limited number case studies in the
engineering the electron transport chain (ETC) for the improvement of electron transfer
rate. These are mainly limited by the little scientific knowledge of extracellular electron
transport chain and interaction between redox mediators and the respiratory chain.
Engineering ETC confronts more technical difficulties than pathway engineering, and will
be discussed in the section.
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Figure 1–5 Schematic view of bio-electrochemical system. This BES system shows
two typical electron transfer patterns, one is direct electron transfer between microbes and
electrodes, another is mediated by electron shuttles.
1.4.2 Strain engineering strategies and challenges for biochemical production in
BES
An ideal electroactive biocatalyst, is expected to be able to efficiently utilize electrons to
produce the product of interest via robust biochemical pathways. Due to the current limited
knowledge of electron transfer mechanism, the establishment of BES biocatalysts
confronts plenty of challenges and hurdles which will be discussed in the metabolic
engineering aspect, and the possible solution will be discussed in this section as well.
There are two strategies to enable a non-electroactive microbe become electroactive. The
non-electroactive microbes can implement the well-studied electron transport chain from
the natural electroactive microbes such as S. oneidensis and G. sulfurreducens into the
non-electroactive microbes. This first strategy reconstitutes a direct extracellular electron
transfer chain in the non-electroactive microbes. The second strategy is enabling the
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mediated electron transfer in non-electroactive microbes. This can be achieved by adding
artificial redox chemicals or engineering strain to self-produce redox mediators as section
1.4.1 discussed. Currently, there are no report about engineering heterologous electron
transport chain (ETC) in Pseudomonas, but have several reports enabling the mediated
electron transfer in P. putida. For an electroactive microbes such as S. oneidensis and G.
sulfurreducens, the current interest is that engineering production pathway to produce
other value-added chemicals, though a faster electron transfer rate is desired. This is the
third strategy for the establishment of BES biocatalysts.
It is interesting and meaningful to enable electrochemical production by implementing the
well-studied electron transport chain from electroactive microbes into a number of
industrial production hosts that already have an established production pathway.
Engineering electron transport chain, which mainly involves the key components in the
ETC which comprises the respiratory chain, the extracellular electron transport pathway
including electrically conductive nanowires (Gorby et al., 2006; Holmes et al., 2016;
Pirbadian et al., 2014), and the components involved in periplasmic electron transfer such
as electron shuttles (Marsili et al., 2008; Newman and Kolter, 2000; Pham et al., 2008).
The mediated electron transport chain engineering does not involve the extracellular
electron transport pathway. But it includes the components interacted with redox mediators
and respiratory chain. To establish BES biocatalysts, strain adaptation should include the
following considerations for this specific purpose.
The first key step of metabolic engineering for strain development is identifying the minimal
set of genes and the adjustment of appropriate protein expression levels that are needed
for minimization of toxicity to the host on one hand and maximization of spatially-delimited
membranous environment on the other hand. If the key components of ETC were to be
correctly assembled and located in the specific location, they would forming a complete
ETC, which can then be expected to endow electro-activity in the new host. From literature,
many ETC gene targets have been effectively obtained from comparative ‘omics
technologies such as genomics, transcriptomics and proteomics (Beliaev et al., 2002a;
Beliaev et al., 2002b; Holmes et al., 2006; Wessels et al., 2016), further demonstrated by
mutagenesis (or gene dele tion) and overexpression complementation experiments
(Bretschger et al., 2008; Jin et al., 2013), and finally characterized specific function during
electron transfer via genetics and biochemistry analysis (Yuan et al., 2011), X-ray
crystallography (structure)(Malvankar et al., 2015), NMR spectroscopy (internal motions
and interactions, thermodynamic characterization) (Dantas et al., 2015). Electron transfer
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chain design could start from the selection of key ETC proteins including extracellular
electron transfer chain (involving electron transfer with the electrode), ‘linker proteins’
supporting the ETC event in periplasm, and proteins involved in the respiratory chain. The
first ETC design was tested in E. coli with the installed MtrCAB pathway (the partial of
extracellular electron transfer chain from S. oneidensis) , enabling the reduction Fe2+ and
solid Fe2O3 but without actual electro-activity in E. coli cells (Jensen et al., 2010). Further,
modified ETC design implemented with cytochrome c complex (CymA) and introduced
exogenous flavins, resulted in fast electron transfer rate and viable cells (Jensen et al.,
2016). This complete ETC design connects the quinone pool in the inner membrane via
CymA and exogenous flavins, then electrons can transfer across the periplasm through
the transmembrane pathway (MtrCAB) to outer membrane, which allows the electron
transfer from the inner membrane to the extracellular acceptors resulted in an enhanced
electron transport rate and even cell growth. This successful example also highlights the
importance of the connection of extracellular and intracellular electron transfer.
The considerations of minimal set of ETC, is not only intended to reduce workload, but
also spatially restricted by membranous environment. Membrane protein expression often
cause toxicity to cells, but the reasons are various and not fully understood now
(Grisshammer, 2006; Gubellini et al., 2011; Kwon et al., 2015; Opekarová and Tanner,
2003; Wagner et al., 2007). The attempts at overexpression of membrane proteins may
overwhelm the cell capacity, and result in misfolded and incorrect assembly (Geertsma et
al., 2008) and the saturation of cytoplasmic membrane protein translocation machinery
(Wagner et al., 2007), subsequently leading to protein aggregates and premature
degradation. Therefore controlling membrane protein expression strength is likely to be an
effective strategy for maintaining the well-being of the biocatalysts. This is can be achieved
by, for example, using tight regulation promoter/regulation system and optimizing
cultivation conditions (such as temperature and inducer concentrations and induction time,
etc.). A general consideration for all gene cloning and heterologous expression usually
includes gene codon usage preference, GC content, mRNA stability and regulatory motifs,
chaperone-assisted protein folding, protein stability etc., and details can be referred to
literature (Frommer and Ninnemann, 1995; Zerbs et al., 2009). Membrane proteins
expression encounters more challenges and difficulty. For the purpose of obtaining
membrane proteins, toxicity problem can be reduced by choosing an appropriate host,
using cell-free system or using membrane protein variants (Bernaudat et al., 2011;
19
Schlegel et al., 2010). While for the proteins involved in electron transfer, the mentioned
general methods for membrane proteins expression are not all suitable here.
Next consideration comes to membrane protein folding and assembly, as proteins must
form a correct and stable conformation or multiple subunits assembly as protein
complexes to maintain the structure and function. On the other hand, proteins folding and
assembly always incurs proteins secretion and localization issues. Some synthesized
proteins (or peptides) are required to localize in a specific region to fulfil their structural or
functional mission after being produced from the protein production machine in the cytosol.
The electron transport protein cytochrome c is a good example to explain this. The
apocytochrome polypeptide and the cofactor heme are separately translocated to
periplasm after the synthesis in the cytosol, and the apoprotein covalently bound to the
cofactor heme to form a mature cytochrome c which the delivery and attachment of
cofactor assisted with the cytochrome c maturation (ccm) systems (Thony-Meyer, 2002).
The system type I is one of three cytochrome c maturation system found in α and γ-
proteobacteria, different bacteria have some differences in the components and
organization of gene cluster (Stevens et al., 2011; Thöny-Meyer, 2002). Shewanella may
have up to 44 c-type cytochromes, and ccm maturation needs additional SO0265 that is
not found in E. coli, and the absence of it resulted in around 65% decrease of heme c yield
(Jin et al., 2013). The E. coli ccm genes (ccmABCDEFGH) have been constructed in a
plasmid (pEC86) for the maturation of heterologous c-type cytochrome in E. coli (Arslan et
al., 1998), the co-expression of MtrA (complex cytochromes) and E. coli ccm genes can
lead to a correctly located and assembled holoprotein in E. coli (Pitts et al., 2003). Many
electron transport proteins require correctly folding and assembly, which are associated
with redox cofactors (e.g. heme, FAD, NAD+, Fe-S clusters, etc.), to reach functional state
(Buckel and Thauer, 2013; Couch et al., 2009; Leys et al., 1999; Wang et al., 2013). The
folding, assembly and localization of the ETC membrane proteins are very complicated,
involving lots of cofactors, chaperones and protein maturation machineries to assist these
processes, and have been reviewed elsewhere (Akhtar and Jones, 2014; Bukau et al.,
2006; Dalbey et al., 2011; Danese and Silhavy, 1998; Green and Mecsas, 2016; Thöny-
Meyer, 1997; Tommassen, 2010). The emphasis of these issues here is to remind the
reader that engineering electron transport proteins may also include the engineering of
corresponding cofactor, chaperones co-expression, and introducing the protein maturation
systems in the host. The major hurdle here is the limited knowledge of electron transfer
chain, especially the electron uptake from a cathode, even for intensively studied exo-
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electrogenic bacteria S. oneidensis and G. sulfurreducens. To date, there is no report of
engineered organism for a cathode reduction process due to the unclear mechanism of
cathodic extracellular electron transfer. Engineering electron transport chain confronts
plenty of challenges and hurdles currently, but the exploration and the progress of
fundamental understanding of ETC would facilitate the strain development.
Given the limited knowledge of electron transfer, adaptation of established or novel
biocatalytic pathways into an electroactive microbes like S. oneidensis and G.
sulfurreducens seems to be easier than the actual manipulation of ETC in non-
electroactive organisms that have a well-established production pathway. The transfer of
heterologous pathway into a new host has been demonstrated in many studies, providing
rich experiences for the establishment of production pathways in electroactive microbe.
But this requires that genetic tools are accessible for electroactive microbes. Currently, the
genetic information and metabolic engineering tools for some well-studied electroactive
microbes like Geobacter and Shewanella are available, but for other bacteria like
Clostridium spp. and Acetogenic microbes, strain development is greatly restricted by the
limited toolbox (Sydow et al., 2014).The considerations here are mainly for various
adaptation including a general heterologous expression issues (e.g. GC content and
codon preference), but the in-depth metabolic engineering should also include elimination
of competing pathway and degradation pathway, minimization by-product formation, fine-
tuning pathway enzyme expression level (modular optimization), pathway bottleneck
identification and removal, cofactor engineering for balancing redox or increasing
availability, transporter engineering for substrate import or product export, etc. For
example, the metabolically engineered S. oneidensis MR-1 produced up to 19.3 mg/L iso-
butanol within 100 h after directly driven by electron supply system (Jeon et al., 2015).
Although the improved productivity is still low for industrial application, this successful
example encourages more efforts to engineer well-studied electroactive bacteria like S.
oneidensis MR-1 to produce value-added chemicals and biofuels.
Apart from the above mentioned strategies to create BES biocatalyst, there is an
increasing interest in the establishment of mediated electrochemical production in P.
putida strains. P. putida KT2440 was capable to produce current in anodic chamber after
implementing phenazine biosynthesis pathway from P. aeruginosa (Schmitz et al., 2015);
P. putida F1 was able to utilize ferricyanide as mediator and the anode as electron sink for
glucose oxidation to produce sugar acids (Lai et al., 2016); more recently, ferricyanide-
mediated P. putida KT2440 can produce small amount of para-hydroxybenzoate
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(Hintermayer et al., 2016), a shikimate pathway derived chemical, showing this strategy
can be potentially produce various of value-added chemicals rather than glucose oxidated
products in periplasm or current and biomass. Integration of advantage from BES and
Pseudomonas spp. would be an interesting exploration, but the unknown interaction
between redox and electron transfer proteins is major hurdle in this strategy development.
The major considerations are improvement of electron transfer rate, mediator
transportation, redox balance, the recycling of mediators and isolation from target product.
1.5 Thesis objectives and organization
Previous studies showed the limitations of E.coli as a PHBA production host. For example,
the product toxicity showed inhibitory effects on cell growth. A considerable amount of by-
products was observed in E. coli cells. P. putida strains have showed their promising
potential in biotechnology applications. But large-scale fermentation for this obligate
aerobe will be problematic due to the insufficient oxygen supply. Studies of microbial
electrosynthesis in our group showed great potential to produce chemicals via this
technique. Considering this, the developed strains will be explored the electrochemical
production under anaerobic condition. The work presented here has three objectives:
The first objective is the development of platform strains for the production of shikimate
pathway derived compounds, particularly the production of para-hydroxybenzoate (PHBA).
Chapter 2 describes the establishment of a platform strain featuring enhanced flux from
central metabolism and blocked aromatic amino acid synthesis branches. Genes encodes
competing pathway and product degradation pathway were deleted from the genome to
avoid precursor drain from the production pathway. In particular, the glucose metabolism
repressor HexR was deleted and a feedback resistant of AroGD146N was introduced as well
in order to enhance flux from central metabolism to the shikimate pathway. This study
helps to better understand shikimate pathway in P. putida, and developed PHBA
production strains that can be further used in the exploration of biochemical production in
bio-electrochemical system.
The second objective is enhancing the electron transfer rate for the improvement of
productivity in the bio-electrochemical system. The obligate aerobe P. putida KT2440 was
firstly tested its anoxic metabolism in bio-electrochemical system but it showed extremely
low productivity due to the low electron transfer rate. The metabolic engineering targets
were identified and overexpressed in the P. putida KT2440 in order to improve the electron
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transfer rate. The effects of overexpression of two membrane-bound dehydrogenases
were investigated for electrochemical production. The discovered intrinsic regulation
between these two dehydrogenases suggested an optimization strategy for the improved
electrochemical production. Details and outcome are showed in chapter 3.
The third objective is investigating the effects of aerobic growth conditions on
electrochemical production under anaerobic production process by mutant strain that
overexpressed two membrane-bound dehydrogenases. Cells grew on glycerol based
medium showed a better performance in electrochemical production than that in glucose
based medium under aerobic cell growth. This is suggested a strategy to improve the
electrochemical performance. Proteomics was employed to investigate the possible
contributors for the better performance in electrochemical production, and also suggested
the enzyme complex maturation was limited by one of its subunit (chapter 4).
The last chapter summarized the thesis conclusions, and discussed the perspectives that
could guide future research efforts.
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Chapter 2 Metabolic engineering P. putida KT2440 to produce para-
Hydroxybenzoate
In this chapter, several PHBA production strains were developed as the PHBA platform
strains and evaluate their performance in shake flask and fed-batch fermentation. The
constructed strains will later be used in the exploration of electrochemical production. The
electrochemical production will be discussed in the next two chapters.
2.1 Abstract
para-Hydroxy benzoate (PHBA) is the key component for preparing parabens, a common
preservatives in food, drugs and personal care products, as well as high performance
bioplastics such as liquid crystal polymers (LCP). Pseudomonas putida KT2440 was
engineered to produce PHBA from glucose via the shikimate pathway intermediate
chorismate. To obtain the PHBA production strain, chorismate lyase UbiC from
Escherichia coli and a feedback resistant 3-deoxy-D-arabino-heptulosonate-7-phosphate
synthase encoded by gene aroGD146N were overexpressed individually and simultaneously.
In addition, genes related to product degradation (pobA) or competing for the precursor
chorismate (pheA and trpE) were deleted from the genome. To further improve PHBA
production, the glucose metabolism repressor hexR was knocked out in order to increase
erythrose-4- phosphate and NADPH supply. The best strain achieved a maximum titre of
1.73 g L-1 and a carbon yield of 18.1 % (C-mol C-mol-1) in a non-optimized fed-batch
fermentation. This is to date the highest PHBA concentration produced by P. putida using
a chorismate lyase.
2.2 Introduction
The aromatic hydroxy acid, PHBA is commonly used in the chemical industry. It is a key
component in the manufacturing of liquid crystal polymers (LCP) with high-value
applications in the thermoplastics market (Ibeh, 2011). PHBA is widely used to prepare
paraben preservatives in the cosmetics, food and pharmaceutical industries. Current
production of PHBA is based on petroleum derived chemicals through the Kolbe-Schmitt
reaction. However the reaction’s requirements for high-temperature / high-pressure
conditions, along with the problem of by-product formation (Yoshida and Nagasawa, 2007)
This chapter incorporates the paper published in Front Bioeng Biotechnol in 2016
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make the production of this aromatic compound relatively expensive. The volatility of raw
material prices and decreasing availability in the future, together with environmental
concerns are driving the development of a renewable and sustainable process for PHBA
production (Erickson et al., 2012; Gavrilescu, 2014).
Microbial production of PHBA has been studied in engineered strains of E. coli (Barker and
Frost, 2001), Klebsiella pneumonia (Müller et al., 1995), S. cerevisiae and P. putida S12.
Barker and colleagues further engineered mutant E. coli (deficient in AAA synthesis) by
inserting extra copies of genes from shikimate pathway aroA, aroL and aroB as well as
overexpressed ubiC, tktA and the feedback-insensitive aroF, achieved a titer of 12 g L-1
and a C-mol yield of 13%. Further increase of the yield was unattainable due to the toxic
effect this concentration of PHBA has on E. coli. Additionally, a significant by-product
formation was observed in the fermentation and the introduction of many unbalanced
genes may lead to metabolic burdens resulting in an undesired fermentation performance.
Pseudomonas putida is well-known for its versatile metabolism, fast growth rate with
simple nutrient requirement, high robustness against harsh environmental conditions and
low cellular maintenance demand. Moreover, P. putida has a natural high resistance to
PHBA. Few or no by-product formation such as acetate, glycerol or ethanol which are
frequently observed in industrial production host E. coli, Bacillus subtilis (B. subtilis), and S.
cerevisiae (Ebert et al., 2011; Poblete-Castro et al., 2012). Furthermore, P. putida almost
exclusively use Entner–Doudoroff pathway (ED pathway) enabling it to generate more
NADPH which is important for maximization of product titre. Shikimate pathway derived
chemicals will benefit from higher NADPH regeneration rate as the conversion of 3-
dehydroshikimate to shikimate needs NADPH as the cofactor. All these features not only
endow it as a flexible cell factory for bulk chemicals production, but also highlight this
strain as a promising workhorse for toxic chemicals production. A number of examples
demonstrated its great potential in the production of a wide range chemicals, especially
toxic aromatics such as phenol (Wierckx et al., 2005), PHBA (Verhoef et al., 2007), 4-
hydroxy styrene (Verhoef et al., 2009), 3-nitrocatechol (Prakash et al., 2010) and 4-
hydroxy quinaldine (Ütkür et al., 2011). But it is also a suitable host for the production of
more traditional bio-products such as poly-hydroxy alkanoates (Le Meur et al., 2012).
Further discussion about the selection of production host for aromatics and the derived
chemicals can be referred to section 1.3.
Metabolic engineering of P. putida for the production of PHBA was first described in strain
S12palB1, this strain was able to produce a maximum titre of 12.9 mM PHBA with a C-mol
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yield of 8.5 % on glycerol in a carbon-limited fed-batch fermentation (Verhoef et al., 2007).
Yields were further increased by a mixed-substrate feeding strategy (Meijnen et al., 2011b).
This PHBA production strain was metabolically engineered based on the coumarate
pathway (tyrosine degradation, Figure 1-1, which has a lower theoretical carbon yield than
production of PHBA using the chorismate lyase (UbiC). In addition, further improvement of
this strain was difficult as the platform strain was based on random nitrosoguanidine (NTG)
mutagenesis, and the unknown genetic basis limits strain improvement.
In this chapter, I present the production of PHBA from glucose using the more efficient
chorismate lyase route in Pseudomonas putida KT2440 using rational engineering.
Increased PHBA production was achieved through genetic deletion of PHBA degrading
pathways as well as pathways competing for chorismate. In addition to overexpression of
ubiC, a feedback-resistant DAHP synthase encoded by (aroGD146N) was also
overexpressed. Finally we explored the effect of deletion of the gene encoding for glucose
metabolism repressor hexR and its effect on PHBA production.
2.3 Materials and Methods
2.3.1 Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are listed in Table 2-1. P. putida KT2440
(DSMZ 6125) was used as production host, and E. coli XL10-Gold (Agilent Technologies
Inc.) was used to prepare all plasmids except the R6K plasmids which were prepared in E.
coli DH5α λpir (Martinez-Garcia and de Lorenzo, 2011).
2.3.2 Chemicals and reagents
All chemicals are of analytical purity, purchased from Sigma-Aldrich (Australia) or Chem-
Supply (Australia). Yeast extracts and tryptone were purchased from Merck and Oxoid
(Australia). Restriction enzymes, T4 ligase, DNA polymerase were purchased from New
England Biolabs (Australia) and were used according to the supplier’s recommendation.
Plasmid isolations or DNA fragment purifications were done using GeneJET kits for
Plasmid Miniprep, Gel Extraction or the PCR Purification (Thermo Fisher Scientific
Australia Pty. Ltd.).
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2.3.3 Media
Lysogeny broth (LB) consisted of 10 g L-1 tryptone, 5 g L-1 yeast extract and 5 g L-1 sodium
chloride (Lennox, 1955) and was used to culture E. coli and P. putida strains. Antibiotics of
the final concentration of 50 μg mL-1 kanamycin or 50 μg mL-1 gentamycin were added into
medium when it was needed. To make solid plates, 1.5 to 1.7 % (w/v) agar was added into
the medium.
Fully chemically defined media were used in shake flask and bioreactor experiments with
the following composition: Chemically defined medium (CDM) for flask cultivation
contained per liter: 6 g Na2HPO4, 3 g KH2PO4, 2 g NH4Cl and 0.2 g MgSO4·7H2O and 15
mg CaCl2·2H2O, and 1 mL trace element solution (1.5 g L-1 FeCl3·6H2O, 0.15 g L-1 H3BO3,
0.03 g L-1 CuSO4·5H2O, 0.18 g L-1 KI, 0.12 g L-1 MnCl2·4H2O, 0.06 g L-1 Na2MoO4·2H2O,
0.023g L-1 NiCl2·6H2O, 0.12 g L-1 ZnSO4·7H2O, 0.15 g L-1 CoCl2·6H2O and 10 g L-1 EDTA).
This medium was supplemented with 5 g L-1 glucose as sole carbon source, 50 μg mL-1
kanamycin (where appropriate), 0.5 mmol L-1 Trp and 0.5 mmol L-1 phenyl pyruvate (PPY).
Based on Sun’s protocol two different media were used for the seed culture and the
fermenter in bioreactor experiments (Sun et al., 2006). Inoculum was prepared in seed
medium containing the following components per liter: 4.7 g (NH4)2SO4, 0.24 g
MgSO4·7H2O, 6.35 g Na2HPO4, 2.7 g KH2PO4, 9.0 g glucose, 15 mg CaCl2·2H2O, 0.75 g
tryptone, 0.3 g NaCl and 0.15 g yeast extract, 1 ml trace metal solution, 0.5 mmol Trp and
1 mmol PPY and 50 mg -1 kanamycin. CDM was modified for bioreactor initial fermentation
containing per liter: 4.7 g (NH4)2SO4, 0.24 g, MgSO4·7H2O, 9.53 g Na2HPO4, 4.05 g
KH2PO4, 1 g glucose, 15 mg CaCl2·2H2O, 1 mL trace metal solution, 0.5 mmol Trp and 1
mmol PPY. Feed solution contained per liter: 600 g glucose, 6 g MgSO4·7H2O, 150 mg
CaCl2·2H2O, 10 mmol Trp, 100 mg kanamycin, 10 ml trace metal solution. Phenylpyruvate
was fed by syringe based on 0.307 mmol PPY gCDW-1. The phenyl pyruvate demand was
calculated based on the abundance of Phe and Tyr in the E. coli biomass composition
(Pramanik and Keasling, 1997), since both bacteria belongs to Gammaproteobacteria.
2.3.4 Cultivation conditions
All shake flask incubation were carried out in in baffled Erlenmeyer flasks in an incubator
(2.5 cm orbit, Multitron, Infors, Bottmingen, Switzerland) at 200 rpm. Incubation
temperature for flasks and plates was 37 ℃ for E.coli and 30 ℃ for P. putida.
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To select best performing strain, the PHBA production strains were first cultivated for 8
hours in 5 mL LB. 50 µL of this culture was inoculated into a fresh 25 mL CDM medium
overnight, and the next day were inoculated to 35 mL CDM medium in a 250 mL baffled
flask to the initial OD600 of 0.2. The inducer isopropyl β-D-1-thiogalactopyranoside (IPTG)
was added to a final concentration of 1 mmol L-1 when the OD600 reached 0.3 to 0.4. Two
additional feeds to the final concentration of 0.5 mM PPY and 5 g L-1 glucose were added
at 6 hours and 20 hours respectively. Samples were centrifuged (16000 g, 10 min, room
temperature) and supernatants were stored in the freezer (-20 °C) for further analysis.
Fed-batch fermentations with P. putida were carried out in two 1.0 L working volume
Biostat B+ bioreactors (Sartorius, Germany), with initial volumes of 0.4 L. Temperature
was set at 30 ℃ ± 0.5℃ and pH was automatically controlled at 7.0 ± 0.1 using 14% -15%
(w/v) NH4OH, which also served as additional nitrogen source for cell growth. Dissolved
oxygen (DO) was maintained at a minimum of 40% through automatic control of the
agitation between 500 and 2000 rpm followed by variation of air flow from 0.15 to 1.5 L
min-1. Seed cultures were grown in seed medium at 30 ℃, 200 rpm flasks overnight
(around 13-16 hours), collected in mid-exponential phase and then inoculated into the
fermenter with initial OD600 of 1.0 ± 0.1. The inducer IPTG was added in the early
exponential phase (3 to 4 hours), with an initial concentration of 2.5 mM. The feed phase
was started half an hour after inoculation (Figure S3). The antifoam polypropylene glycol
P2000 (Sigma Aldrich, Australia) was added when onset of foaming was observed.
2.3.5 DNA manipulation
2.3.5.1 Gene deletions (∆pobA, ∆pheA, ∆trpE, ∆hexR)
Gene deletions were performed in P. putida following a multiple, seamless and markerless
genomic editing method from the de Lorenzo group (Martinez-Garcia and de Lorenzo,
2011). The resulting strains are listed in Table 2-1 and gene knockout process or
overexpression are shown in supplementary file (Figure S2-1. A, B, C).. Primers used in
this study are listed in Table 2-2. The pEMG-based knockout plasmids were constructed
using a standard restriction and ligation approach. To ease the constructions, the nested
fusion PCR approach was applied to increase PCR amplification specificity. Briefly, the
fusion gene fragments and pEMG vector were digested with BamHI/EcoRI, ligated with a
T4 DNA ligase and transformed into chemical competent cells (E. coli DH5α λpir). The
positive transformants were obtained from blue-white screening, and further verified with
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colony PCR, restriction digestion and sequencing (performed by Australian Genome
Research Facility Ltd.), resulting in the four knockout plasmids pEMG-∆pobA, pEMG-
∆pheA, pEMG-∆trpE and pEMG-∆hexR. The plasmids were electro-transformed into P.
putida competent cells according to Choi’s protocol (Choi and Schweizer, 2006). The
resulting strains were transformed with the plasmid expressing ISce-I endonuclease (pSW-
2) for cutting the pEMG vector backbone. Then the strains were induced with 15 mM 3-
methylbenzoate for 6 to 8 hours, and spread on LB plates containing 50 μg mL-1
gentamycin. Finally, selected mutant strains were confirmed using colony PCR with
primers of P2/P5. The desired mutant should have the expected size of around 1000 bp.
Auxotrophic mutants were also verified on solid CDM medium plate, 5 g L-1 glucose with
and without 0.5 mM Trp, and / or 0.5 mM Phe and 0.5 mM Tyr supplementation (the
deletion of gene trpE generated the tryptophan auxotroph, and the deletion of gene pheA
yielded tyrosine and phenylalanine double auxotrophic mutants).
2.3.5.2 Expression plasmid construction
The genes ubiC encoding chorismate lyase from E.coli K12 substr.W3110 (CAA40681.1)
and aroGD146N encoding feedback insensitive DAHP synthase (Kikuchi et al., 1997) were
codon optimized and synthesized by Integrated DNA Technologies, Inc. These two genes
were digested with EcoRI, SalI and HindIII respectively, then inserted into the vector
pSEVA234 (Silva-Rocha et al., 2013), resulting in the plasmids pSEVA234-ubiC and
pSEVA234-UA (Figure S2-1. C). The sequencing-verified plasmids were electro-
transformed into each of the knock-out mutant P. putida strains.
2.3.6 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
Culture samples for SDS-PAGE were collected by centrifugation (16000 g, 5 min, and
room temperature). Pellets were washed with buffer once and resuspended with 50 mM
Tris-HCl buffer (pH 7.5). Cells were then disrupted using sonication for 5-10 cycles of 10 s
pulse with 10 s interval on ice to prepare protein extracts. For preparation of whole-cell
protein samples, the loading buffer was added directly to the crude lysate. For the analysis
of soluble protein expression, the cell lysate was first centrifuged at 16,000 g for 20 min at
4℃ to remove cell debris and insoluble particles. Then the loading buffer containing β-
mercaptoethanol and SDS was added, and heated (5 min, 95-99 °C) to denature the
protein. SDS-PAGE was performed using 12 % polyacrylamide gel according to Laemmli’s
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protocol (Laemmli, 1970) in a vertical slab gel apparatus from Bio-Rad Laboratories‎ .
Coomassie brilliant blue G-250 was used for gel staining.
2.3.7 Analytical methods
Pseudomonas putida cell densities were monitored by a spectrophotometry (GENESYS
10S UV-Vis, USA) at the wavelength of 600 nm (OD600) against water. The correlation
between OD and cell dry weight (CDW) was empirically determined to be CDW (g/L) =
0.486 OD600. Sugars, organates (Lai et al., 2016a) and aromatic compounds (Lai et al.,
2016b) were measured by high performance liquid chromatography (HPLC). Carbon
dioxide was monitored by gas analyser (Balzers Thermostar GSD 300 T3, Liechtenstein).
Carbon balance calculation was following the equation of F(C, in) = F(C, out) ≈ F(C,
sugars) + F(C, organates) + F(C, aromatics) + F(C, CO2) + F (C, biomass). Specifically,
carbon composition in P. putida KT2440 biomass is 48.8% (W W-1) (van Duuren et al.,
2013).
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Table 2-1 The strains and plasmids used in this study
characteristics references
Plasmids
pSEVA234 (Silva-Rocha et al.,
2013)
pSEVA234-ubiC kmR, expression vector containing the gene of ubiC This study
pSEVA234-UA kmR, expression vector containing the gene of ubiC and
the gene aroG D146N mutant DAHP synthase
This study
pEMG (Martinez-Garcia and
de Lorenzo, 2011)
pEMG-
pobATS1TS2
kmR, using for pobA gene deletion from genome. This study
pEMG-
pheATS1TS2
kmR, using for pheA gene deletion from genome. This study
pEMG-
trpETS1TS2
kmR, using for trpE gene deletion from genome. This study
pEMG-
hexRTS1TS2
kmR, using for hexR gene deletion from genome. This study
Stains’ name
E.coli
XL10-Gold
endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 tetR F '[proAB
lacIqZΔM15 Tn10(TetR Amy CmR)
Stratagene
technologies
E.coli
DH5α λpir
endA1 hsdR17 glnV44 (, supE44) thi-1 recA1 gyrA96 relA1
φ80dlacΔ(lacZ)M15 Δ(lacZYA-argF)U169 zdg-232::Tn10
uidA::pir+
(Martinez-Garcia and
de Lorenzo, 2011)
S0 Pseudomonas putida KT2440 DSM 6125, wild type DSMZ
S1 The stain S0 knockout the gene pobA and overexpress
gene ubiC.
This study
S2 S2 derived from strain S1 by the further deletion of pheA,
overexpress gene ubiC
This study
S3 S3 derived from strain S2 by the further deletion of trpE,
overexpress gene ubiC
This study
S4 S4 derived from strain S3 by the further deletion of hexR,
overexpress gene ubiC
This study
S5 S5 derived from strain S3 by the overexpression of ubiC
and aroG D146N
This study
S6 S6 derived from strain S4 by the overexpression of ubiC
and aroG D146N
This study
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Table 2-2 The primers used in this study
Primers name sequences purpose
KTKO PobA P1 agcgcggtcaccaatgcttcgag Knockout pobA
KTKO PobA P2 ccggaattctgtaaagcgcctcctgatcct Knockout pobA
KTKO PobA P3 gccagcacctgcaccggcgcctgcaacctgagttttcat Knockout pobA
KTKO PobA P4 ggcgccggtgcaggtgctggcttcgaggaagttgcctgaggg Knockout pobA
KTKO PobA P5 cgcggatccaggcgctgttccaggttcgcta Knockout pobA
KTKO PobA P6 aagcggtcgggacttaaggaggg Knockout pobA
KTKO PheA P1 ttacgactacctggccatccc Knockout pheA
KTKO PheA P2 cggaattctgtcgcagttcggcctgatc Knockout pheA
KTKO PheA P3 ccgccttcggctcctgttcggacat Knockout pheA
KTKO PheA P4 gaacaggagccgaaggcggtgctttgat Knockout pheA
KTKO PheA P5 gatggatccacgcctctaccccgctctgctcg Knockout pheA
KTKO PheA P6 gcggaacaaggtggcattggacg Knockout pheA
KTKO TrpE P1 ctggacggtaccctgatcgattc Knockout trpE
KTKO TrpE P2 cggaattcctggaccagatgaagatcggta Knockout trpE
KTKO TrpE P3 ggaagtctgctcttcttcgcggttcatgag Knockout trpE
KTKO TrpE P4 atgaaccgcgaagaagagcagacttccgccagata Knockout trpE
KTKO TrpE P5 tagggatccggctacgacgagaagagc Knockout trpE
KTKO TrpE P6 ggccagtgcctttgcccaatac Knockout trpE
KTKO HexR P1 cgtcatcccagcgaagacctgt Knockout hexR
KTKO HexR P2 cggaattcatggcggctggacctgtg Knockout hexR
KTKO HexR P3 acccatggaccgcgtgcgaaacatcgaggacgacgacctcaactg Knockout hexR
KTKO HexR P4 tcagttgaggtcgtcgtcctcgatgtttcgcacgcggtccatgggt Knockout hexR
KTKO HexR P5 cgcggatccttcgcagatggccccatacacc Knockout hexR
KTKO HexR P6 gcccaggtaatggtcaatgcggta Knockout hexR
Ubic EcoRI Pf gggaattctaaggaggtaaccaaatgagccatccggccctg Cloning UbiC
Ubic Hind III Pr gtccaagctttcagtacagcgggctgg Cloning UbiC
AroG SalI Pf tgagtcgactacccaaaagcca Cloning AroGD146N
AroG Hind III Pr ctcaagctttcaaccgcga Cloning AroGD146N
SEQ 234F ctgtggtatggctgtgcaggt Sequencing primer
SEQ 234 R ggacccctggattctcaccaa Sequencing primer
SEQ pEMG fwd2 ccccatgcgctccatcaagaaga Sequencing primer
SEQ pEMG rwd cgactggaaagcgggcagtgag Sequencing primer
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2.4 Results and discussion
2.4.1 Metabolic engineering of PHBA production strains
There is a solid body of research for the metabolic engineering of shikimate pathway
derived aromatics, mainly using E. coli and C. glutamicum. Pseudomonas putida strain
development for the production of PHBA can be built on this knowledge and apply
successful genetic engineering strategies. Knockout targets were chosen based on their
ability to degrade PHBA and to compete with the enzyme responsible for PHBA production
(UbiC) for precursor availability. Compared to E. coli and C. glutamicum, more unique to P.
putida strains is the ability for aromatics degradation and the multitude of degradation
pathways for different aromatics (Jiménez et al., 2002). To increase PHBA concentration,
the genes pobA, pheA, trpE and hexR were deleted from the genome of P. putida KT2440
using the pEMG / pSW-2 system (Martinez-Garcia and de Lorenzo, 2011). The pobA gene
encodes p-hydroxy benzoate hydroxylase and causes product degradation. The gene
pheA encodes the bifunctional enzyme of prephenate dehydratase and chorismate mutase,
this will direct carbon flux into the tyrosine and phenylalanine synthesis, and is a major
competitor for the precursor chorismate. The disruption of trpE, which encodes
anthranilate synthase component I, is likely to reduce the drain of chorismate into the
tryptophan biosynthesis. As a consequence the deletion of pheA and trpE was carried out
to increase precursor supply to PHBA production by blocking the branching of the flux
towards the synthesis of the aromatic amino acids (Figure 2-1). Both deletions resulted in
aromatic amino acids auxotrophic mutants, but when depleted would cause the natural
feedback inhibition of the shikimate pathway to be alleviated. It is also important to note
that Pseudomonas species can degrade Phe and Tyr through the homogentisate pathway
(Figure 2-1), which can cause a difficulty to screen ∆phe mutant and the inconvenience in
fed-batch fermentation. Phe is firstly converted to Tyr by the action of the gene products of
phhAB phenylalanine hydroxylase, which are regulated by the PhhR regulator protein in
the presence of the two amino acids (Phe and Tyr) (Herrera and Ramos, 2007). They are
then further degraded via the homogentisate degradation pathway, and metabolites are
channelled to the tricarboxylate (TCA) cycle (Arias-Barrau et al., 2004). Glucose
metabolism repressor hexR controls glucokinase (glu), glyceraldehyde-3-phosphate (gap-
1) and several Entner-Doudoroff pathway enzymes (zwf, pgl,edd and eda) , the deletion of
this repressor may increase the flux towards pentose phosphate pathway and NADPH
pool. The deletion of hexR was expected to increase availability of shikimate pathway
precursors E4P and the necessary reducing equivalents NADPH (Figure 2-1). Successful
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deletants were chosen based on LB screening with the appropriate antibiotic selection as
described in Materials and Methods.
Figure 2–1 Schematic view of metabolic engineering in P. putida for PHBA
production. AroGD146N, feedback resistant DAHP synthase; phospho-2-dehydro-3-
deoxyheptonate aldolase synthase; E4P, erythrose 4-phosphate; HPP, 4-hydroxyphenyl
pyruvate; PEP, phosphoenolpyruvate; ANAT, anthranilate; PheA, chorismate
mutase/prephenate dehydratase; PhhAB, phenylalanine hydroxylase; PPA, prephenate;
PPY, phenylpyruvate; PobA, p-hydroxy benzoate hydroxylase; TrpE, anthranilate synthase
component I; UbiC, chorismate lyase; HexR, repressor for glucose metabolism.
Chorismate lyase encoded by ubiC is a key enzyme in the PHBA synthesis, it specifically
hydrolyzes chorismate into the products PHBA and pyruvate. The ubiC gene from E. coli
K-12 strain was cloned into vector pSEVA234 regulated with Ptrc /LacIQ. E. coli wild type
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UbiC enzyme was shown to be insoluble when overexpressed in E. coli, protein
manipulations made to increase solubility resulted in some loss of enzyme activity (Holden
et al., 2002; Stover et al., 2000). To optimize expression of soluble UbiC, different culture
temperature (25℃ and 30 ℃) and induction time (6 and 8 hours) were performed. However,
unlike previous work in E. coli we didn’t observe protein precipitation in P. putida in any of
the tested conditions. Instead over 90% of E. coli wild type UbiC was present in soluble
form in P. putida KT2440 using culture condition as described above (Figure 2-2 and Table
S1).
Figure 2–2 SDS-PAGE analysis of soluble expression of wild type UbiC in P. putida
KT2440. All cultures were performed in CDMF medium with 5 g L-1 glucose as the carbon
source, induced with 1mM IPTG when OD600 reach to 0.3-0.4. The control is the strain
containing empty vector pSEVA234. Red arrow indicate target protein UbiC. Soluble
protein amount was quantified by Pierce BCA Protein Assay Kit, and loading around 40 µg
for each sample.
Finally, to further improve the production of PHBA in P. putida, the gene encoding the
feedback insensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase
isoenzyme mutant AroGD146N (Kikuchi et al., 1997) was constructed in the same operon
with UbiC, regulated by the Ptrc /LacIQ system (Figure S1. C). This caused an
unregulated influx of carbon into the shikimate pathway.
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On a side note, it was earlier postulated by Kuepper et al (Kuepper et al., 2015) after
screening more than a thousand colonies for pheA knockout-mutants on complex medium
that the presence of the homogentisate degradation pathway might hamper the positive
identification of positive colonies and the addition of precursor phenyl pyruvate (PPY) in
minimal medium was helpful to screen for this mutant (Kuepper et al., 2015). We
successfully identified pheA mutants on rich medium when looking for tiny colonies that
could be easily overlooked amongst the big colonies that did not contain the knockouts.
2.4.2 Evaluation of the PHBA production strains in shake flasks
The performance of the genetically engineered strains described above (S1-S6, Table 2-1)
was evaluated for PHBA production in shake flasks, showing a maximum yield of 1.30 ±
0.01 mmolPHBA gCDW-1, a titre of 4.96 ± 0.146 mM and 7% (C-mol C-mol-1) (Figure 2-3). The
single knockout strain containing the over expression plasmid of UbiC (Strain S1)
produced 0.23 mM PHBA with a yield of 0.075 mmolPHBA gCDW-1. An increase of around 5
folds in titre and yield was achieved with the deletion of chorismate precursor competing
genes pheA (strain S2). Compared to S1, this was further increased to 12 and 16 fold
increase in titre and yield, respectively, by the deletion of the second precursor competing
gene trpE (strain S3). Overall indicating a positive effect when deleting precursor
competing genes. The knockout of hexR in the S3 background did not lead to a very large
increase in yield and titre (strain S4) nor did the overexpression of the feedback resistant
DAHP synthase (strain S5). However, when combining the knockout of hexR with
overexpression of DAHP synthase (strain S6) a remarkable increase of 22 and 17 fold
increase in titre and yield was achieved relative to the base strain.
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Figure 2–3 Various P. putida KT2440 mutant strains for PHBA production in shake
flask. All mutants were grown in CDM medium supplemented with 5 g L-1 glucose
and phenyl pyruvate and tryptophan as described above. Two additional feeds of 5
g L-1 glucose and 0.5 mM PPY were added after 6 and 20 hour, respectively. All data
were from triplicate biological repeats at the late stationary time point of 44 hours.
S1, P. putida KT∆pobA/234-ubiC; S2, P. putida KT∆pobApheA/234-ubiC; S3, P.
putida KT∆pobApheA∆trpE/234-ubiC; S4, P. putida KT∆pobApheA∆trpE∆hexR/234-
ubiC; S5, P. putida KT∆pobApheA∆trpE/234-ubiC-aroGD146N;S6, P. putida
KT∆pobApheA∆trpE∆hexR/234-ubiC- aroGD146N.
Compared to S3, S4 has no significant increase in yield and titre, and it can be explained
by the fact that our limited feeding of phenylpruvate and tryptophan alleviated or
diminished feedback inhibition to their native DAHP synthase in P. putida. Unexpectedly,
compared to S3, the hexR knockout showed no substantial improvement for PHBA
production but the hexR knockout strain combined overexpression of DAHP synthase,
showed a significant improvement in titre and yield. A possible reason for that is that the
native DAHP synthase was not strong enough to drain flux from central metabolism.
Interestingly, the combination of both genetic manipulations can synergistically drain the
flux from central metabolism to shikimate pathway for PHBA production, leading to a
significant improvement both in titre and yield. The reason for the increase could be that
Pseudomonas like many bacteria features an imbalanced supply of phosphoenolpyruvate
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(PEP) and erythrose-4-phosphate (E4P), and increasing pentose phosphate pathway
(PPP) flux was demonstrated to increase aromatic production in several bacteria including
Pseudomonas putida (Chassagnole et al., 2002; Fuhrer et al., 2005; Nikel et al., 2015a).
The general strategies to increase the E4P supply are to express gene tktA encoding
transketolase and /or tal encoding transaldolase (Ikeda and Katsumata, 1999; Lu and Liao,
1997). The role of the hexR protein as a transcriptional repressor of zwf encoding the
committing step into PPP was described in P. putida and its deletion led to the increased
flux of PPP and reduction of the NADP+ pool (del Castillo et al., 2008; Meijnen et al., 2012).
In our study, titre increased significantly in the S6 strain, likely due to an increased
precursor supply for our PHBA production from glucose.
2.4.3 PHBA production by fed-batch fermentation
The best PHBA producing strain (S6) was selected from the flask experiment to evaluate
its potential in a fed-batch fermentation. P. putida will quickly degrade the provided
aromatic amino acids Phe and Tyr in fermentation due to the homogentisate degradation
pathway. This would lead to growth arrest in our ∆pheA strains, or the need for a constant
feed of those amino acids. Instead of feeding the two amino acids, we fed the precursor
PPY. This feed did not stop degradation through the homogentisate pathway completely
but slowed down the process. We assumed P. putida KT2440 has a similar biomass
composition to E. coli, since both species are γ- proteobacteria (Blank et al., 2008) and
calculated the necessary PPY feed based on the demand for Tyr and Phe. Glucose
concentration was 1 g L-1 at the start of the fermentation and was fed as described above
after inoculation. PPY solution was fed with 0.307 mmol gCDW-1 based on the actual cell
density at several intervals (5 h, 8h, 10 h, 15 h, 20 h, and 25 h). Biomass kept growing
after OD600 reached ~12 and 6.05 g CDW were obtained after 32 hours. Fermentation was
stopped when the working volume of the reactor was reached. Due to the volume change
in the fed-batch the following section will discuss absolute amounts. The carbon balance
closed at 100.6 % meaning that all carbon could be accounted for. As the major by-
products 2-ketogluconate was accumulated (545 mmol) and CO2 was released (177 mmol)
and about half the fed glucose (~765 mmol) remained unused. This was due to the fact
that glucose was not the limiting factor in the fed-batch but PPY instead. P. putida will
oxidise glucose in periplasm to gluconate and then to 2-ketogluconate. In future
experiments the feed regime should be optimized. Nevertheless, PHBA accumulated over
time and reached a maximum titre of 12.46 mmol (12.5 mM at the end of fermentation),
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and a yield of 2.6 mmol PHBA gCDW-1 (Figure 2-4). The product on substrate yield of PHBA
based on the consumed C6 molecules and PPY (excluding extracellular glucose and 2-
ketogluconate, which were not taken up by the cells), reached 18.1 % (C-mol C-mol-1).
Smaller amounts of pyruvate, lactate and succinate could also be observed to accumulate
throughout the fermentation (data not shown). The only other major by-product was
acetate at 13 mmol which accumulated in the first 20 hours and was consumed thereafter
(Figure 2.4). This might indicate a redirection of intracellular fluxes around the 20 h mark,
but this remains to be studied in more detail.
Figure 2–4 Profile of mutant strain KT∆pobA∆pheA∆trpE∆hexR/234UA in phenyl
pyruvate limited fed-batch fermentation in a controlled reactor. Insert is showing the
yield coefficient (slope of dashed line, 2.6 mmolPHBA gCDW-1). ●, Biomass, gCDW L-1; ▲,
Biomass (gCDW); ◆ , PHBA (mmol); ▼,PHBA Yield (mmol gCDW-1); ●,consumed glucose
(mmol); ★,CO2, (mmol); ▼, KGA: 2-ketogluconate (mmol); ■, GA, gluconate (mmol); ▲,
acetate (mmol).
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In summary, the fed-batch process was able to achieve higher titre than the shake-flask
experiments, but the feeding still requires optimization. Compared to published results we
achieved a similar titre but a higher yield 18.1% (C-mol C-mol-1). P. putida S12palB1 (8.5
C-mol C-mol-1) was engineered based on the coumarate pathway and had optimized
carbon flux towards L-tyrosine (Verhoef et al., 2007), and P. putida S12pal_xylB7 (16.3 C-
mol C-mol-1) used an optimized mixed-substrate feeding strategy but also the coumarate
pathway (Meijnen et al., 2011b). While the experimentally observed yields are not yet
approaching the calculated theoretical yields of the pathways (Kromer et al., 2013), this
might still indicate that the UbiC based route has a higher potential for biotechnological
production of PHBA.
2.5 Conclusion
P. putida strains show high potential for industrial aromatic production, mainly due to their
high tolerance towards toxic aromatics and the reduced formation of by-products. In this
chapter we described P. putida production of PHBA from glucose as sole carbon source
via the chorismate lyase from E. coli, which has a higher theoretical yield than the
previously described coumarate pathway. The mutant strain
KT∆pobA∆pheA∆trpE∆hexR/234UA achieved a maximum titre of 12.5 mM in a phenyl
pyruvate limited fed-batch fermentation. This was achieved using a stable, scar-less and
marker-less deletion method, to meet industrial application requirements. This study lays
the basis for using P. putida as a PHBA production host. Further metabolic engineering
strategies can be applied to enhance production, for example, balancing the precursors
PEP and E4P or increasing the availability of the reducing equivalent NADPH.
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Chapter 3 Anoxic biochemical production using Pseudomonas putida in
bio-electrochemical system enhanced by membrane-bound
dehydrogenase expression
Pseudomonas putida is a potential industrial production host, which has attracted strong
research interest from the metabolic engineering community over recent years. At the
same time a new technology, microbial electrosynthesis emerged as a new tool to balance
microbial redox metabolism, a key to chemical and biofuel production. In this chapter, we
explore the suitability of microbial electrochemical technologies to enable the obligate
aerobe P. putida to perform biochemical conversions under oxygen free conditions. In this
system we utilize ferricyanide as an electron acceptor, which shuttles excessive electron to
an anode. Under such conditions, P. putida was shown to be able to, produce 2-
ketogluconate in the bio-electrochemical system. However, the productivity was too low for
industrial application. Strain improvement will be conducted for the improvement of
productivity and carbon yield for the 2-ketogluconate production in the bio-electrochemical
system.
3.1 Abstract
By providing an electrode and redox mediator, Pseudomonas putida can perform anoxic
metabolism and convert glucose to sugar acids at a high yield in bio-electrochemical
system (Lai et al., 2016). However, the low productivity limited its industrial application
significantly. Metabolic engineering targets for strain improvement were firstly identified as
glucose dehydrogenase (mGCD) and gluconate dehydrogenase (GADH). Real time RT-
qPCR revealed the intrinsic regulation system of mGCD and GADH, where mGCD was
induced by its substrate and product gluconate. While the gluconate serves as inducer
further simulated the upregulation of GADH. Utilized this self-regulation, the single
overexpression mutant (strain mGCD) gave outstanding performance in the electron
transfer rate and 2-ketogluconate productivity. The peak anodic current density and 2-
ketogluconate productivity were 0.12 mA/cm2, and 1.59 ± 0.00 mmol/gCDW/day,
respectively. This is a 300 % increase compared to the parental strain of P. putida KT2440
respectively. This work demonstrated that expression dehydrogenases involved in electron
transfer can significantly improve productivity, and controlled membrane protein in a
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reasonable level is necessary for the well-being of BES biocatalyst as well as productivity
improvement.
3.2 Introduction
Bio-based economy is highly boosted by the need for economic, social, and environmental
sustainability in recent years. Bio-based products are increasing their market share
annually, and expected to reduce the heavy dependency on fossil fuel in a distant future
(Dammer et al., 2013; de Jong et al., 2012; Waltz, 2008). However, the majority of bio-
production processes are still struggling with low yield and productivity, and high
production cost which limit their industrial application. Redox imbalance (Chen et al., 2014;
van Hoek and Merks, 2012), by-production formation (Arshad et al., 2008; Lee et al., 2001)
and metabolic burden (Wu et al., 2016) are often seen thorny problems during bio-
production processes. Solving these issues and increasing its competitiveness against
chemical production processes, has attracted plenty of research interests.
Microbial electrosynthesis, powered the microorganism with electricity for biosynthesis of
commodity chemicals has attracted strong research interest (Angenent and Rosenbaum,
2013; Rosenbaum and Franks, 2014). Since the electricity can be from renewable
resources such as wind, wave and solar energy, this technique is becoming an attractive
alternative for energy storage and transportation (Rabaey et al., 2011). In the
electrochemical production processes, electrons are taken from electroactive
microorganism to drive oxidation processes in anode or supplied to biocatalysts for fuelling
reduction reactions in cathode. For the past decade, research is mainly focus on
physiological phenomenon and discovery of new electroactive microbes (Rosenbaum and
Henrich, 2014). The modification and optimization of microbes for the target products
biosynthesis in electrochemical system, is progressing slowly mainly due to the little
scientific insight of electron transfer. Low conversion rate and productivity can be seen
from many reported cases (Hintermayer et al., 2016; Jeon et al., 2015; Lai et al., 2016;
Nevin et al., 2010), highlighting the utmost necessity to improve the electron transfer rate.
Currently, the main focus is on optimizing electrode materials and surfaces to increase
current densities (Chen and Xue, 2015; Pocaznoi et al., 2012; Rabaey et al., 2011; Zhang
et al., 2013), but the move towards new organisms that are accessible for metabolic
engineering also enable us to improve the current density by changing the number of
redox active enzymes in the cell surface.
This chapter incorporates the manuscript to be submitted in Biotechnol Bioeng. (Accepted)
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Pseudomonas putida is remmended as the next generation synthetic biology chassis for
extraordinary features as industrial workhorse (Adams, 2016). P. putida possess a
versatile metabolism that can fulfil various production purposes (Loeschcke and Thies,
2015). Its glycolysis is almost exclusively through the Entner–Doudoroff pathway enabling
for high yield of NADPH (Nikel et al., 2015a), which offers more reducing power for the
maximization product titres (Ng et al., 2015) and prevention oxidative stress (Chavarría et
al., 2013). Pseudomonas spp. are well-known for their high tolerance for toxicity (Nikel et
al., 2014b; Wierckx et al., 2005), the robustness of metabolism (Belda et al., 2016), and
flexibility in adaptation to various environmental fluctuation and stimulus e.g. oxidative
stress (Ebert et al., 2011), highlights its advantages acting as industrial workhorse in
aerobic processes. However, P. putida is an obligate aerobic bacteria, and a highly
aerobic industrial-scale production will often encounter the problems of oxygen transfer,
carbon loss and more investment in expensive equipment and additional utility (Noorman,
2015). On the other hand, a classical anaerobic bacterium will have many alternative ways
to ferment the provided substrate into undesired by-products. Thus, metabolically
engineering P. putida has been attempted for the adaptation performance in anoxic
conditions (Chavarría et al., 2013; Steen et al., 2013), but with limited practical success.
Combining the above mentioned bio-electrochemical system with an obligate aerobe
under anoxic conditions provides a new opportunity to steer metabolism to desired
outcomes. With the aid of bio-electrochemical system, we demonstrated that the
environmental isolate P. putida F1 was able to utilize electrode and exogenous redox
mediator as the electron sink and performed anoxic sugar metabolism (Lai et al., 2016).
Around 90 % of glucose converted into 2-ketogluconate and the produced excessive
electrons were transferred to redox mediator ferricyanide and ultimately shuttled to the
anode. Proton gradient was formed to trigger the ATP synthesis for cell maintenance.
However, the productivity was too low for industrial application and significant
improvement is necessary. With the surging interest in establishment of P. putida as
industrial platform strain in recent years, tools and genetic information are being developed
for various application purposes, mainly on the background of the KT2440 strain, the same
strain that is used for aromatics production. The KT2440 strain can perform anoxic
metabolism in the same condition (Lai et al., 2016), but achieved a lower carbon yield of
about 65% (C-mol C-mol-1) for 2-ketogluconate from glucose, and 5 fold decrease of
productivity compared to F1 strain. This poor performance by KT2440 strain in
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electrochemical production suggests that further strain improvement is necessary before
the exploration of aromatics production in BES.
In this work, P. putida KT2440 strain was metabolically engineered for improving its
performance in the BES system. Two metabolic targets (glucose dehydrogenase (mGCD)
and gluconate dehydrogenase (GADH) were identified as potential genetic targets pointing
toward to improve electron transfer rate. The intracellular regulation system of these two
enzymes were also hinted by quantitative real-time PCR and metabolites analysis. With
this intrinsic regulation system, a P. putida mutant (strain mGCD) was constructed, and
showed significant improvement in the electron transfer rate. This resulted in high
productivity and high yield of the product 2-ketoglucoconate.
3.3 Material and Method
3.3.1 Chemicals, plasmid, strain and cultivation condition
Bacterial strains and plasmids used in this study are listed in table 3.1. P. putida KT2440
(DSMZ 6125) was used as production host in BES and cultivated at 30 ℃, and E. coli
XL10-Gold (Agilent Technologies Inc.) was used for the cloning procedure and cultivated
at 37 ℃. All chemicals for medium preparation or BES fermentation are analytical grade,
purchased from Sigma-Aldrich (Australia) or Chem-Supply (Australia). Yeast extract and
tryptone were purchased from Merck and Oxoid (Australia), respectively. Plasmid
isolations or DNA fragment purifications used GeneJET kits, following the manufacturer’s
instructions (Thermo Fisher Scientific Australia Pty. Ltd.).
All Pseudomonas strains were aerobically cultivated in a defined mineral medium (DM9)
contained glucose (5 g), Na2HPO4 (6 g), KH2PO4 (3 g), NH4Cl (1.0 g), MgSO4▪7H2O (0.1 g),
CaCl2▪2H2O (15 mg) and 1 ml trace element solution per litre ddH2O. The trace element
solution was prepared as previous description in chapter 2. The pH was adjusted around
7.0 ± 0.1. The solid plates were prepared by adding 1.5-1.7 % (w/v) agar into the medium.
Medium was added 50 µg/ml gentamycin or kanamycin for maintain plasmid stability for
the strains containing plasmids.
3.3.2 Strain and plasmid constructions
Duet co-expression plasmid, pSEVA644D, was constructed for introducing multiple genes
targets into two multiple cloning sites (MCS), each of which was regulated by a trc
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promoter, lac operator and ribosome binding sites independently. Firstly, fragments
containing lacIq , Ptrc and lac operator were cloned from the plasmid of pSEVA234 using
the primers of SEQ T0 Pf and SEQ 234R, digested with PacI and HindIII (New England
Biolabs (NEB), Australia) and then inserted into vector pSEVA641. The resulting plasmid
pSEVA644 was introduced the second MCS containing an artificial terminator BBa_B1002
(gBlocks® Gene Fragment, Integrated DNA Technologies, Singapore) by inserting into the
position of KpnI / BamHI (NEB, Australia), resulting in pSEVA644D. The membrane-bound
glucose dehydrogenase (mGCD, PP_1444) was cloned from P. putida KT2440 using the
primers of mGCD KT2440 Pf and mGCD KT2440 Pr, and inserted into vector pSEVA644D.
The gene cluster containing the gluconate dehydrogenase (GADH, PP_3382, PP_3383,
PP_3384) were also cloned from P. putida KT2440, inserting into the second MCS of
pSEVA644D-mgcd. The RNase E binding site in this gene cluster was removed to
increase RNA stability. The expression strength of mGCD and GADH were controlled
using similar strength of synthetic RBS calculated by the RBS calculator (Salis, 2011). All
constructed plasmids were verified by sequencing (AGRF, Australia) and then electro-
transformed into P. putida KT2440 according to Choi’s protocol (Choi and Schweizer,
2006). All primers and the maps of constructed plasmids can be found in supplementary
material (Table 3-1 and Figure S3-1), and all primers used in this study were listed in
Table 3-2.
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Table 3-1 Plasmids and strains used or constructed in this study.
Strains or plasmids Relevant characteristics Source
plasmids
pSEVA234 kmR, expression vector regulated with Ptrc-
lacIq system
(Silva-Rocha et
al., 2013)
pSEVA644D GmR, duet co-expressionregulated with
Ptrc-lacIq system.
This study
pSEVA644D-mgcd GmR, containing the gene of membrane-
bound glucose dehydrogenase (mgcd,
PP_1444) under the control of the trc
inducible promoter and lac repressor.
This study
pSEVA644D-gadh GmR, r containing the gene cluster of 2-
keto-gluconate dehydrogenase (gadh,
PP_3382, PP_3383, PP_3384) regulated
by trc inducible promoter respectively.
This study
pSEVA644D-GK GmR, duet co-expression vector containing
the genes (mGcd, PP_1444) and
gluconate dehydrogenase (gadh,
PP_3382, PP_3383, PP_3384) which were
regulated by two trc inducible promoter
respectively.
This study
P. putida strains
KT2440 Wild type DSMZ
KT2440/644D Containing the empty expression vector of
pSEVA644Duet
This study
KT2440/644D-mgcd Containing the expression vector of
pSEVA644D-mgcd
This study
KT2440/644D-gadh Containing the co-expression vector of
pSEVA644Duet-gadh
This study
KT2440/644D-GK Containing the duet co-expression vector
of pSEVA644D-mgcd-gadh
This study
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Table 3-2 Primers used in this study.
primer name sequence purpose
SEQ T0 PF ctcaggagagcgttcaccgaca Sequencing primers/
for cloning lacIq
fragment
SEQ 234 R ggacccctggattctcaccaa Sequencing primers/
for cloning lacIq
fragment
mGCD KT2440 PF cggaattctcgtctccaagacgatcccgacgag
gaaagaagttatgagcactgaaggtgcg
For the amplification
of mgcd gene
mGCD KT2440 PR gccccgggtacctcattactcggctaatttgtaag
caatgatg
For the amplification
of mgcd gene
GADH PF1 attcgttaagcaaggagaaagatatgcctgagca
tgccccaga
For the amplification
of gadh gene cluster
GADH PF2 cgcggatcctgaaggacgacattcgttaagcaa
ggaga
For the amplification
of gadh gene cluster
GADH PR cgcaagctttcagcgcaggctctttacatcacctgc
ggt
For the amplification
of gadh gene cluster
SEQ VT PF cgactggaaagcgggcagtgag Sequencing primer
SEQ GADH R1 tcgaacagccttgccgatac Sequencing primer
SEQ GADH F1 aggcctggaccgtcaaag Sequencing primer
SEQ GADH R2 caacagtgtcttcatgct Sequencing primer
SEQ GADH F2 tgcgctcacgtactggtc Sequencing primer
mGCD-F cgtggcgtctcgtactatg For RT-qPCR
mGCD-R cgttgtcggcgttgatgg For RT-qPCR
GADH-F gtgattctggcggcgttc For RT-qPCR
GADH-R aagttgttggtgtaggtgtcc For RT-qPCR
fliS-F gatttctgaagccactccg For RT-qPCR
fliS-R cttgcccagcattacacc For RT-qPCR
Note, restriction sites were showed in italic.
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3.3.3 Bio-electrochemical system set up
The construction and set-up of bio-electrochemical system (BES) were the same as stated
in previous study (Lai et al., 2016). The procedure for electro-fermentation inoculum
described as following. Glycerol stock was revived on the LB plates (strains with plasmids
using the LB containing 50 µg/ml gentamycin) at 30℃ for one day. The single colony was
inoculated into fresh DM9 medium, and grown at 30℃, 200 rpm overnight. Cell
suspensions were transferred into fresh DM9 medium and set up the initial OD600 of ~0.2,
added 1 mM IPTG when OD600 reached to 0.3-0.4. Cells were collected after 6 h or 12 h
induction by centrifugation and resuspended in fresh DM9 medium for inoculation.
3.3.4 Metabolite analysis
Details methods refer to Chapter 2.
3.3.5 RNA extraction and RT-PCR analysis
To extract RNA for RT-PCR analysis, cell pellets were harvested by centrifugation (12000
g, 3 min, 4 °C), immediately frozen in liquid nitrogen and then stored in -80 ℃ freezer until
use. Total RNA was isolated using a commercial bacteria total RNA extraction kit (Pexbio,
China) following the manufacturer’s instruction. RNA concentrations were measured using
Nanodrop (NanoQ, Capitalbio, China), and the integrity and purity of extracted total RNA
were assessed by agarose gel electrophoresis.
Before RT-PCR analysis, 1 µg of purified RNA was treated with DNA-free DNase I
(Invitrogen, US) to remove the contamination from DNA, and reverse transcribed to cDNA
using random hexamer primer and GoScriptTM Reverse Transcriptase (Promega, US).
Quantitative PCR experiment was performed in the CFX96 Real-Time PCR Detection
System (Bio-rad, USA) with SsoAdvanced™ Universal SYBR® Green Supermix (Bio-rad,
USA), with diluted cDNA and qPCR primers (Table S1). Melting curves and agarose gel
analyses were used to confirm the specificity of the PCR products. Two reference genes,
16s RNA and Flis, were selected and validated the stability in this study using Bestkeeper
tool (Pfaffl et al., 2004) and the more stable reference gene, Flis, was used for statistic
calculation. All experiments were conducted in triplicates, and the threshold cycle (CT)
values for each target gene was normalized to the reference gene Flis. The 2-ΔΔCT method
was used to calculate the relative expression level, where ΔΔCT = (CTtarget−CTref) sample −
(CTtarget−CTref) control (Livak and Schmittgen, 2001), and the values for the wild type control
were normalised to be 1 for all genes.
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3.3.6 Cell growth kinetics determination
All tested strains were incubated in DM9 medium with glucose as the sole substrate with
or without antibiotics following the procedure mentioned in the section 3.2.3. Sampling was
conducted every 20 mins after the addition of IPTG until the end of log phase. Cell
densities were immediately measured, sample supernatant was collected by centrifugation
(16, 000 g, 10 min, room temperature) and stored at -20 ℃for HPLC analysis. The
maximum cell densities were measured during the stationery phase. The maximum growth
rate (µmax, h-1) was the slope of the growth curve in the exponential phase in a semi-
logarithmic plot of cell density ln (OD600) vs time. The specific glucose uptake rate (rs,
mmol/g CDW/h) were calculated based on the formula of rs [mmol/g CDW/h] = µmax / Yx/s,
where Yx/s are the yield coefficient of biomass on substrate. All experiments have at least
three biological repeats.
3.4 Results and discussion
3.4.1 Anoxic glucose metabolism of P. putida KT2440
The obligate aerobe P. putida F1 cannot survive without oxygen, but can perform anoxic
metabolism to produce 2-ketoglunate as the main product from glucose when supplied
with an alternative electron acceptor, such as the mediator such as ferriycyanide, and an
electrochemical system (Lai et al., 2016). This indicates P. putida F1 is likely be a platform
strain for anoxic biochemical production in anodic chamber. However, P. putida F1 was
found not be a good strain for metabolic engineering due to around 100 folds lower
transformation efficiency than that of the model strain KT2440 (tested over 10 times),
when using the same protocol from Choi and its optimized protocols (Choi and Schweizer,
2006). The low efficiency can be also seen in method of conjugation (three-parental
mating). This low transformation efficiency increase the difficulty in genomic editing and
work efficiency, though plasmid expression can be performed in this strain. Moreover,
about 82% of coding DNA sequences from P. putida F1 have orthologous relationship with
the genes from P. putida KT2440 (Table 3.2 Pseudomonas genome data, access date
14/02/2017). P. putida KT2440 is the model strain and most of information can be easily
accessed and referenced with the publications. In addition, PHBA production strains were
developed in the strain of P. putida KT2440, and it is interesting to explore electrochemical
production. For these reasons, the electrochemical activity was tested for P. putida
KT2440 in DM9 medium with glucose as sole carbon source and 1 mM ferricyanide as
redox mediator.
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Table 3-3 Comparison of the general genome features of P. putida KT2440 and F1
KT2440 F1
Number of bases (bp) 6181873 5959964
Number of CDSs 5788 5458
CDSs with predicted function (%) 75.2% 75
Orthologous CDSs in KT2440
and F1
4471 4471
Orthologous relationship (%) 100 82
Pseudogenes 57 56
% GC 61.5 61.9
tRNAs 75 75
rRNA 22 19
The numbers of genome features have been retrieved from the Pseudomonas Genome
database.
Compared with strain P. putida F1, the current density for KT2440 increased slower than
that in F1 strain after inoculation, although the inoculum biomass KT2440 was 7 folds
higher than F1 (Figure 3-1). KT2440 took an additional 100 hours to fully convert the
glucose to metabolites with a carbon yield of 65 % C-mol C-mol-1 for 2-ketogluconate, and
one third carbon yield for the by-products e.g. acetate, pyruvate, succinate and lactate in
bio-electrochemical production (Figure 3-1). In contrast, F1 strain can oxidise 90% glucose
to produce 2-ketogluconate in a shorter time. Regarding to productivity, the KT strain only
gained about 0.56 ± 0.01 mmol product/gCDW/day in comparison with the productivity of 2.90
± 0.61 mmol product/gCDW/day by P. putida F1. This suggested both strains can perform
anoxic metabolism in anodic chamber with the added redox mediator ferricyanide, but
KT2440 strain was less efficient in the electrochemical production, probably because of
the low electron transfer rate. This low conversion rate and low electron transfer rate in P.
putida KT2440 are expected to improve by metabolically engineering strain.
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Figure 3–1 Bio-electrochemical production in anodic chamber by P. putida KT2440
and F1 with ferricyanide as the mediator. The anode potential was set up as +0.5 V vs
Ag/AgCl/Sat. KCl. Data take the means for all the results shown in this figure. Data for
KT2440 are from two biological repeats and data for F1 are from 10 biological repeats.
(Note: data were provided by Bin Lai to reproduce the figure (Lai et al., 2016))
The wild type P. putida KT2440 and F1 can oxidise glucose to produce 2-ketogluconate as
the main product in BES (Figure 3-1). But the sugar acid was the glucose oxidation
product in the periplasm, and the estimated flux distribution in P. putida F1 indicated that
limited flux towards acetate synthesis by the acetyl-CoA synthetase and basically no
carbon flux flow to downstream pathway of central pathway. It is interesting to know
whether this electrochemical production system can be used for produce other products
from downstream pathways of central metabolism. To test it, PHBA production strain P.
putida KT∆pobApheA∆trpE∆hexR/234UA was aerobically grown in DM9 medium with
glucose as the sole carbon source (fed with phenyl pyruvate and phenylalanine for
auxotrophy), but no detectable PHBA was produced during the electrochemical production.
The second try was to aerobically grow the PHBA production strain in terrific broth
followed by the same electrochemical production, observed an accumulation of PHBA over
time from 2 µM detected on the fifth day to 29 µM on seventeenth day, this result
suggested the electrochemical system can be potentially used for the production of other
value-added compounds by P. putida but the extremely low productivity needs to
significantly improve. Enhancing the electron transfer rate is key to improve the
productivity in bio-electrochemical system, and this can be achieved by strain
improvement or growth condition to simulate the beneficial proteins for electron transfer.
This chapter mainly focus on the strain development and improvement, and next chapter
will discuss how growth conditions influence the electrochemical production.
3.4.2 Membrane-bound dehydrogenases as potential metabolic engineering targets
The incomplete oxidation reactions in BES system by Pseudomonas spp. is similar to the
so called “oxidative fermentation” with acetate bacteria, where sugars was oxidised to
sugar acids (Matsushita and Matsutani, 2016). These partial oxidation reactions in the
periplasm are done by primary dehydrogenase located on the periplasmic surface of the
cytoplasmic membrane, which is directly coupled to the respiratory chain and generate
proton motive force by ubiquinol oxidase for ATP synthesis as showed in Figure 3-1. The
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enzymes are characterized with their prosthetic groups and can be divided into two
categories. One is membrane-bound quinoprotein containing pyrroloquinoline quinone
(PQQ) as the prosthetic group, the others are generally comprising three-subunit complex
covalently bound with FAD, PQQ, heme c, and molybdopterin cofactor (Matsushita and
Matsutani, 2016).
In the case of partial oxidation in periplasm by P. putida in BES condition, two
dehydrogenases involved in this enzymatic reactions suggested by recent updated
Pseudomonas genome annotation (Figure 3-2): glucose dehydrogenase (mGCD,
PP_1444, quinoprotein) and gluconate dehydrogenase (GADH, three-subunit complex of
PP_3382 (containing cytochrome c), PP_3383 (containing FAD), PP_3384). The produced
electrons were transferred by cofactors of PQQ, FAD and cytochrome c subunit (PP_3382)
via ubiquinone pool (MATSUSHITA et al., 1979; Matsushita et al., 1989), and finally given
the electrons to the anode via the mediator ferricyanide. The periplasmic respiration could
generate the proton motive force for ATP synthesis. Revisiting Figure 3-1, the current
density and the production rate of 2-ketogluconate showed an overall increasing trend until
glucose became limited, indicating the activities of the two key dehydrogenases were
functional working in BES condition and coupled with electron transfer chain. This result
also suggested they could be potentially metabolic engineering targets.
These two dehydrogenases were firstly analysed for their subcellular localization by well-
predicted bioinformatics tools TMHMM 2.0 (Krogh et al., 2001) and PRED-TAT (Bagos et
al., 2010), and confirmed mGCD is a transmembrane protein and GADH contained the
Sec signal peptide (PP_3382 and PP_3383) and Tat signal peptide (PP_3384), therefore
GADH was presumed to be enzyme complex located on inner membrane surface. Based
on the above analysis, these two enzymes were selected candidates for the
overexpression to evaluate improvement of electron transfer rate and productivity.
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Figure 3–2 Metabolic engineering membrane-bound dehydrogenases for the
improvement of productivity and carbon yield.
3.4.3 Growth kinetics affected by overexpression of mGCD and GADH
The overexpression of membrane proteins often incurs the toxicity to the host which could
be caused by various reasons and not fully understood currently (Grisshammer, 2006;
Gubellini et al., 2011; Kwon et al., 2015; Opekarová and Tanner, 2003; Wagner et al.,
2007). The attempts at overexpression of membrane proteins may overwhelm the cell
capacity, resulting in a series of consequences. For example, the overexpression could
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saturate the cytoplasmic membrane protein translocation machinery and subsequently
lead to lower accumulation of respiratory chain complexes (Wagner et al., 2007).
Therefore, toxicity effects on growth kinetics was firstly evaluated before electrochemical
production. The toxicity effect was firstly observed in the cloning procedure of constructing
GADH from background expression of trc promoter, alleviated by catabolite repression of
added glucose in E. coli. Further observations showed the toxicity effects by monitoring
growth kinetics in recombinant P. putida strains and its wild type strain (Table 3-4). The
expression of GADH showed a sharp drop of maximum growth rate (µmax), but observed a
moderate decrease of µmax in mGCD recombinant strain and a neglectable decrease in
empty vector strain, indicating a high toxicity effect of GADH expression to cell. In the
metabolic flux analysis of wild type P. putida KT2440, 90% of the uptake glucose was
converted into gluconate in periplasm and most of it into central metabolism as 6-
phosphogluconate further catabolized via ED pathway, while only about 12% of gluconate
converted into 2-ketogluconate in periplasm (Nikel et al., 2015a). The overexpression of
GADH would interrupt this naturally favoured carbon flux distribution significantly and lead
to higher accumulation of 2-ketogluconate. While the conversion of 2-ketogluconic to 6-
phosphogluconate consumes NADPH, and this attempt would finally result in cellular
redox imbalance which could significantly affect the well-being (Trachootham et al., 2008).
In contrast, overexpression mGCD led to the accumulation of gluconate, and caused less
negative effect to the host, indicated by growth kinetics (Table 3-4). Although all mutants
were observed more or less slowed down in growth rate, the glucose uptake rates were
substantially increased when overexpression of mGCD or both (rs, Table 3-4). The
overexpression of glucose dehydrogenase (mGCD) could facilitate the conversion of
glucose to gluconate, while this process could be further enhanced by additional
overexpression of gluconate dehydrogenase (Table 3-4). However, the overexpression of
GADH only resulted in a significant decrease of glucose uptake, possibly because of the
aftermath of redox imbalance discussed above.
Overexpression of dehydrogenase mGCD and GADH showed perturbation to both the cell
maximum growth rate and glucose uptake rate, but all the mutants could reach reasonable
same levels of the maximum cell densities as the wild type strain (Cx, max, Table 3-4).
This indicated overexpression two enzymes strongly interfering the early steps of
glycolysis, but the perturbation do not impede the expression of functional protein
expression.
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Table 3-4 Growth kinetics of P. putida KT2440 and its mutants.
Strains µmax [h-1]
Cx, max
[g CDW/L]
rs
[mmol/g
CDW/h]
P. putida KT2440
0.68 ±
0.04
1.89 ±
0.07
16.75 ± 1.32
P. putida KT2440/644D
0.65 ±
0.05
1.74 ±
0.03
19.22 ± 1.27
P. putida KT2440/644D-mgcd
0.51 ±
0.02
1.69 ±
0.03
24.01 ± 0.76
P. putida KT2440/644D-gadh
0.33 ±
0.02
1.77 ±
0.04
12.39 ± 0.45
P. putida KT2440/644D-mgcd-gadh
0.38 ±
0.02
1.63 ±
0.07
30.76 ± 3.94
All data presented are average and standard deviation of at least three biological repeats.
Experiments were mainly conducted by the author, and assisted by Bin Lai and Endah
Lestari.
3.4.4 Overexpression of mGCD and GADH increase the electron transfer rate and
improve the anoxic metabolism of Pseudomonas putida
After confirming mGCD and GADH as good metabolic engineering targets, the
electrochemical production was evaluated next. These two dehydrogenases were
regulated in the same promoter Ptrc and operator and similar strength synthetic RBS
(Salis et al., 2009), transcriptionally stopped either by an artificial terminator (BBa_B1002)
and lambda T0 terminator, respectively. The putative RNAase E binding site in gadh gene
cluster was analysed by Operon calculator to optimize coding sequence (Salis et al., 2009),
and the putative RNAase E binding site was removed to increase mRNA stability. BES
fermentations were performed with the mutant P. putida KT2440/644D-mgcd-gadh, with
control groups of the wild type and the empty vector strain. After induction time of 6 h and
12 h for testing strains, cells were collected for inoculation into BES system. BES
fermentation results were shown in Figure 3-2 and numerical data were presented in Table
3-4.
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Figure 3–3 Representative profiles of electrochemical activity and anoxic glucose
catabolism of P. putida KT2440/644D induction for 6 hours (A), P. putida
KT2440/644D-GK induction for 6 hours (B), and induction for 12 (C) in bio-
electrochemical system. P. putida KT2440/644D-GK was added inducer IPTG when
OD600 of 0.3-0.4, and induced for 6 or 12 hours for protein expression, followed by cell
collection and fermentation in BES. All experiments at least run two batches in BES.
Empty vector strain has four batches, and the double expression mutant has run four
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batches for the 6 hour induction (B), and two batches for 12 hours induction (C). The
experiments were conducted with support from lab member Bin Lai.
In sum, the recombinant strain P. putida KT2440/644D-mgcd-gadh strain gave
distinguished performance compared to the wild type strain (Figure 3.2) in BES. The
electrochemical production time was shortened from over 400 h to less than 250 h, and
the glucose conversion rate was doubled. The peak current density right after inoculation
was increased from ~0.025 mA/cm2 for wild type strain to be about 0.06 mA/cm2 for the
mutant, which was mainly due to the mGCD and GADH overexpression in the inoculum.
The overall maximum current density was also doubled, from about 0.04 to 0.08 mA/cm2.
In addition, longer induction time (12 h), showed better performance in the operation time
and peak current (Figure 3-2 B, C). All these results demonstrated the important role of the
two membrane dehydrogenases in the electron transportation process and anoxic sugar
metabolism in BES condition. In this case, the long induction mutant achieved nearly a
threefold increase productivity of 2-ketogluconate (Table 3-4).
Table 3-5 Glucose catabolism by P. putida KT2440 and its mutants in BES
Groups 1 2 3 4
strains KT2440 KT2440/ 644D KT2440/644D-GK
Induction Time NA 6 h 6 h 12 h
CB [%] 98.63 96.64 93.20 97.30
CE [%] 102.39 98.48 95.30 96.50
Yields [molproduct / molglucose]
Y2-ketogluconate 0.68 ± 0.04 0.92 ± 0.01 0.81 ± 0.02 0.86 ± 0.01
Yacetate 0.26 ± 0.03 0.10 ± 0.01 0.19 ± 0.03 0.15 ± 0.01
Ygluconate 0.13 ± 0.01 0 0.12 ± 0.03 0.09 ± 0.003
Yelectrons 4.1 ± 0.14 3.95 ± 0.04 3.85 ± 0.08 3.97 ± 0.03
Rates [mmol/L/day]
rglucose 0.67 ± 0.02 1.03 ± 0.06 0.76± 0.86 0.96 ± 0.19
r2-ketogluconate 0.44 ± 0.01 0.90 ± 0.03 0.61 ± 0.07 0.91 ± 0.03
racetate 0.26 ± 0.03 0.12 ± 0.01 0.2 ± 0.05 0.22 ± 0.01
rgluconate 0.06 ± 0.002 0 0.06 ± 0.02 0.05 ± 0.001
relectrons 2.59 ± 0.28 4.05 ± 0.16 3.09 ± 0.29 4.32 ± 0.04
2-ketogluconate Productivity(mmol/gCDW/day)
0.56 ± 0.01 1.44 ± 0.1 0.99 ± 0.16 1.59 ± 0.00
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Note:
For each group of experiments, there were at least two batches electrochemical production in the
bio-electrochemical reactors (4 batches for group 3 and group 2, and the rest groups run for 2
batches for each group 1 and 2). The author performed four batches of experiments and others
were performed by lab member Bin Lai. Yields obtained were plotted the plotting the products
quantity against consumed glucose. Rates were based on average value over the whole processes.
The calculation of productivity is based on the assumption of no biomass formation and no cell
death during electrochemical production process and initial inoculum biomass was used all the
calculation. This is because the biofilm formation on the anode influence the measurement of
biomass making calculation for each time point is impossible.
Unexpectedly, the empty vector control has a similar glucose conversion rate with mutant,
a higher glucose conversion rate than that in wild type KT2440. Undoubtedly, PQQ is
essential as a bound cofactor for a functional holoenzyme of mGCD and simultaneously
upregulated PQQ biosynthesis and mGCD would be expected to enhance glucose
catabolism in BES fermentation. The possible reason for the higher rate for empty vector
control is oxidative stress from antibiotics induced beneficial proteins expressions. It was
reported that antibiotic chloramphenicol can induce the PQQ biosynthesis gene cluster
upregulation in P. putida KT2440, while the PQQ not only serves as an important cofactor
for a number of dehydrogenases, but is also involved in anti-oxidative defence (Fernández
et al., 2012a). In this study, the detected better performance of the empty vector control
may contribute to the upregulation of PQQ synthesis, but further experiments are needed
to confirm this.
Although the empty vector control achieved similar glucose conversion rate to the mutant,
the mutant performed in an un-optimized condition which the expression level of glucose
dehydrogenase and gluconate dehydrogenase can be optimized for electrochemical
production. Given enzymatic kinetics studies of the glucose dehydrogenase and gluconate
dehydrogenase from P. fluorescens, the maximum reaction rate for D-gluconate
dehydrogenase (277 µM (min·mg)-1) (MATSUSHITA et al., 1979), was almost 4 times
higher than D-glucose dehydrogenase (57 µM (min·mg)-1) using ferricyanide as electron
acceptor (Matsushita et al., 1980). Therefore, the next consideration for further improving
the productivity in BES is to investigate the protein expression levels and their effects.
3.4.5 RT-PCR reveals expression of mGCD could induce GADH expression
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Glucose and gluconate can induce the expression of glucose dehydrogenase from P.
aeruginosa (Goodwin and Anthony, 1998; Whiting et al., 1976), and gluconate can induce
gluconate dehydrogenase from P. aeruginosa (Hunt and Phibbs, 1983) and the ED-
pathway enzymes in P. fluorescens (Quay et al., 1972). To test substrate and product
regulation for these two enzymes, quantitative real-time PCR (Figure 3-4) was performed.
Two strains, P. putida KT2440/644D-mgcd and P. putida KT2440/644D-gadh, were
constructed, with each only containing the gene mgcd or gadh respectively. Regarding to
the mGcd overexpressing strain, the RNA levels of mgcd across time were showed a
downwards trend, suggesting that mGCD expression level was downregulated during the
time period examined. Although mgcd in the plasmid was induced by the inducer IPTG,
the mgcd expression level was downregulated simultaneously with the decrease of
concentration of glucose and gluconate (Figure 3-4, B and C, Table 3-4 growth kinetics),
which hinted mgcd was likely to be induced by glucose and gluconate. However, the
expression level of gadh was also much higher at time 0 h than the wild type strain, and a
peak value was detected at time 3 h (Figure 3-4 B). This indicated that the expression of
GADH was also induced in the strain P. putida KT2440/644D-mgcd, and the likely process
was GADH was induced by gluconate and the expression level followed the decrease of
the gluconate concentration. As mentioned above, glucose dehydrogenase and from P.
aeruginosa were induced by glucose and gluconate, but gluconate dehydrogenase
enzyme complex was induced by gluconate only. Based on our result, it is highly possible
that similar regulation pattern exists in P. putida KT2440. The GADH strain has an
extremely high expression level in comparison to the native mGCD (NmGCD) expression
from genome, reach to more than 400 fold difference between the GADH and NmGCD
(Figure 3-4 C). In contrast, the expression of glucose dehydrogenase from plasmid
enhanced the accumulation of gluconate, while this potential inducer gluconate could
stimulate the expression of gluconate dehydrogenase from genome (Figure 3-4 C). In sum,
the GADH enzymatic catalysis product 2-ketogluconate did not induce the mgcd,
otherwise upregulation expression level should have been observed in GADH strain. This
intrinsic regulation is likely to satisfy cellular glucose metabolism when overexpressing
mgcd only and native GADH from genome could be upregulated by the inducer gluconate
corresponding to cellular gluconate.
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Figure 3–4 Evaluation of regulation between mGCD and GADH in P. putida KT2440.
(A) The putative regulation pattern of mGCD and GADH in P. putida KT2440. (B, C)
quantitative PCR results of the mGCD or GADH expression strain respectively. Both
mGCD and GADH were examined in both strains, and three time points were tested (0 h,
3 h, 6 h after the addition of inducer IPTG). The relative expression level was normalised
to the wild type P. putida KT2440. Data presented were mean ± SD (n, 3).
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3.4.6 Productivity of 2-ketogluconate boosted by mGCD overexpression
The native GADH was shown to be up regulated when only mGCD was overexpressed,
and the expression of GADH was well regulated by the concentration first enzyme mGCD
product gluconate. (Figure 3-4). In P. putida KT2440, mGCD like other glucose
dehydrogenase from the Pseudomonas family can be induced by glucose and gluconate
(Whiting et al., 1976), GADH is likely to be regulated by gluconate. Based on the above
analysis, overexpression of GADH is unnecessary. It might even be deleterious to the cells.
Considering the overexpression of GADH could increase metabolic burden or membrane
protein overexpression associated problems to cells. Furthermore, the overexpression of
the GADH enzyme complex probably needs the upregulation of the synthesis of the
corresponding cofactors (heme and FAD). Therefore, a possible approach to optimize the
ratio between mGCD and GADH would be overexpressing mgcd gene only by the
recombinant plasmid with intrinsic self-regulation system to induce native GADH
expression. This optimised condition could possibly result in a very high production rate of
2-ketogluconte without the side effects from overexpression of GADH.
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Figure 3–5 Evaluation of the BES fermentations with mGCD strain. (A) Anodic current
density and metabolic profile of P. putida KT2440/644D-mgcd in BES. (B)Glucose
consumption rate and and products formation rate. Mutant aerobically grown in DM9
medium with 6 hours induction for mGCD expression. All data were from at least three
biological repeats. All biomass used for the calculation is using the measured initial
biomass of inoculum for bio-electrochemical reactors. Figure was reproduced from the
data provided by Bin Lai.
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As expected, the electron transfer rate and production rate were significantly improved in
the mutant P. putida KT2440/644D-mgcd in BES. The current density reached 0.10
mA/cm2 within 30 hours and peaked at 0.12 mA/cm2 until glucose was fully consumed
(Figure 3-5). The peak current density was over three folds higher than that of wild type,
around 1.5 folds as higher as double dehydrogenase expression mutant (644D-GK),
around 10 % higher than the strain containing empty vector. The faster electron transfer
resulted in significant improvement in operation time in BES system, shortened two thirds
of time for wild type, and half of time for double enzyme expression mutant or empty vector
control strain. The whole electrochemical production process operated around 130 h, and
achieved a productivity of 3.17 ± 0.44 mmol/gCDW/day for 2-ketogluconate , which was
558% of that of wild type strain, strongly demonstrated to improve productivity by
metabolic engineering membrane dehydrogenases and optimized using self-regulation.
3.5 Conclusions
Pseudomonas spp. has the advantages of being considered as a next generation synthetic
biology chassis and, can be integrated with the advanced technique of bio-electrochemical
systems to overcome cellular redox imbalance problems. The low productivity currently still
limits industrial application for most of the current electrochemical production process. Two
dehydrogenases involved in glucose catabolism coupled with electron transportation were
overexpressed, resulted in a significant improvement of 2-ketogluconate production rate.
The real time RT-qPCR hinted intrinsic regulation system where the glucose
dehydrogenase was induced glucose and its product gluconate and gluconate
dehydrogenase was only induced by its substrate gluconate. Utilized this self-regulation
system, the overexpression glucose dehydrogenase (mGCD strain) in plasmid only
already satisfy the requirement of optimized the expression level of glucose
dehydrogenase and gluconate dehydrogenase in a reasonable range. The strain mGCD
showed outstanding performance in BES, the specific glucose consumption rate and 2-
ketogluconate productivity were 364% and 558% increased of rates by wild type P. putida
KT2440 respectively. This work showed promising potential to significantly improve the
productivity by manipulating redox balances involving in the expression specific
dehydrogenases that coupled catalytic reaction to electron transport chain, and the
optimization of expression indicated it was important for the improvement of productivity
and the fitness of bacteria.
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Chapter 4 The effects of aerobic growth conditions on electrochemical
production by P. putida KT2440/644D-GK during aerobic-anaerobic
dual-phase fermentation
The electrochemical production processes were performed in a way of aerobic-anaerobic
dual-phase fermentation, and each phase was optimized for the improvement of
productivity and/or carbon yield. The optimization of anaerobic conditions such as the
selection of working electrode, stirrer speed and redox potential resulted in a maximal
para-hydroxybenzoate (PHBA). yield of of 9.91 mmolCPHBA molC-1citrate with a 68%
increase in aerobic PHBA yield by the strain of KT∆pobA/234U in the optimized stirrer
speed of 700 rpm and the redox potential EMedium at 225 mV (vs. Ag/AgCl) (Hintermayer et
al., 2016). This work was done in collaboration with Sarah Hintermayer. In the previous
observation, the PHBA production strain P. putida KT∆pobApheA∆trpE∆hexR/234UA
aerobically grew on glucose as sole carbon source but failed to produce the detectable
para-hydroxybenzoate (PHBA) in a bio-electrochemical system. When this mutant strain
was aerobically grown on terrific broth resulted in a small amount of accumulation of PHBA
over time in the bio-electrochemical system (Figure 4-1). Therefore, I hypothesize that
different growth conditions, especially different carbon sources in aerobic growth of first
phase will influence cells performance in the second phase for electrochemical production.
In this chapter, I mainly focus on the optimization of aerobic conditions and possible
explanation for the observation.
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Figure 4–1 The electrochemical activity and anoxic metabolism by the PHBA
production strain P. putida KT∆pobApheA∆trpE∆hexR/234UA in bio-electrochemical
system. The strain grew aerobically on terrific broth added 0.8 % (v/v) glycerol as the
carbon source. Cells were added 1mM IPTG when OD600 reached to 0.3  0.4, and
collected as inoculum in bio-electrochemical reactors. There are three-batch tests for
PHBA electrochemical production.
4.1 Abstract
The 2-ketogluconate production by P. putida KT2440/644D-GK involved two phas
processes: the growth phase (the first phase in aerobic condition) and the electrochemical
production process (the second phase in anaerobic condition). Cells were grown in
different medium and carbon sources were investigated for the effects on the second
phase performance. The rich medium (terrific broth, TB) and minimal medium with glycerol
as the carbon sources showed a remarkable performance in second phase of
electrochemical production than the minimal medium with glucose as the carbon sources.
The TB-grown cells used around 113 hours to convert around 91% glucose to be 2-
ketogluconate with the productivity of 2.53 ± 0.09 mmol 2-KGA/gCDW/day; and the glycerol-
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grown cells achieved a highly pure product (around 98% carbon yield) and a slightly lower
productivity of 2.33 ± 0.43 mmol 2-KGA/gCDW/day; but the glucose-grown cells gave the
worse performance in terms of carbon yield, electron transfer rate or productivity. The
proteomics analysis suggested the overexpression gluconate dehydrogenase enzyme
complex was limited by cofactor-bound subunit PP_3382.
4.2 Introduction
Microbial bio-production to produce commodity chemicals, bioplastics and biofuels from
renewable resources has attracted plenty of research interest from metabolic engineering
community. For the large-scale production of bulk chemicals via bio-production processes,
the cost of feedstock accounts for more than 50 % of the total production cost (Noorman,
2015). The bio-production processes prefer to use cheaper, abundant and renewable
feedstock such as lignocellulosic hydrolysates and by-products from various industry
production processes e.g. straw (Wi et al., 2015), bagasse (Pereira et al., 2015), and
crude glycerol from biodiesel industry (da Silva et al., 2009). To use these feedstocks, it is
important to know the catabolism, regulations and metabolic responses. Glucose is
common carbon source favored by many bacteria, and the use in fermentation and its
catabolism and regulations have been extensively studied in many bacteria (Doelle et al.,
1982; Shimizu, 2013) including P. putida (Daddaoua et al., 2010; Nikel et al., 2014a; Nikel
et al., 2015b). In recent years, large-scale bio-production of biodiesel generates large
amount of glycerol as by-product, which can be a promising and abundant carbon sources
for industrial microbes (da Silva et al., 2009). P. putida S12 can efficiently use crude
glycerol as a feedstock without effects of growth inhibition that have caused harmful
effects to a number of other bacteria (da Silva et al., 2009; Ohrem and Voβ, 1996; Verhoef
et al., 2014). In P. putida, glycerol metabolizes via a glycerol kinase (GlpK) and glycerol
phosphate dehydrogenase (GlpD) to produce dihydroxyacetone phosphate which later
enters into central metabolism (Nikel et al., 2014a). P. putida growing on glycerol not only
changes the genes encoding metabolism but also alter genes involved in stress responses
and respiratory, signaling, transport system and many other unknown functions (Nikel et
al., 2014a).
The electrochemical production process was performed in an aerobic–anaerobic dual
phase mode, which comprise an initial aerobic growth phase followed by an anaerobic
production phase in bio-electrochemical system. Initial optimization was mainly focused on
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the second phase—the bio-electrochemical system such as electrode design, surface and
material modification, and scale up (Angenent and Rosenbaum, 2013; Couper et al., 1990;
Logan, 2010; Rosenbaum and Franks, 2014). However, the effect of the initial phase of
cell growth was overlooked. In this work, three different media compositions were
investigated for the culturing of the 2-ketogluconate production cells under aerobic growth
conditions and subsequent effects on electrochemical production under anaerobic
condition were studied. Results suggested medium compositions can greatly affect the
quality of inoculum which later produce distinct performance in electrochemical production.
Comparing glycerol and glucose as sole carbon source for the preparation of inoculum
suggested that glycerol-grown P. putida KT2440/644D-GK can better adapt to the
electrochemical environment. By revisiting the published transcriptomics data (Nikel et al.,
2014a) and combined analysis with proteomics data, it suggested cofactor synthesis
pathway upregulation is likely to be important for the maturation of apoenzymes in mutant
P. putida KT2440 overexpression of membrane-bound dehydrogenases.
4.3 Material and methods
4.3.1 Strains and cultivation, analytic methods
All material and methods can be referred to chapter 2 and chapter 3.
4.3.2 Proteomics samples preparation and data analysis
Cell pellets were collected by centrifugation (12, 000 g, 3min, 4 ℃) and immediately frozen
at -80 for all proteomics samples. Cells were resuspended in cell lysis buffer (Mandalakis
et al., 2013) containing proteinase inhibitor (cOmplete ULTRA Tablets, Roche Life Science,
Australia), and further disrupted by French Press three times (1500 psi, High position,
Thermo Fisher, Australia), followed by centrifugation (16,000 g, 4 °C) for 10 min to remove
the non-lysed cells and debris. Protein concentration was quantified using 2-D Quant kit
(80-6483-56, GE Healthcare Life Sciences, Australia). Protein digestion was performed
using the protocol of filter-aided sample preparation (Wisniewski et al., 2009). One
hundred microgram protein was loaded onto a membrane filter (MRCF0R030, Millipore,
Australia), and washed with UA buffer (8 M urea was dissolved in 100mM Tris-HCL, pH
8.5) twice by centrifugation (14,000 g, 15 min, room temperature). The proteins were
alkylated by added 100 µL UA buffer containing 50 mM iodoacetamide in darkness for 20
mins at room temperature. Samples were washed twice with 100 µL UA buffer and then
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another wash with 100 µL 50 mM ammonia bicarbonate buffer twice. Proteins were
digested by adding 40 µL ABC buffer and 1 ug trypsin (V5111, Promega, Australia)
overnight. The digested peptides were washed from the filter units by adding 40 µL 50 mM
ammonia bicarbonate buffer followed by centrifugation (14,000 g, 15 min, room
temperature). The eluted peptides were desalted by Ziptip C18 pipette tips (ZTCC18S096,
Merck Millipore, Australia), and then dried and resolved in 40 µL 0.1% formate in water.
Samples separation was using reversed-phase chromatography on a Shimadzu
Prominence nanoLC system (Austrailia) with a flow rate of 30 µl/min. Samples were
desalted on an Agilent C18 trap (0.3 x 5 mm, 5 µm) for 3 min, followed by separation on a
Vydac Everest C18 (300 A, 5 µm, 150 mm x 150 µm) column at a flow rate of 1 µl/min.
The peptides were separated using the a gradient of 10-60% buffer (acetonitrile with 0.1%
formate) over 45 min. Eluted peptides were injected into a 5600 TripleTOF mass
spectrometer (AB Sciex, Australia), followed by information dependent acquisition (IDA) of
up to 20 peptides with intensity greater than 100 counts, across 40-1800 m/z (0.05 sec per
spectra) using collision energy (CE) of 40 +/- 15 V. SWATH analyses was used 26 m/z
isolation windows for 0.1 sec, across 400-1250 m/z.
MS data were combined and searched using ProteinPilot version 5.01 to the Uniprot
database of P. putida KT2440 with 5947 proteins (assess date: /11/2016). The generated
files from the database searches were loaded to PeakView (version 1.2) and exported as
libraries in CSV format and further analysed using the software skyline (version 3.6-64 bit).
Protein intensities were exported using an external tool MPPReport (version 1.0).
Differentially expressed proteins were defined as the proteins that showed a fold change of
higher than 1.3 in relative abundance and a p-value <0.05.
4.4 Results and Discussion
4.4.1 Electro-fermentative PHBA production at optimal process conditions
The electrochemical production of PHBA and the optimization of condition in bio-
electrochemical system was investigated in P. putida KT2440 ΔpobA/234U which
overexpressed the chorismate-pyruvate lyase gene and deleted product degradation gene
encoding 4-hydroxybenzoate 3-monooxygenase from genome. To reduce interference and
simplify the research, the single knockout production host was chosen rather that aromatic
amino acids (AAA) auxotrophic mutants that produced a much higher amount of PHBA in
chapter 2. Because P. putida auxotrophic mutants requires the feeding of AAA solution,
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however the strains has the ability to utilize the aromatic amino acids as the carbon source
to support growth or degraded AAA via homogentisate degradation pathway (Arias-Barrau
et al., 2004), which making this proof of principle complicated.
A batch electro-fermentative production of pHBA was performed with a constant stirrer
speed of 700 rpm and a controlled redox potential in the medium at 225 mV (Figure 4-2 A)
by the feeding of K3Fe(CN)6 with the concentration from 0 mM to 100 mM at the end of the
batch process (Figure 4-2 H). The substrate citrate was catabolised in a constant rate
0.21 mmol (gX h)−1 during the process period of 0 h to 420 h, increased the uptake rate
after the stirrer speed increased, ended at a process time of 600 h due to substrate
depletion in the medium (Figure 4-2 B, F). Most of substrate was converted into malate
which reached to a maximal yield of 0.84 molCmalate molC−1citrate at a process time of 300 h
and a maximal concentration of 3.12 g L−1 and a yield of 0.75 molCmalate molC−1citrate at a
process time of 420 h. The target product PHBA was finally achieved 36.1 mg L−1 (9.91
mmolCpHBA molC−1citrate) (Figure 4-2 E). The biomass concentration was 0.32 g L−1 with a
yield of 0.07 molCX molC−1citrate. Under this conditions, the PHBA yield was 72 folds higher
than that operated at 400 rpm without feeding of redox mediator, increased by 69% in
comparison with the aerobic batch process, but the rates for growth, citrate uptake and
PHBA formation was 10 folds decreased compared to aerobic fermentation batch. In this
anodic batch electrochemical production system, the PHBA production strain
characterized with a the maximal growth rate 0.01 h−1, the maximal specific citrate uptake
rate 0.30 mmol (gX h)−1 and PHBA formation rate was 0.003 mmol (gX h)−1.
The low mass transfer rate was reduced by increased the stirrer speed. The mediator
K3Fe(CN)6 is unlikely to be a limitation here since this small molecular (MW 212 g mol-1)
can freely enter outer cell membrane via porins like OmpF that allowing molecule size up
to 600 kDa pass it (Arunmanee et al., 2014). Redox imbalance was one of key problem
for P. putida anodic electro-fermentation rather than the energy yield suggested in anoxic
metabolism in P. putida F1 in bio-electrochemical system (Lai et al., 2016), but it needs
further experimental verification for the mutant PHBA production strain. On the other side,
low respiratory rate is potentially slow down the catabolism resulted in slow rates of
substrate uptake, cell growth and production formation, in agreement with the observation
in E. coli and S. oneidensis (Andersen and Meyenburg, 1980; Carmona-Martinez et al.,
2011; Jensen et al., 2016).
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Figure 4–2 Electro-fermentative batch conversion of citrate with P. putida KT2440
ΔpobA/pSEVA-ubiC: Electro-fermentation with a stirrer speed of 700 rpm and
control of the redox potential in the medium at 225 mV. A: Stirrer speed (dashed line)
and redox potential in the medium (black line). (Cited from (Hintermayer et al., 2016))
4.4.2 Effects of different medium in the preparation of inoculum for anoxic glucose
catabolism by P. putida KT2440 /644D-GK in bio-electrochemical system
It was reported that E. coli aerobic growth conditions significantly influenced anaerobic
succinate production in dual fermentation because of upregulated enzymes activities in
aerobic conditions which provided intracellular redox balance for the succinate production
in the second phase anaerobic production (Jiang et al., 2010). The electrochemical
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production by P. putida KT2440/644D-GK also used aerobic–anaerobic dual phase
fermentation strategy, and it is interesting to know how aerobic growth conditions affect
anaerobic production in bio-electrochemical system. Medium optimization is often needed
to maximize the yield and reduce the production cost during the fermentation (Singh et al.,
2016b). In this study, three different media were investigated their effects on second phase
production: terrific broth + 0.08 % (v/v) glycerol, DM9 + 0.05% (w/v) glucose and DM9 +
0.08 % (v/v) glycerol.
The mutant P. putida KT2440/644D-GK performed obviously better in bio-electrochemical
system when inoculums were aerobically cultured in the media supplied with glycerol
(Figure 4-3). The current density was quickly increased after inoculation within one hour,
particularly TB-grown cells reached a current density of 0.075 mA /cm2, over 400 % higher
than the glucose-grown cells of 0.17 mA /cm2. TB-grown cells also reached to highest
peak current of 0.18 mA /cm2 and maintained high current density in the range of 0.16
0.18 mA /cm2 around 100 hours until the end of process. In contrast, glucose-grown cells
only reached to the peak current of 0.4 mA /cm2, and maintain the current density of 0.3 
0.4 mA /cm2 until the end of process. While the glycerol-grown cells showed a different
profile of current change over time, glycerol-grown cells reached to the current density of
0.7 mA /cm2 in 10 hours and further increased the current density to 0.13 in the mid of
process time, and decreased slowly until the process time 117 hour and followed by a
sharp decrease to reach the end of process. The results suggested TB-grown cells has
best interaction with mediator ferricyanide which further transport the electrons to the
working electrode shown a fastest increase of current density and the peak current in
comparison of glycerol-grown cells and glucose-grown cells (Figure 4-3 A). By looking into
the production processes, the TB-grown cells produced the highest amount of electrons,
slightly higher than glycerol-grown cells and glucose-grown cells (Figure 4-1 B, C, and D).
The pH value decreased quickly in TB-grown cells and glycerol-grown cells groups and
TB-grown cells reached to the lowest pH value of the three groups. An extremely slow
decrease rate in pH value was observed in glucose-grown cells (Figure 4-1 B, C, and D).
The main product 2-ketogluconate accumulated over time and stopped with the
consumption of glucose. The main by-products acetate and gluconate accumulated over
time in the TB-grown cells and glucose-grown cells, but were hardly detectable in the end
of electrochemical production in glycerol-grown cells groups (Figure 4-1 B, C, and D),
indicating glycerol-grown cells achieved a higher carbon yield in the electrochemical
production of 2-ketogluconate.
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Figure 4–3 The effects of aerobic growth conditions on electrochemical production
by P. putida KT2440/644D-GK during aerobic-anaerobic dual-phase fermentation. P.
putida KT2440/ 644D-GK were grown in the terrific broth (TB) + 0.08% (w/v) glycerol, DM9
+ 0.05% (w/v) glucose and DM9 + 0.08 % (w/v) glycerol, respectively. Cells were added
1mM inducer IPTG for 6 hours induction when the OD600 reached to 0.3-0.4. The TB-
grown cells were washed with DM9 medium before the inoculation remove residue
components from rich medium. Each condition at least has two batches of electrochemical
fermentation. Working electrode potential was set up at 0.5 V Vs reference electrode
(Ag/AgCl with saturated KCl, with 1mM potassium ferricyanide added as external electron
shuttle. (Note: all conditions were run at least two batches in bio-electrochemical system (8 batches in total)
in which two batches of glucose-grown cells dataset was provided by my team member Bin Lai.)
By looking at the yield and production rate for these three type aerobic conditions, the
glycerol-grown cell obtained superior highest carbon yield of 0.98±0.05 mol2-KGA molglucose-1
with a production rate of 2.33±0.43 mmol2-KGA gCDW -1day-1; the TB-grown cells gain the
second highest carbon yield of 0.91 ± 0.02 molproduct molglucose-1 with a 9% higher production
rate; the glucose-grown cells gave the worst performance both in carbon yield and
production rate (Table 4-1 A). The anodic Coulombic efficiency (CE) showed how efficient
electrons are transferred from the electron donor (glucose) to the electrode. All groups
achieved high Coulombic efficiency, and TB-grown cells has a CE over 100 % may due to
the residue substances from rich medium though the TB-grown cells have been washed
with fresh DM9 medium before inoculation. These results suggested the medium
components strongly influenced the aerobic physiological state and subsequently
influenced the adaptation in electrochemical production. The optimization of medium
formula is not only to increase the yield but also to significantly reduce the feedstock cost
as it account for major part of overall production cost (Noorman, 2015; Singh et al., 2016b).
In sum, the glycerol-grown cells in the aerobic conditions resulted in an overall better
performance in electrochemical production of 2-ketogluconate
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Table 4-1 The effects of aerobic growth conditions on electrochemical production
by P. putida KT2440/644D-GK during aerobic-anaerobic dual-phase fermentation.
Preculture medium
Group 1
DM9+0.05%
glucose
Group 2:
DM9+0.08%
glycerol
Group 3:
TB+0.08%
glycerol
Carbon balance [%] 117.87 101.09 108.79
Coulombic efficiency [%] 93.33 93.46 107.94
Yields (molproduct molglucose-1)
Y2KGA 0.85 ± 0.04 0.98 ± 0.05 0.91 ± 0.02
Yacetate 0.13 ± 0.01 0.09 ± 0.02 0.20 ± 0.03
Ygluconate 0.40 ± 0.10 0.12 ± 0.05 0.22 ± 0.04
Yelectrons 4.20 ± 0.07 4.00 ± 0.20 5.03 ± 0.09
Rates (mmol L-1 day-1)
rglucose 1.25 ± 0.05 1.53 ± 0.08 1.82 ± 0.08
racetate 0.16 ± 0.01 0.14 ± 0.01 0.36 ± 0.02
r2KGA 1.06 ± 0.04 1.50 ± 0.08 1.66 ± 0.07
rgluconate 0.50 ± 0.02 0.18 ± 0.01 0.40 ± 0.02
relectrons 5.25 ± 0.21 6.12 ± 0.32 9.15 ± 0.40
Productivity for 2-ketogluconate (mmol product gCDW-1 day-1)
0.99±0.16 2.33±0.43 2.53±0.09
Note: each group at least run two batches in the bio-electrochemical reactors (4 batches
for Group 1 in which 2 batches data was provided by Bin Lai, and 2 batches for each
Group 2 and Group 3). Yields obtained were plotted the products quantity against
consumed glucose. Rates were based on average value over the whole processes. The
calculation of productivity is based on the assumption of no biomass formation during
electrochemical production process and initial inoculum biomass was used all the
calculation.
4.4.3 Proteomics reveals the potential contributors for a better performance in
electrochemical production of 2-ketoglucoante
All heterotrophic microbes require nutrients (e.g. sources for carbon, nitrogen and
inorganic salts, etc.) for energy generation and cellular biosynthesis, and accordingly
medium composition has significant effect on microbial metabolism and physiology (Egli,
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2015). The carbon source is not only used for energy generation, but also provides the
basic building blocks for biomass, major cell components (proteins, carbohydrates, lipids
and nucleates), and the target product (Parekh and Vinci, 2002). While nitrogen source
support the biosynthesis of all-nitrogen containing compounds e.g. amino acids, purines
and pyrimidines (Parekh and Vinci, 2002). Media compositions strongly affected the
production strain performance in bio-electrochemical system (BES) (Figure 4-3). The
terrific broth (TB broth) has a very complicated medium components which probably have
multifaceted effects on the cells and subsequently incurred distinct performance in BES.
Note that the terrific broth was also added the considerable amount of glycerol used as the
carbon source, and therefore glycerol may have main contribution to the distinct
performance in BES. By comparing the glycerol-grown cells and glucose-grown cells in
the defined medium, glycerol is the composition resulted in a significant improvement of
electrochemical production. It is interesting to know why glycerol as the carbon source in
the aerobic cell growth can lead to such a big different performance in electrochemical
production.
The SWATH-MS proteomics identified 829 proteins, in which 594 proteins were quantified
and 367 differentially expressed proteins that may be associated to the growth on glycerol
(supplementary material for chapter 4). Proteins activities were lowered in peripheral
pathway, ED pathway and TCA cycle, but a higher activity of glyoxylate shunt was
observed in the glycerol-grown cells (Vs glucose-grown cells). These result was in
agreement with the transcriptomic prediction from a wild type P. putida KT2440 grew on
glycerol as sole carbon source (Vs glucose) (Nikel et al., 2014a). The proteins involved
electron transport merit the attention. The impermeable redox chemical ferricyanide is
reduced by the redox proteins and/or protein complexes on the cytoplasmic membrane
(Van Duijn et al., 1998). Although the interaction between ferricyanide and redox proteins
and / or complex is unclear, it suggested that ferricyanide could drain the electrons from
mitochondrial bc1 complex (Pasquali et al., 1985) and the terminal oxidases from B.
subtilis (Bisschop et al., 1975). It was also suggested that ferricyanide can obtain electrons
from some membrane quinohemprotein alcohol dehydrogenases (Matsushita et al., 1999;
Toyama et al., 1995), but failed to capture electrons from the methanol dehydrogenase or
type I alcohol dehydrogenase that did not contain a cytochrome c (Chen et al., 2002).
Proteins search in P. putida KT2440 genome database failed to find any quinohemprotein
alcohol dehydrogenases. Therefore, the detected increased abundance in several alcohol
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dehydrogenases did not contribute to the better performance in the bio-electrochemical
system.
P. putida KT2440 possesses five different terminal oxidases with different characteristics
in redox potential and regulation, oxygen affinity and proton pumping efficiency. (Nikel et
al., 2014a). The better performance in the bio-electrochemical system may attribute to the
increased abundance in Cbb3 type terminal oxidase and the decreased abundance of Cio
oxidase (bd type) and Cyo oxidase (bo3 type) (Table 4-2). In theoretically, the rates of
electron transfer increase when the Gibbs free energy change ∆G for the reaction
becomes more favourable (more negative) (Berg et al., 2015; Page et al., 1999). ). Based
on Nernst equation (Baucke, 1994), the negative ∆G is proportional to the positive cell
redox potential ∆E. Consequently, the higher electron transfer rate would be expected in
the redox reaction of higher difference of redox potential. Therefore, a faster electron
transfer rate is more likely to be observed between ferricyanide and Cbb type oxidases
than other type cytochrome oxidase. The experiments of reduction the ferricyanide by
different types of cytochromes suggested all other types of cytochromes can be oxidized
by ferricyanide except the cytochrome a cannot be or partially be oxidized by ferricyanide
(Bisschop et al., 1975; Cheldelin and King, 1957). Note that the difference of redox
potential ∆E is almost closed to zero for the ferricyanide and cytochrome a. The
differences of redox potentials for cytochromes and ferricyanide are showed below
(Kracke et al., 2015), suggesting the favourable redox reaction for the ferricyanide and
cytochromes.
[∆E=0.6 (Volts, 25 °C, pH,7] > ∆ECyt c (ox/red) > ∆ECyt b (ox/red) >∆ECyt o (ox/red)> ∆ECyt d (ox/red)> ∆ECyt
a (ox/red) ≈ 0)
Next, the evaluation will go to the impacts of glycerol on the overexpression of two
membrane-bound dehydrogenases mGCD (PP_1444) and GADH enzyme complex
(PP_3382, PP_3383 and PP_3384). The genomic annotation suggested this gluconate
dehydrogenase is a heterotrimeric subunit complex, in which PP_3382 contains
cytochrome c, PP_3383 contains flavin and PP_3384 is gamma subunit with unclear
function. It is reasonable understanding that the cofactors (e.g. FAD, heme and PQQ)
should have corresponding upregulation when overexpressed the glucose dehydrogenase
and gluconate dehydrogenases complex. This is because the insufficient supply of
cofactors will lead to high ratio of apoenzymes without function, which means the
apoenzymes needs to be folding correctly with their cofactors to form holoenzymes to fulfil
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the enzymatic functions (Akhtar and Jones, 2014). The involved cofactor biosynthesis
genes or pathways was indicated in Figure 4-4.
The cofactor pyrroloquinoline quinone (PQQ) serves as the prosthetic group for the
membrane-bound glucose dehydrogenase (PP_1444). This cofactor PQQ is found in
some dehydrogenases e.g. membrane glucose dehydrogenases, quinoprotein alcohol and
aldehyde dehydrogenases, and the enzymatic reactions were coupled with electrons
transfer chain (Goodwin and Anthony, 1998). PQQ synthesis is not coordinated with
apoenzyme biosynthesis, and it is actually made when the quinoprotein is also being
synthesized (Goodwin and Anthony, 1998). The PQQ biosynthesis pathway is not fully
understood currently, and genes involved PQQ synthesis in bacteria often contains the
conserved pqq gene cluster (pqqABCDEF) encoding proteins with unclear biochemical
functions (Choi et al., 2008). In P. putida KT2440, the pqqABCDEFH can at least form two
transcripts: the pqqABCDEH and and pqqF (Figure 4-4 A) The PQQ synthesis is
transcriptionally regulated and influenced by growth conditions (Choi et al., 2008; Gliese et
al., 2009). It is interesting to notice that the inconsistent results in two publications (An and
Moe, 2016; Nikel et al., 2014a), which the same strain P. putida KT2440 grown on DM9
medium with glycerol or glucose as the sole carbon sources. Apparently, it looks like both
publications conducted in a similar conditions. In fact, the trace amount of rich medium
introduced into minimal medium in An and Moe’s experiments may result opposite results.
The experiments and conducted experiments in this study are using the similar conditions
and procedure as author suggested (Nikel et al., 2014a). In this condition, the glycerol-
grown cells can lead to upregulation of PQQ biosynthesis pathway (Table 4-2), which may
contribute to the functional glucose dehydrogenase biosynthesis and subsequently lead to
a better electrochemical production. Although the proteomics failed to detect the PQQ
biosynthesis proteins due to the low abundance in the extracted protein samples.
The gluconate dehygorenase enzyme complex contains the cofactors of heme and FAD.
In gammaproteobacteria, heme synthesis is used the C5-pathway, genes encoding heme
synthesis enzymes are subjected to multiple level regulations such as transcription,
proteolysis and growth conditions in gammaproteobacteria (e.g. E. coli and P. aeruginosa)
(Schobert and Jahn, 2002). This regulation pattern may be helpful to bacteria that can
avoid to accumulate the free heme or biosynthetic intermediates of the pathway, which can
cause toxicity to the cells (Nakahigashi et al., 1991). The regulation of heme synthesis is
not fully understood, and the information is limited to several model bacteria (e.g. E. coli
and P. aeruginosa) (Schobert and Jahn, 2002). Proteomics identified several genes
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(hemBFN, and PP_0189) that were responsible for the heme synthesis, but only hemF
showed down-regulation in glycerol condition (Vs glucose) and others were failed to
quantify. Further study is needed to confirm it. FAD is another important cofactor for the
gluconate dehydrogenase enzyme complex. In bacteria, the flavin biosynthesis starts from
guanosine 5’-triphosphate (GTP) and ribulose-4-phosphate (Ru5P) as substrates, which
are produced from two branches of pathway (Figure 4-4) (Abbas and Sibirny, 2011).
Regulation of riboflavin synthesis is repressed at transcriptional level by flavin
mononucleotide (FMN) via the so-called riboswitch that the cofactor FMN binds to nascent
noncoding mRNA and blocks further transcription (Abbas and Sibirny, 2011). Flavin
synthesis is not as precisely adjusted to the physiological needs, and is found
overproduced in E. coli, B. subtilis and P. fluorescens (Wilson and Pardee, 1962). But it is
not clear whether P. putida KT2440 overproduce flavin.
Although other proteins showed differentiated expression changes when cells were grown
on glycerol (supplymentary material Table S4-1), how these expression level changes
influence the electron transfer and the interaction with mediator is unclear. The significant
up-regulation of PQQ synthesis pathway and cytochrome c maturation pathway was
revealed by the published transcriptomics data (Nikel et al., 2014a), and FAD synthesis
pathway was slightly downregulated suggested by proteomics data. But it cannot confirm
that the downregulation of cofactor biosynthesis pathway will become the limiting factor for
the maturation of gluconate dehydrogenase enzyme complex. The further analysis of
gluconate dehydrogenase enzyme complex will be discussed in the next section.
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Table 4-2 Gene changes in cells grown on glycerol compared to glucose and only
listed genes that may influence the electrochemical production.
Genes name Up-
regulation
Down-
regulation
functions
(pqqBCDE) a + Cofactors PQQ biosynthesis
(ccmCDEF) a + Cytochrome c maturation
ssuE a, ribH b -, - Riboflavin biosynthesis
hemF b - Heme synthesis
ccoO-2 a, ccoN-2 a,
ccoP-2 a,b,
ccoQ-2 a
+ Electron transfer chain
Terminal oxidasesa
Cbb3-1, Cbb3-2
cyoA a,b,cyoB a,b,
cyoC a, cyoD a, cyoE-2
a
-, -,
-, -, -
Electron transfer chain
Terminal oxidases: bo3 oxidase
Note:
a: transcriptomics data indicated (data from the publication (Nikel et al., 2014a)). The wild
type P. putida KT2440 grown on glycerol and glucose and collected in the log phase
(OD600 = 0.5);
b: Proteomics data. Mutant P. putida KT2440/644D-GK grown on glycerol and glucose,
collected after 6 hours induction.
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Figure 4–4 Genes involve cofactor synthesis or apoenzyme maturation by P. putida
KT2440.
(A) PPQ synthesis gene cluster (pqqABCDEFH), PP_0375 is annotated as pqqH here
based on its high orthologous relationship with pqqH from P. aeruginosa PAO1; (B)
cytochrome c maturation genes (ccmABCDEFGHI), cycH is alternative name for ccmI.
PP_4319 is a hypothetic protein co-transcribed with ccmCDEFGHI; (C) riboflavin synthesis
pathway and the involved genes; (D) heme systhesis pathway in P. putida KT2440. All
information was from Pseudomonas genome database and KEGG.
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4.4.4 Quantitative proteomics reveals the cask effect for the expression of
gluconate dehydrogenase enzyme complex
In P. aeruginosa, the gluconate dehydrogenase (GADH) was heterotrimeric enzyme
complex containing three subunits (cytochrome c precursor subunit, subunit containing
Flavin, and subunit with unknown function) (Matsushita et al., 1982). The genes encoding
three subunits for gluconate dehydrogenase enzyme complex from P. aeruginosa were
organized as an operon. The gluconate dehydrogenase enzyme complex from P. putida
KT2440 has a similar gene organization and each subunit has a high identity in amino acid
sequence compared to the subunits from P. aeruginosa (74% for PP_3382, 76% for
PP_3383, and 58 % for PP_3384). Gluconate dehydrogenase enzyme complex from P.
putida KT2440 is highly likely to form heterotrimeric enzyme complex. The biosynthesis
and assemble of each subunit is important for the formation of gluconate dehydrogenase,
and ratio of each subunit in the enzyme complex naturally favors to be 1:1:1. In this
section, the expression of subunits of gluconate dehydrogenase was evaluated.
If we assumed the gluconate dehydrogenase enzyme complex achieved the desirable
ratio of 1:1:1 in wild type, then the expression of subunits in the gluconate dehydrogenase
enzyme complex showed an imbalanced biosynthesis (Figure 4-5). This indicated that the
maturation of gluconate dehydrogenase enzyme complex was limited by the biosynthesis
of subunit PP_3382. Compared to the growth on glucose, the glycerol-grown cells showed
less imbalanced expression of gluconate dehydrogenase enzyme complex. By analyzing
the amino acid sequence of the subunit PP_3382, three heme c binding motifs were found:
C41VACH45, C188GACH192 and C324CACH328. As suggested before, the gene hemF was
slightly down-regulated compared to glucose-grown cells. But due to the heme synthesis
pathway is subjected to multiple level regulation, further experimental confirmation is
needed. The subunit PP_3382 contains c-type cytochrome, and the maturation of c-type
cytochromes needs the attachment of heme to apocytochromes that are assisted by three
cytochrome c maturation system (Thöny-Meyer, 2002). The Pseudomonas species use
the cytochrome c maturation (ccm) – system I, which contains nine (CcmABCDEFGHI,
Figure 4-4 B) membrane proteins working together to deliver and attach the cofactor to
apocytochrome (Cianciotto et al., 2005). The co-expression the ccm genes with c-types
cytochromes have been demonstrated the beneficial effects for the functional cytochrome
c in E. coli (Arslan et al., 1998).The subunit PP_3382 abundance in mutant strain was over
three folds of that in wild type, and the glycerol-grown cells was slightly higher than
glucose-grown cells. The cofactor heme attachment was important for the stability of c-
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type cytochromes and barely has the accumulation in heme-deficient cells (Gao and
O'Brian, 2007). The detected increase amount of subunit PP_3382 was consistent with
transcriptomics data that the upregulation of cytochrome c maturation pathway in glycerol-
grown cells (Nikel et al., 2014a).
The subunit PP_3383 contains FAD as the cofactor. The flavinylation and assembly with
apoproteins could prevent the protein degradation (Henriques et al., 2009; Kim and Winge,
2013), suggesting that the cofactor biosynthesis is important for the proteins function and
stability. Only one gene ssuE (PP_0236) encoding the enzyme in the branch of riboflavin
synthesis pathway showed down-regulation by transcriptomics analysis(Nikel et al.,
2014a), but the down-regulation of branch for FMNH2 synthesis does not necessary
indicate another branch for FAD synthesis also was downregulated as well in glycerol-
grown cells. However, the detected another gene ribH (PP_0517) encoding the enzyme
from the stem pathway for the riboflavin synthesis was slightly down-regulated suggested
by proteomics analysis (Table 4-2), this finding implied the riboflavin biosynthesis was
downregulated in the glycerol-grown cells (Figure 4-5). But the downregulation of FAD
biosynthesis pathway does not suggest insufficient supply of flavin will be occurred, which
subsequently influence the maturation of gluconate dehydrogenase. Compared to the wild
type grown on glucose, the abundance of PP_3383 has a greatest increasing range
among the three subunits (Figure 4-5). The overexpression strain showed the abundance
of subunit PP_3383 was 46 and 76 fold increase in glycerol-grown cell and mutant
glucose-grown cells, respectively. This result of detected less abundance of PP_3383 in
mutant glycerol-grown cells was in agreement with the down-regulation FAD biosynthesis
pathway in this condition. In addition, the subunit PP_3384 in the mutant strain were
detected a significant increased amount in glycerol-grown cells and glucose-grown cells in
comparison with wild type, but the glycerol-grown cells showed a less increasing range
than the glucose-grown cells. Overall, the glycerol-grown cell showed better expression of
gluconate dehydrogenase enzyme complex.
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Figure 4–5 The detected abundance of three subunits of gluconate dehydrogenase
in mutant P. putida KT2440/644D-GK and its wild type using glycerol or glucose as
the sole carbon source. Ratios for relative abundance of each subunit were calculated as:
each subunit abundance from mutant strain divided its abundance of the corresponding
subunit in wild type. Data were presented as mean value from three biological samples.
In sum, the expression of gluconate dehydrogenase enzyme complex in mutant using
different carbon source suggested that an imbalanced biosynthesis of subunits in
gluconate dehydrogenase enzyme complex. The observation of “cask effect” formation of
holoenzyme complex in mutant indicated PP_3382 was the short plank in mutant strain
(Figure 4-5). The limited amount of formation of PP_3382 was likely limited by the ability of
cytochrome c maturation machinery and/or heme biosynthesis. The glycerol-grown cells
showed better expression of gluconate dehydrogenase enzyme complex compared to the
glucose-grown cells. This may attribute to a better performance in the electrochemical
production by glycerol-grown cells.
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4.5 Conclusions
In aerobic-anaerobic dual production process by P. putida KT2440/644D-GK, the growth
condition in the first phase can significantly influence the performance in electrochemical
production of second phase. Cells grown in terrific broth or using glycerol as sole carbon in
DM9 medium can lead to remarkable improvement in electron transfer, carbon yield and
productivity. The TB-grown cells and glycerol-grown cells achieved high carbon yield (over
90%) and more than two folds higher of production rate than glucose-grown cells
(2.33±0.43 mmol 2-KGA/gCDW/day and 2.53±0.09 mmol 2-KGA/gCDW/day, respectively for cells
grown on TB and DM9 + glycerol). Proteomics analysis suggested the better performance
by the glycerol-grown cells may attribute to the simulation of the upregulation for cofactors
biosynthesis pathway, and maturation of gluconate dehydrogenase enzyme complex is
likely limited by the synthesized cofactor bounded subunit PP_3382. This work suggested
growth conditions can be optimized for simulation of the upregulation of the cofactors for
the dehydrogenases, but may lead to different expression level of subunits which influence
the amount of functional enzyme complex.
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Chapter 5 Conclusions and perspectives
5.1Thesis conclusions
For the past three decades, microbes have been engineered to synthesize various
compounds, including chemicals, biofuels, biopharmaceuticals, and polymers. However,
these microbial cell factories are limited to laboratory-scale due to the high production cost,
low yield and low production efficiency. There have been many efforts to push the
transition from laboratory-scale to industrial production. One such approach is using a
robust production host such as Pseudomonas putida. In this thesis, I performed studies to
tackle several problems in the production of para-hydroxybenzoate (PHBA) when using
traditional cell factories. To expand the potential of P. putida, anaerobic production was
explored using a bio-electrochemical system.
First, P. putida was rationally engineered to develop PHBA production strains and the
aerobic PHBA production process was established, which is shown in Chapter 2. The best
strain ultimately achieved a higher carbon yield than that reported in engineered E. coli
strains using the UbiC conversion route, and slightly higher than P. putida using the
coumarate pathway. This work allows the readers to better understand the differences
between the shikimate pathway and the expanded pathway in P. putida and E. coli, which
would promote Pseudomonas strain development and improvement for production of
aromatics. The developed PHBA production strains could be used as platform strains for
the production of other shikimate pathway-derived compounds.
Despite the successful fed-batch fermentation in this study, oxygen supply is a common
problem for obligate aerobes in large-scale fermentations. To overcome the difficulties of
large-scale aerobic fermentation, the production of PHBA and 2-ketogluconate were
explored via a bio-electrochemical system under anaerobic conditions. The wild type P.
putida strain KT2440 can perform anoxic metabolism to oxidise glucose to 2-ketogluconate,
but with a low productivity and carbon yield. The overexpression of glucose
dehydrogenase and the gluconate dehydrogenase enzyme complex substantially
improved the electron transfer rate, resulting in better productivity than the wild type. This
shows that overexpression of periplasmic enzymes can lead to an increased electron
transfer rate, and improved yield and productivity. This work also reveals the potential
transcriptional regulation of these two enzymes, and thereby offers a strategy for gene
expression and optimization.
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Finally, to further improve the electron transfer rate, the working electrode, stirrer speed
and redox potential were optimized for the batch production of PHBA in a bio-
electrochemical reactor. This collaborative work with Sarah Hintermayer shows the
feasibility of anaerobic production of PHBA using a bio-electrochemical system. The
effects of aerobic cultivation conditions on electrochemical production were investigated.
This work shows that glycerol as a medium component contributes to better performance
in bio-electrochemical production of 2-ketolguconate and PHBA. Proteomics analysis
revealed that gluconate dehydrogenase complex formation was limited by the low
abundance of the subunit containing cytochrome c.
This thesis presents PHBA production via chorismate lyase (UbiC) conversion route in
Pseudomonas putida KT2440, and demonstrates the feasibility of producing PHBA and 2-
ketogluconate in P. putida KT2440 via a bio-electrochemical system. The yield and
productivity has not reached the optimal level, and more work can be done to further
improve the yield and titre, or the electron transfer rate in a bio-electrochemical system.
5.2 Challenges
5.2.1 Challenges with Pseudomonas as a chassis for industrial biotechnology
With the need for sustainable development, industrial biotechnology holds great promise
for tackling environmental issues and resource depletion, as well as providing the world
with food, energy and materials. Over the last two decades, many compounds have been
successfully biosynthesized at the laboratory scale, but only a handful of them have been
commercialized. There are several challenges that impede commercialization of
biotechnological production processes. Firstly, compared to chemical production routes,
the yield and productivity of current microbial cell factories (e.g. E. coli, C. glutamicum, S.
cerevisiae and Bacillus) are generally very low. Secondly, product separation and
purification accounts for a considerable part of the production cost, especially when
fermentation titres are low. Thirdly, feedstock pretreatment (e.g. lignocellulosic
hydrolysates) and the production facilities for fermentation are costly. Finally, scaling the
aerobic microbial bio-production process is very challenging, and requires additional
capital and operating costs for the supply of oxygen. As discussed earlier in this thesis, P.
putida is recommended as a next generation synthetic biology chassis for its robustness,
versatile metabolism, low nutritional requirements and genetic accessibility. For example,
remarkable tolerance of many compounds allows for the production of high product titres
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without inhibitory effects. This feature implys the potential to achieve higher titres that
could reduce product recovery costs. Furthermore, feedstocks such as lignocellulosic
hydrolysates often contain many toxic substances, and the high tolerance of P. putida may
enable use of this cheap feedstock, significantly reducing production costs.
The challenges for developing Pseudomonas as a chassis in the biotech industry:
1. Systems biology knowledge for Pseudomonas is largely missing, which makes
rational strain engineering difficult.
2. Current key production processes are built on other model microbes. The aerobic
fermentation for obligate aerobes is difficult to scale up.
3. More convenient toolkits are needed for strain development and rapid integration of
synthetic pathways.
5.2.1 Challenges with industrial bio-electrochemical production
The current bio-electrochemical production processes are faced with the problems of low
productivity and/or low yield, which limit their industrial application. Successful
commercialization of bio-electrochemical production will require significant improvement in
the electron transfer rate. However, this is limited by the little scientific knowledge of the
extracellular electron transfer mechanism. Besides, the interaction between redox
mediators and the electron transport chain is unknown. These factors greatly limit strain
development for microbial electrosynthesis. Moreover, the manipulation of components in
the electron transport chain is much more complex than engineering the metabolic
pathway. This manipulation involves several key elements: a membranous environment,
protein and complex folding and assembly, protein secretion and localization, redox,
chaperones and protein maturation systems, etc. Discovery of the excellular electron
transport mechanism and the interaction between mediators and the respiratory chain will
be a breakthrough for the development of microbial electrosynthesis catalysts.
5.3 Perspectives
5.3.1 PHBA production strain improvement
The current obtained outcomes could guide future research efforts. The objective for the
PHBA production strain development is to significantly increase yield and titre. This
objective includes several main tasks as discussed in section 1.4.2. Pathway bottleneck
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identification and removal is one important strategy for strain improvement. Chorismate
lyase is the key enzyme that catalyses the conversion of the shikimate pathway
intermediate chorismate into the product, PHBA, but this enzyme is subjected to serious
product inhibition. Chorismate pyruvate lyase (UbiC) has a KM of 29±2 µM, but with a Ki for
PHBA of 2.1±0.4 µM (Holden et al., 2002). Moreover, the PHBA inhibition of this enzyme
was irreversible (Siebert et al., 1994). Since the product inhibition of chorismate pyruvate
lyase seriously hampers bio-production improvement, mutagenesis may provide a method
to improve protein fitness in the future. However, direct screening of the mutant enzyme
UbiC is impractical for the following reasons: (1) the substrate chorismate is an unstable
intermediate (Gibson, 1964), and is too expensive to use as a substrate in screening; (2)
its direct product PHBA is colourless, and HPLC is currently the most effective method to
identify or quantify this compound; (3) the developed chromogenic detection method for
the PHBA production strain on minimal medium plates was still not sensitive enough for
the current strains, and the requirement for a highly toxic and volatile reagent restricted
use of this method in the lab. Inspired by chemotaxis of P. putida towards aromatic
compounds, the PHBA regulator and sensing protein was used to create a PHBA
biosensor for mutant UbiC screening or strain evolution (unpublished data). Briefly, future
PHBA sensors can be modified from the current constructed device by fusing the PHBA
sensing promoter with a fluorescent protein, which is triggered by the molecule of PHBA
produced from the enzymatic reaction of chorismate lyase. The change of activity and/or
expression level of chorismate lyase could directly influence the amount of PHBA, which
could be reflected by the intensity of florescence signal.
The practicality of scaling up engineered strains needs to be considered by the metabolic
engineering community. The current PHBA strains had permanently deleted aromatic
amino acids biosynthesis genes (pheA and trpE); however, such deletion can decrease
the growth rate and/or final cell density (Christensen and Steele, 2003), produce
auxotrophs and resulting difficulties for larger scale cultivations (Verhoef et al., 2007).
Furthermore, P. putida possesses the homogentisate degradation pathway that could
utilize aromatic amino acids as carbon sources; therefore, the fed-batch feeding was
replaced with a relatively expensive precursor phenyl pyruvate for the auxotrophic mutant.
Considering these weaknesses of permanent deletion, a PHBA sensing switch was
constructed to direct the flux to the production pathway from biomass formation
(unpublished data). The genes of pheA and trpE were expressed under the Ptrc promoter
in the plasmid during the cell growth phase. This cell growth mode was switched off by the
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expression of the lacIq repressor that was controlled by the PHBA sensing device, resulting
in a production mode. However, the serious leakage of the negative-regulated promoter
Ptrc makes precise regulation in P. putida very hard to achieve (unpublished data). precise
control of flux requires the tight and sensitive regulation in all used promoters, and this is
achievable by replacing with a tighter promoter and regulator, mutant lacIq (Gatti-
Lafranconi et al., 2013) or DNA looping (Becker et al., 2014).
The aim to capture the maximal carbon atoms into a target product with minimal effort is
desirable for the metabolic engineering community. Strain improvement requires us to
efficiently and effectively identify beneficial engineering targets for the further improvement
of yield and titre. Strain improvement also involves the understanding of regulation in
specific conditions and a holistic view of cell factories. This information can be obtained via
multi-omics (genomics, transcriptomics, proteomics, metabolomics and fluxomics), in silico
modeling and systems biology-based approaches. A systems biology approach was
employed to reveal the impact and regulation of n-butanol formation in P. putida KT2440 at
the metabolic, proteomic, and transcriptional levels (Vallon et al., 2015). It showed that
central metabolism was split into a glucose-fueled ED/PP pathway and an n-butanol-fueled
TCA cycle when glucose and n-butanol were both used as carbon substrates. Furthermore,
the n-butanol degradation pathway was unraveled by transcriptome and proteome analysis.
More recently, the approach of comparative genomics and proteomics analysis was
applied to reveal the carbon utilization pattern and lignin degradation mechanisms in a
unique lignin-utilizing P. putida A514, and further guided the design to enable a
consolidated lignin bioconversion route in A514 (Lin et al., 2016). Computational tools offer
an opportunity for identification of the beneficial genetic targets and the optimization of
growth conditions and pathway flux (Blazeck and Alper, 2010; Copeland et al., 2012;
Medema et al., 2012). Using in silico modelling, glucose dehydrogenase (gcd) was
predicted as a beneficial knockout for increased accumulation in P. putida without harmful
effects (e.g. decrease in growth rate) (Poblete-Castro et al., 2013). Their experimental
proof showed an 80% increase in PHA yield, a 100% increase in titre and a 50% increase
in PHA content in this single knockout strain, and revealed almost unaffected growth and
diminished by-product formation. These approaches and tools could be also applied to the
prediction of beneficial genetic targets and pathway optimization for the strain
improvement.
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5.3.2 Improvement and development of microbial electrosynthesis biocatalysts
Microbial electrosynthesis is explored in my thesis study. But it is still in its infancy. The
exploration of electrochemical production in the bio-electrochemical system suggested
several future research efforts which need to be focused on. As discussed before, the
production strain needs to significantly improve the productivity and/or yield for
electrochemical production. Improving the electron transfer rate is the key task for strain
improvement. Due to the unclear extracellular electron transfer mechanism and the
unknown interaction between the electron transport chain and redox mediators, identifying
genetic targets is difficult. However, it is possible to narrow the range of targets, for
example key components involved in electron transport chain e.g. electron donors (some
specific dehydrogenases), electron carriers (quinone and cytochromes), and terminal
oxidases. As mentioned above, a multi-omics approach is a powerful tool for identifying
genetic target. In this thesis study, comparative proteomics was employed for analysis of
the impact on electrochemical production when using glucose or glycerol as the sole
carbon source. The proteomics analysis combined with the published transcriptomics data
can better reveal that membrane-associated maturation of gluconate dehydrogenase
enzyme complex was limited by the subunit containing cofactor heme c, and suggested
that the co-expression of the cytochrome c maturation operon is likely to improve the
maturation of this enzyme complex. The expression of ccm genes in the mutant strain is
likely a promising direction for future work.
The proteome scale identification and quantification would help to better understand
holistic bio-electrochemical systems. Currently, shotgun proteomics is the most powerful
method for proteome scale analysis, but the isotope labeling strategy makes the
quantification procedure complicated and expensive (Gouw et al., 2010; Ye et al., 2009).
The recently developed strategy of sequential window acquisition of all theoretical
fragment ion mass spectra (SWATH) is a high throughput and label-free protein
quantification method, which combines data-independent acquisition and targeted data
analysis (Gillet et al., 2012). The SWATH-MS based proteomics analysis has been
successfully applied in a number of case studies (Liu et al., 2014; Rosenberger et al., 2014;
Selevsek et al., 2015). This method heavily relies on the peptide spectral library, which
theoretically limits its exploration of the deeper proteome compared to shotgun proteomics
(Huang et al., 2015). Huang et al. showed SWATH-MS can be applied for whole-scale
proteome analysis when shotgun MS was performed for the same samples and the MS
data was used for generation of peptide spectral library for SWATH analysis (Huang et al.,
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2015). The SWATH-MS based proteomics analysis can only identify and quantify up to
1000 proteins in our study, which means it cannot cover the whole proteome. This can be
overcome by using a better strategy for future SWATH-MS proteomics analysis and the
current data can be re-analyzed when shotgun MS data is ready for the regeneration of
the peptide spectral library.
Note that the expressed glucose dehydrogenase (an integral membrane protein) is difficult
to identify and quantify. This is mainly because this type of membrane protein is often rigid,
highly hydrophobic and typically present in low abundance (Vaisar, 2009). Many
membrane proteins require strong ionic detergents for solubilization. Many integral
membrane proteins are difficult to solubilize using the commonly used zwitterionic
detergent CHAPS, even at high concentration or in combination with urea and thiourea
(Rabilloud, 1998). The use of the strong detergent amidosulfobetaine-14 (ASB-14) showed
better solubilization and improvement in the identification of membrane proteins
(Henningsen et al., 2002; Schluesener et al., 2005). Furthermore, the membrane proteins
are inefficiently digested with trypsin when they contain hydrophobic transmembrane
domains; this can be overcome by using chymotrypsin for better digestion (Fischer et al.,
2006). These two issues suggested that an optimized protocol can be developed for the
membrane proteomics analysis in future research.
In addition to this, the identification and quantification of low abundance proteins is
important for studying the components of electron transport chain since many membrane
proteins are present at low concentrations. Ion underestimation occurred at high ion
concentration due to ion suppression and the limitation of the time-to-digital converter
(TOF digitizer) (Huang et al., 2015). Underestimation can be avoided by manually
processing MS data in the software of Skyline to improve the accuracy for protein
quantification. This may be achievable with better-developed software that automatically
filters high ion bound peptides for the calculation.
Next, I will discuss some interesting observations in the thesis study of electrochemical
production. Glucose catabolism by P. putida F1 was likely limited by insufficient NADPH in
the bio-electrochemical system (Lai et al., 2016). Unexpectedly, the expression of
transhydrogenase PntAB did not lead to enhanced performance in BES. On the contrary, it
substantially slowed down the electrochemical production process. The 2-ketogluconate
production needs the cofactor FAD, however the regeneration by an oxidoreductase from
Burkholderia cepacia also did not lead to the desired results. It was hypothesized that the
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preferred reversible reaction was different between the BES condition and the aerobic
cultural condition.
In summary, this thesis study showed the potential of metabolic engineering in P. putida
for the production of PHBA, and suggested current several key issues that need to be
solved in the near future when using the chorismate lyase conversion route. The
development of a BES catalyst is quite challenging, several future work were discussed for
the improved electrochemical production. However, rational design of the BES catalysts
requires fundamental understanding of electron transfer mechanism as well as the
convenient and efficient tools for strain engineering.
93
References
Abbas, C. A., Sibirny, A. A., 2011. Genetic control of biosynthesis and transport of
riboflavin and flavin nucleotides and construction of robust biotechnological
producers. Microbiol Mol Biol Rev. 75, 321-360.
Adams, B. L., 2016. The next generation of synthetic biology chassis: moving synthetic
biology from the laboratory to the field. ACS Synthetic Biology. 5, 1328-1330.
Akhtar, M. K., Jones, P. R., 2014. Cofactor engineering for enhancing the flux of metabolic
pathways. Front Bioeng Biotechnol. 2.
Amaratunga, M., et al., Genetically engineered microorganisms and method for producing
4-hydroxybenzoate. Washington, DC: U.S. Patent and Trademark Office, U.S, 2000.
An, R., Moe, L. A., 2016. Regulation of PQQ-dependent glucose dehydrogenase activity in
the model rhizosphere dwelling bacterium Pseudomonas putida KT2440. Appl.
Environ. Microbiol.
Andersen, K. B., Meyenburg, K., 1980. Are growth rates of Escherichia coli in batch
cultures limited by respiration? J. Bacteriol. 144, 114.
Angenent, L. T., Rosenbaum, M. A., 2013. Microbial electrocatalysis to guide biofuel and
biochemical bioprocessing. Biofuels. 4, 131-134.
Arias-Barrau, E., et al., 2004. The Homogentisate pathway: a central catabolic pathway
involved in the degradation of l-phenylalanine, l-tyrosine, and 3-
hydroxyphenylacetate in Pseudomonas putida. J. Bacteriol. 186, 5062-5077.
Arshad, M., et al., 2008. Optimization of process variables for minimization of byproduct
formation during fermentation of blackstrap molasses to ethanol at industrial scale.
Lett. Appl. Microbiol. 47, 410-4.
Arslan, E., et al., 1998. Overproduction of the Bradyrhizobium japonicum c-type
cytochrome subunits of the cbb3 oxidase in Escherichia coli. Biochem. Biophys.
Res. Commun. 251, 744-747.
Arunmanee, W., et al., 2014. Outer membrane protein F stabilised with minimal amphipol
forms linear arrays and LPS-dependent 2D crystals. J. Membr. Biol. 247, 949-956.
Baez, A., Shiloach, J., 2014. Effect of elevated oxygen concentration on bacteria, yeasts,
and cells propagated for production of biological compounds. Microb Cell Fact. 13,
181.
Bagdasarian, M. M., et al., 1983. Activity of the hybrid trp-lac (tac) promoter of Escherichia
coli in Pseudomonas putida. Construction of broad-host-range, controlled-
expression vectors. Gene. 26, 273-82.
94
Bagos, P. G., et al., 2010. Combined prediction of Tat and Sec signal peptides with hidden
Markov models. Bioinformatics. 26, 2811-7.
Bakke, I., et al., 2009. Random mutagenesis of the Pm promoter as a powerful strategy for
improvement of recombinant-gene expression. Appl. Environ. Microbiol. 75, 2002-
2011.
Barker, J. L., Frost, J. W., 2001. Microbial synthesis of p-hydroxybenzoate from glucose.
Biotechnol. Bioeng. 76, 376-390.
Baucke, F. G. K., 1994. Thermodynamic origin of the sub-Nernstian response of glass
electrodes. Anal. Chem. 66, 4519-4524.
Baumberg, S., et al., 1980. Expression of the lactose transposon Tn951 in Escherichia coli,
Proteus and Pseudomonas. J. Gen. Microbiol. 119, 257-62.
Becker, N. A., et al., 2014. Bacterial promoter repression by DNA looping without protein–
protein binding competition. Nucleates Res. 42, 5495-5504.
Belda, E., et al., 2016. The revisited genome of Pseudomonas putida KT2440 enlightens
its value as a robust metabolic chassis. Environ. Microbiol. 18, 3403-3424.
Beliaev, A. S., et al., 2002a. Microarray transcription profiling of a Shewanella oneidensis
etrA mutant. J. Bacteriol. 184, 4612-6.
Beliaev, A. S., et al., 2002b. Gene and protein expression profiles of Shewanella
oneidensis during anaerobic growth with different electron acceptors. OMICS. 6, 39-
60.
Bentley, R., 1990. The shikimate pathway - a metabolic tree with many branches. Crit. Rev.
Biochem. Mol. Biol. 25, 307-384.
Berg, J. M., et al., 2015. Biochemistry New York : W.H. Freeman.
Bernaudat, F., et al., 2011. Heterologous expression of membrane proteins: choosing the
appropriate host. PLoS One. 6, e29191.
Bisschop, A., et al., 1975. Respiratory-Chain Linked Ferricyanide Reduction Drives Active-
Transport in Membrane-Vesicles from Bacillus Subtilis. FEBS Lett. 60, 11-15.
Blank, L., et al., 2008. Metabolic response of Pseudomonas putida during redox
biocatalysis in the presence of a second octanol phase. FEBS J. 275, 5173 - 5190.
Blazeck, J., Alper, H., 2010. Systems metabolic engineering: Genome-scale models and
beyond. ‎ J. Biotechnol. 5, 647-659.
Bretschger, O., et al., 2008. Current production and metal oxide reduction by Shewanella
oneidensis MR-1 wild type and mutants. Appl. Environ. Microbiol. 74, 553-553.
Brown, K. D., Somerville, R. L., 1971. Repression of aromatic amino acid biosynthesis in
Escherichia coli K-12. J. Bacteriol. 108, 386-99.
95
Buckel, W., Thauer, R. K., 2013. Energy conservation via electron bifurcating ferredoxin
reduction and proton/Na+ translocating ferredoxin oxidation. Biochim. Biophys. Acta.
1827, 94-113.
Bukau, B., et al., 2006. Molecular chaperones and protein quality control. Cell. 125, 443-51.
Calhoun, D. H., et al., 1973. Channel-shuttle mechanism for the regulation of
phenylalanine and tyrosine synthesis at a metabolic branch point in Pseudomonas
aeruginosa. J. Bacteriol. 113, 241-251.
Carmona-Martinez, A. A., et al., 2011. Cyclic voltammetric analysis of the electron transfer
of Shewanella oneidensis MR-1 and nanofilament and cytochrome knock-out
mutants. Bioelectrochemistry. 81, 74.
Cavka, A., Jönsson, L. J., 2013. Detoxification of lignocellulosic hydrolysates using sodium
borohydride. Bioresour. Technol. 136, 368-376.
Chassagnole, C., et al., 2002. Dynamic modeling of the central carbon metabolism of
Escherichia coli. Biotechnol. Bioeng. 79, 53-73.
Chavarría, M., et al., 2013. The Entner–Doudoroff pathway empowers Pseudomonas
putida KT2440 with a high tolerance to oxidative stress. Environ. Microbiol. 15,
1772-1785.
Cheldelin, V. H., King, T. E., 1957. Glucose oxidation and cytochromes in solubilized
particulate fractions of Acetobacter suboxydans. J. Biol. Chem. 224, 579-90.
Chemler, J. A., et al., 2010. Improving NADPH availability for natural product biosynthesis
in Escherichia coli by metabolic engineering. Metab. Eng. 12, 96-104.
Chen, B., et al., 2013. Transporter engineering for improved tolerance against alkane
biofuels in Saccharomyces cerevisiae. Biotechnol Biofuels. 6, 21.
Chen, K., Xue, D., 2015. Searching for electrode materials with high electrochemical
reactivity. J Materiomics. 1, 170-187.
Chen, X., et al., 2014. Engineering redox balance through cofactor systems. Trends
Biotechnol. 32, 337-43.
Chen, Z. W., et al., 2002. Structure at 1.9 angstrom resolution of a quinohemoprotein
alcohol dehydrogenase from Pseudomonas putida HK5. Structure. 10, 837-849.
Chin, W.-C., et al., 2013. Improvement of n-butanol tolerance in Escherichia coli by
membrane-targeted tilapia metallothionein. Biotechnol Biofuels. 6, 130.
Choi, K. H., Schweizer, H. P., 2006. Mini-Tn7 insertion in bacteria with single attTn7 sites:
example Pseudomonas aeruginosa. Nat. Protoc. 1, 153-161.
Choi, O., et al., 2008. Pyrroloquinoline quinone Is a plant growth promotion factor
produced by Pseudomonas fluorescens B16. Plant Physiol. 146, 657-668.
96
Christensen, J. E., Steele, J. L., 2003. Impaired growth rates in milk of Lactobacillus
helveticus peptidase mutants can be overcome by use of amino acid supplements.
J. Bacteriol. 185, 3297-3306.
Chubukov, V., et al., 2016. Synthetic and systems biology for microbial production of
commodity chemicals. npj Syst. Biol. Appl. 2, 16009.
Cianciotto, N. P., et al., 2005. Impact of the bacterial type I cytochrome c maturation
system on different biological processes. Mol. Microbiol. 56, 1408-15.
Copeland, W. B., et al., 2012. Computational tools for metabolic engineering. Metab. Eng.
14, 270-280.
Cornejo, J. A., et al., 2015. Surface modification for enhanced biofilm formation and
electron transport in Shewanella Anodes. J. Electrochem. Soc. 162, H597-H603.
Couch, V. A., et al., 2009. Electrostatics of the FeS clusters in respiratory complex I.
Biochim. Biophys. Acta. 1787, 1266-1271.
Couper, A. M., et al., 1990. Electrode materials for electrosynthesis. Chem. Rev. 90, 837-
865.
Curran, K. A., et al., 2013. Metabolic engineering of muconate production in
Saccharomyces cerevisiae. Metab. Eng. 15, 55-66.
da Silva, G. P., et al., 2009. Glycerol: A promising and abundant carbon source for
industrial microbiology. Biotechnol. Adv. 27, 30-39.
Daddaoua, A., et al., 2010. Compartmentalized glucose metabolism in Pseudomonas
putida is controlled by the PtxS repressor. J. Bacteriol. 192, 4357-4366.
Dalbey, R. E., et al., 2011. Assembly of bacterial inner membrane proteins. Annu. Rev.
Biochem. 80, 161-87.
Dammer, L., et al., Market developments of and opportunities for biobased products and
chemicals. Nova Institute for Ecology and Innovation, 2013.
Danese, P. N., Silhavy, T. J., 1998. Targeting and assembly of periplasmic and outer-
membrane proteins in Escherichia coli. Annu. Rev. Genet. 32, 59-94.
Dantas, J. M., et al., 2015. Rational engineering of Geobacter sulfurreducens electron
transfer components: a foundation for building improved Geobacter-based
bioelectrochemical technologies. Front. Microbiol. 6, 752.
de Jong, E., et al., 2012. Product developments in the bio-based chemicals arena. Biofuels,
Bioproducts and Biorefining. 6, 606-624.
del Castillo, T., et al., 2008. A set of activators and repressors control peripheral glucose
pathways in Pseudomonas putida to yield a common central intermediate. J.
Bacteriol. 190, 2331-2339.
97
Deutscher, J., 2008. The mechanisms of carbon catabolite repression in bacteria. Curr.
Opin. Microbiol. 11, 87-93.
Dodds, D., Humphreys, B., 2013. Production of aromatic chemicals from biobased
feedstock. catalytic process development for renewable materials. Wiley-VCH
Verlag GmbH & Co. KGaA, pp. 183-237.
Doelle, H. W., et al., 1982. regulation of glucose metabolism in bacterial systems.
Microbial Reactions. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 1-35.
Ebert, B. E., et al., 2011. Response of Pseudomonas putida KT2440 to increased NADH
and ATP demand. Appl. Environ. Microbiol. 77, 6597-6605.
Egli, T., 2015. Microbial growth and physiology: a call for better craftsmanship. Front.
Microbiol. 6.
Erickson, B., et al., 2012. Perspective on opportunities in industrial biotechnology in
renewable chemicals. ‎ J. Biotechnol. 7, 176-185.
Fernández, M., et al., 2012a. Mechanisms of resistance to chloramphenicol in
Pseudomonas putida KT2440. Antimicrob. Agents Chemother. 56, 1001-1009.
Fernández, M., et al., 2012b. Enhanced tolerance to naphthalene and enhanced
rhizoremediation performance for Pseudomonas putida KT2440 via the NAH7
catabolic plasmid. Appl. Environ. Microbiol. 78, 5104-5110.
Fink, J. K., 2014. Chapter 17 - Liquid crystal polymers. High performance polymers
(Second Edition). William Andrew Publishing, pp. 381-400.
Fischer, F., et al., 2006. Toward the complete membrane proteome: High coverage of
integral membrane proteins through transmembrane peptide detection. Mol. Cell.
Proteomics. 5, 444-453.
Flamholz, A., et al., 2013. Glycolytic strategy as a tradeoff between energy yield and
protein cost. Proc. Natl. Acad. Sci. 110, 10039-10044.
Frommer, W. B., Ninnemann, O., 1995. Heterologous expression of genes in bacterial,
fungal, animal, and plant-Cells. Annu. Rev. Plant Physiol. Plant Mol. Biol. 46, 419-
444.
Fuhrer, T., et al., 2005. Experimental identification and quantification of glucose
metabolism in seven bacterial species. J. Bacteriol. 187, 1581-1590.
Gao, T., O'Brian, M. R., 2007. Control of DegP-dependent degradation of c-Type
cytochromes by heme and the cytochrome c maturation system in Escherichia coli.
J. Bacteriol. 189, 6253-6259.
Gatti-Lafranconi, P., et al., 2013. A single mutation in the core domain of the lac repressor
reduces leakiness. Microb Cell Fact. 12, 67-67.
98
Gavrilescu, M., 2014. Biomass potential for sustainable environment, biorefinery products
and energy. In: Visa, I., (Ed.), Sustainable energy in the built environment - steps
towards nZEB: Proceedings of the conference for sustainable energy (CSE) 2014.
Springer International Publishing, Cham, pp. 169-194.
Geertsma, E. R., et al., 2008. Quality control of overexpressed membrane proteins. Proc.
Natl. Acad. Sci. 105, 5722-5727.
Gibson, F., 1964. Chorismate: purification and some chemical and physical studies.
Biochem. J. 90, 256-&.
Gillet, L. C., et al., 2012. Targeted data extraction of the MS/MS spectra generated by
data-independent acquisition: A new concept for consistent and accurate proteome
analysis. Mol. Cell. Proteomics. 11.
Gliese, N., et al., 2009. The PQQ biosynthetic operons and their transcriptional regulation
in Pseudomonas aeruginosa. Arch. Microbiol. 192, 1.
Goodwin, P. M., Anthony, C., 1998. The biochemistry, physiology and genetics of PQQ
and PQQ-containing enzymes. In: Poole, R. K., (Ed.), Adv. Microb. Physiol. vol.
Volume 40. Academic Press, pp. 1-80.
Gorby, Y. A., et al., 2006. Electrically conductive bacterial nanowires produced by
Shewanella oneidensis strain MR-1 and other microorganisms. Proc. Natl. Acad.
Sci. 103, 11358-11363.
Gosset, G., 2009. Production of aromatic compounds in bacteria. Curr. Opin. Biotechnol.
20, 651-658.
Gouw, J. W., et al., 2010. Quantitative proteomics by metabolic labeling of model
organisms. molecular and cellular proteomics : MCP. 9, 11-24.
Graf, N., Altenbuchner, J., 2011. Development of a method for markerless gene deletion in
Pseudomonas putida. Appl. Environ. Microbiol. 77, 5549-5552.
Green, E. R., Mecsas, J., 2016. Bacterial secretion systems – an overview. Microbiol
Spectr. 4, 10.1128/microbiolspec.VMBF-0012-2015.
Grisshammer, R., 2006. Understanding recombinant expression of membrane proteins.
Curr. Opin. Biotechnol. 17, 337-340.
Gubellini, F., et al., 2011. Physiological response to membrane protein overexpression in
E. coli. Mol. Cell. Proteomics: MCP. 10, M111.007930.
Harnisch, F., et al., 2015. Electrifying white biotechnology: engineering and economic
potential of electricity-driven Bio-production. ChemSusChem. 8, 758-766.
99
Henningsen, R., et al., 2002. Application of zwitterionic detergents to the solubilization of
integral membrane proteins for two-dimensional gel electrophoresis and mass
spectrometry. Proteomics. 2, 1479-1488.
Henriques, B. J., et al., 2009. Role of flavinylation in a mild variant of multiple Acyl-CoA
dehydrogenation eficiency: a molecular rationale for the effects of riboflavin
supplementation. J. Biol. Chem. 284, 4222-4229.
Herrera, M. C., et al., 2010. Identification and characterization of the PhhR regulon in
Pseudomonas putida. Environ. Microbiol. 12, 1427-1438.
Herrero, M., et al., 1993. A T7 RNA polymerase-based system for the construction of
Pseudomonas strains with phenotypes dependent on TOL-meta pathway effectors.
Gene. 134, 103-6.
Herrmann, K. M., Weaver, L. M., 1999. The shikimate pathway. Annu. Rev. Plant Physiol.
Plant Mol. Biol. 50, 473-503.
Hintermayer, S., et al., 2016. Anodic respiration of Pseudomonas putida KT2440 in a
stirred-tank bioreactor. Biochem. Eng. J. 115, 1-13.
Holden, M. J., et al., 2002. Chorismate lyase: kinetics and engineering for stability.
Biochim Biophys Acta Protein Struct Molec Enzym. 1594, 160-167.
Holmes, D. E., et al., 2006. Microarray and genetic analysis of electron transfer to
electrodes in Geobacter sulfurreducens. Environ. Microbiol. 8, 1805-1815.
Holmes, D. E., et al., 2016. The electrically conductive pili of Geobacter species are a
recently evolved feature for extracellular electron transfer. Microbial Genomics. 2.
Huang, Q., et al., 2015. SWATH enables precise label-free quantification on proteome
scale. Proteomics. 15, 1215-1223.
Hunt, J. C., Phibbs, P. V., Jr., 1983. Regulation of alternate peripheral pathways of
glucose catabolism during aerobic and anaerobic growth of Pseudomonas
aeruginosa. J. Bacteriol. 154, 793-802.
Ibeh, C. C., 2011. Thermoplastic materials : properties, manufacturing methods, and
applications. Boca Raton, FL: CRC Press, Boca Raton, FL.
Ikeda, M., Katsumata, R., 1999. Hyperproduction of tryptophan by Corynebacterium
glutamicum with the modified pentose phosphate pathway. Appl. Environ. Microbiol.
65, 2497-2502.
Jantama, K., et al., 2008. Eliminating side products and increasing succinate yields in
engineered strains of Escherichia coli C. Biotechnol. Bioeng. 101, 881-893.
Jensen, H. M., et al., 2010. Engineering of a synthetic electron conduit in living cells. Proc.
Natl. Acad. Sci. 107, 19213-19218.
100
Jensen, H. M., et al., 2016. CymA and exogenous flavins improve extracellular electron
transfer and couple it to cell growth in Mtr-expressing Escherichia coli. ACS
Synthetic Biology. 5, 679-688.
Jeon, J.-M., et al., 2015. Isobutanol production from an engineered Shewanella oneidensis
MR-1. Bioprocess Biosystems Eng. 38, 2147-2154.
Jeske, M., Altenbuchner, J., 2010. The Escherichia coli rhamnose promoter rhaPBAD is in
Pseudomonas putida KT2440 independent of Crp–cAMP activation. Appl. Microbiol.
Biotechnol. 85, 1923-1933.
Jiang, M., et al., 2010. Effect of growth phase feeding strategies on succinate production
by metabolically engineered Escherichia coli. Appl. Environ. Microbiol. 76, 1298-
1300.
Jiménez, J. I., et al., 2002. Genomic analysis of the aromatic catabolic pathways from
Pseudomonas putida KT2440. Environ. Microbiol. 4, 824-841.
Jin, M., et al., 2013. Unique organizational and functional features of the cytochrome c
maturation system in Shewanella oneidensis. PLoS One. 8, e75610.
Jönsson, L. J., Martín, C., 2016. Pretreatment of lignocellulose: Formation of inhibitory by-
products and strategies for minimizing their effects. Bioresour. Technol. 199, 103-
112.
Karpf, M., Trussardi, R., 2009. Efficient access to oseltamivir phosphate (Tamiflu) via the
O-trimesylate of shikimate ethyl ester. Angew. Chem. Int. Ed. Engl. 48, 5760-2.
Kikuchi, Y., et al., 1997. Mutational analysis of the feedback sites of phenylalanine-
sensitive 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase of Escherichia
coli. Appl. Environ. Microbiol. 63, 761-2.
Kim, H. J., Winge, D. R., 2013. Emerging concepts in the flavinylation of succinate
dehydrogenase. Biochim. Biophys. Acta. 1827, 627-636.
Koma, D., et al., 2012. Production of aromatic compounds by metabolically engineered
Escherichia coli with an expanded shikimate pathway. Appl. Environ. Microbiol. 78,
6203-6216.
Kracke, F., et al., 2015. Microbial electron transport and energy conservation – the
foundation for optimizing bioelectrochemical systems. Front. Microbiol. 6.
Krogh, A., et al., 2001. Predicting transmembrane protein topology with a hidden markov
model: application to complete genomes1. J. Mol. Biol. 305, 567-580.
Kromer, J. O., et al., 2013. Production of aromatics in Saccharomyces cerevisiae-A
feasibility study. J. Biotechnol. 163, 184-193.
101
Kuepper, J., et al., 2015. Metabolic engineering of Pseudomonas putida KT2440 to
produce anthranilate from glucose. Front. Microbiol. 6.
Kwon, S. K., et al., 2015. Comparative genomics and experimental evolution of
Escherichia coli BL21(DE3) strains reveal the landscape of toxicity escape from
membrane protein overproduction. Sci. Rep. 5, 16076.
Laemmli, U. K., 1970. Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature. 227, 680-5.
Lai, B., et al., 2016. Anoxic metabolism and biochemical production in Pseudomonas
putida F1 driven by a bioelectrochemical system. Biotechnol Biofuels. 9, 39.
Lee, P. C., et al., 2001. Succinate production with reduced by-product formation in the
fermentation of Anaerobiospirillum succiniciproducens using glycerol as a carbon
source. Biotechnol. Bioeng. 72, 41-48.
Leys, D., et al., 1999. Structure and mechanism of the flavocytochrome c fumarate
reductase of Shewanella putrefaciens MR-1. Nat. Struct. Biol. 6, 1113-7.
Lin, L., et al., 2016. Systems biology-guided biodesign of consolidated lignin conversion.
Green Chem. 18, 5536-5547.
Liu, Y.-S., et al., 2006. Characterization of oxygen transfer conditions and their effects on
Phaffia rhodozyma growth and carotenoid production in shake-flask cultures.
Biochem. Eng. J. 27, 331-335.
Liu, Y., et al., 2014. Glycoproteomic analysis of prostate cancer tissues by SWATH mass
spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine
kinase 7 as signatures for tumor aggressiveness. Mol. Cell. Proteomics. 13, 1753-
68.
Liu, Y., et al., 2004. Simple and sensitive electrode design for microchip
electrophoresis/electrochemistry. Anal. Chem. 76, 1513-1517.
Livak, K. J., Schmittgen, T. D., 2001. Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25, 402-8.
Loeschcke, A., Thies, S., 2015. Pseudomonas putida—a versatile host for the production
of natural products. Appl. Microbiol. Biotechnol. 99, 6197-6214.
Logan, B. E., 2010. Scaling up microbial fuel cells and other bioelectrochemical systems.
Appl. Microbiol. Biotechnol. 85, 1665-1671.
Lopez, M. J., et al., 2004. Isolation of microorganisms for biological detoxification of
lignocellulosic hydrolysates. Appl. Microbiol. Biotechnol. 64, 125-31.
Lu, J.-l., Liao, J. C., 1997. Metabolic engineering and control analysis for production of
aromatics: Role of transaldolase. Biotechnol. Bioeng. 53, 132-138.
102
Luo, X., et al., 2016. Pseudomonas putida KT2440 markerless gene deletion using a
combination of λ Red recombineering and Cre/loxP site-specific recombination.
FEMS Microbiol. Lett. 363, fnw014-fnw014.
Malvankar, N. S., et al., 2015. Structural basis for metallic-like conductivity in microbial
nanowires. mBio. 6.
Mandalakis, M., et al., 2013. Comparative proteomic analysis reveals mechanistic insights
into Pseudomonas putida F1 growth on benzoate and citrate. AMB Express. 3, 64.
Marsili, E., et al., 2008. Shewanella secretes flavins that mediate extracellular electron
transfer. Proc. Natl. Acad. Sci. U. S. A. 105, 3968-3973.
Martínez-García, E., et al., 2014. New transposon tools tailored for metabolic engineering
of Gram-negative microbial cell factories. Front Bioeng Biotechnol. 2, 46.
Martínez-García, E., et al., 2011. pBAM1: an all-synthetic genetic tool for analysis and
construction of complex bacterial phenotypes. BMC Microbiol. 11, 38.
Martinez-Garcia, E., de Lorenzo, V., 2011. Engineering multiple genomic deletions in
Gram-negative bacteria: analysis of the multi-resistant antibiotic profile of
Pseudomonas putida KT2440. Environ. Microbiol. 13, 2702-2716.
Mary J. Biddy, C. S., and Christopher Kinchin, Chemicals from biomass: A market
assessment of bioproducts with near-term potential. 2016.
Matsushita, K., Matsutani, M., 2016. Distribution, evolution, and physiology of oxidative
fermentation. In: Matsushita, K., Toyama, H., Tonouchi, N., Okamoto-Kainuma, A.,
Eds.), Acetate Bacteria: Ecology and Physiology. Springer Japan, Tokyo, pp. 159-
178.
Matsushita, K., et al., 1980. Membrane-bound D-glucose dehydrogenase from
Pseudomonas sp.: solubilization, purification and characterization. Agric. Biol.
Chem. 44, 1505-1512.
Matsushita, K., et al., 1979. Membrane-bound D-gluconate dehydrogenase from
Pseudomonas aeruginosa: its kinetic properties and a reconstitution of gluconate
oxidase. J. Biochem. 86, 249-256.
Matsushita, K., et al., 1989. Reactivity with ubiquinone of quinoprotein D-glucose
dehydrogenase from Gluconobacter suboxydans. J. Biochem. 105, 633-637.
Matsushita, K., et al., 1982. [31] D-gluconate dehydrogenase from bacteria, 2-keto-d-
gluconate-yielding, membrane-bound. Methods Enzymol. 89, 187-193.
Matsushita, K., et al., 1999. The quinohemoprotein alcohol dehydrogenase of
Gluconobacter suboxydans has ubiquinol oxidation activity at a site different from
the ubiquinone reduction site. Biochim. Biophys. Acta. 1409, 154-164.
103
Medema, M. H., et al., 2012. Computational tools for the synthetic design of biochemical
pathways. Nature Rev. Microbiol. 10, 191-202.
Meijnen, J.-P., et al., 2012. Metabolic and regulatory rearrangements underlying efficient
d-xylose utilization in engineered Pseudomonas putida S12. J. Biol. Chem. 287,
14606-14614.
Meijnen, J. P., et al., 2011a. Sustainable production of fine chemicals by the solvent-
tolerant Pseudomonas putida S12 using lignocellulosic feedstock. Int Sugar J. 113,
24-30.
Meijnen, J. P., et al., 2011b. Improved p-hydroxybenzoate production by engineered
Pseudomonas putida S12 by using a mixed-substrate feeding strategy. Appl.
Microbiol. Biotechnol. 90, 885-893.
Meisner, J., Goldberg, J. B., 2016. The Escherichia coli rhaSR-PrhaBAD inducible
promoter system allows tightly controlled gene expression over a wide range in
Pseudomonas aeruginosa. Appl. Environ. Microbiol. 82, 6715-6727.
Mingardon, F., et al., 2015. Improving olefin tolerance and production in E. coli using
native and evolved AcrB. Biotechnol. Bioeng. 112, 879-888.
Muday, G. K., et al., 1991. The tyrosine repressor negatively regulates aroH expression in
Escherichia coli. J. Bacteriol. 173, 3930-2.
Mukhopadhyay, A., Tolerance engineering in bacteria for the production of advanced
biofuels and chemicals. Trends Microbiol. 23, 498-508.
Müller, R., et al., 1995. Microbial production of specifically ring C-13 Labeled 4-
hydroxybenzoate. Appl. Microbiol. Biotechnol. 43, 985-988.
Nakahigashi, K., et al., 1991. Photosensitivity of a protoporphyrin-accumulating, light-
sensitive mutant (visA) of Escherichia coli K-12. Proc. Natl. Acad. Sci. U. S. A. 88,
10520-4.
Nelson, K. E., et al., 2002. Complete genome sequence and comparative analysis of the
metabolically versatile Pseudomonas putida KT2440. Environ. Microbiol. 4, 799-808.
Nevin, K. P., et al., 2010. Microbial electrosynthesis: feeding microbes electricity to convert
carbon dioxide and water to multicarbon extracellular organic compounds. mBio. 1.
Newman, D. K., Kolter, R., 2000. A role for excreted quinones in extracellular electron
transfer. Nature. 405, 94-7.
Ng, C. Y., et al., 2015. Rational design of a synthetic Entner–Doudoroff pathway for
improved and controllable NADPH regeneration. Metab. Eng. 29, 86-96.
104
Nguyen, A. D. Q., et al., 2013. Improved tolerance of recombinant Escherichia coli to the
toxicity of crude glycerol by overexpressing trehalose biosynthetic genes (otsBA) for
the production of β-carotene. Bioresour. Technol. 143, 531-537.
Nikel, P. I., et al., 2015a. Pseudomonas putida KT2440 strain metabolizes glucose through
a cycle formed by enzymes of the Entner-Doudoroff, Embden-Meyerhof-Parnas,
and Pentose Phosphate Pathways. J. Biol. Chem. 290, 25920-25932.
Nikel, P. I., de Lorenzo, V., 2013. Engineering an anaerobic metabolic regime in
Pseudomonas putida KT2440 for the anoxic biodegradation of 1,3-dichloroprop-1-
ene. Metab. Eng. 15, 98-112.
Nikel, P. I., et al., 2014a. Metabolic and regulatory rearrangements underlying glycerol
metabolism in Pseudomonas putida KT2440. Environ. Microbiol. 16, 239-254.
Nikel, P. I., et al., 2014b. Biotechnological domestication of pseudomonads using synthetic
biology. Nat Rev Micro. 12, 368-379.
Nikel, P. I., et al., 2015b. The glycerol-dependent metabolic persistence of Pseudomonas
putida KT2440 reflects the regulatory logic of the GlpR repressor. mBio. 6.
Noorman, H., 2015. Scale-up and scale-down. Fundamental Bioengineering. Wiley-VCH
Verlag GmbH & Co. KGaA, pp. 463-498.
Ohrem, H. L., Voβ, H., 1996. Inhibitory effects of glycerol on Gluconobacter oxydans.
Biotechnol. Lett. 18, 245-250.
Opekarová, M., Tanner, W., 2003. Specific lipid requirements of membrane proteins—a
putative bottleneck in heterologous expression. Biochim. Biophys. Acta. 1610, 11-
22.
Page, C. C., et al., 1999. Natural engineering principles of electron tunnelling in biological
oxidation-reduction. Nature. 402, 47-52.
Palmqvist, E., Hahn-Hägerdal, B., 2000a. Fermentation of lignocellulosic hydrolysates. I:
inhibition and detoxification. Bioresour. Technol. 74, 17-24.
Palmqvist, E., Hahn-Hägerdal, B., 2000b. Fermentation of lignocellulosic hydrolysates. II:
inhibitors and mechanisms of inhibition. Bioresour. Technol. 74, 25-33.
Pandit, A., An in silico Characterization of microbial electrosynthesis for metabolic
engineering of biochemicals. Vol. MR85723. University of Toronto (Canada), Ann
Arbor, 2012, pp. 79.
Panke, S., et al., 1999. Engineering of a stable whole-cell biocatalyst capable of (S)-
styrene oxide formation for continuous two-liquid-phase applications. Appl. Environ.
Microbiol. 65, 5619-23.
105
Parekh, S. R., Vinci, V. A., 2002. Handbook of industrial cell culture mammalian, microbial,
and plant cells. Totowa, NJ : Humana Press : Imprint: Humana Press.
Park, D. H., Zeikus, J. G., 2003. Improved fuel cell and electrode designs for producing
electricity from microbial degradation. Biotechnol. Bioeng. 81, 348-55.
Pasquali, P., et al., 1985. Effect of ubiquinone extraction on the reaction of the
mitochondrial bc1 complex with ferricyanide. J. Bioenerg. Biomembr. 17, 283-94.
Peplow, M., 2016. Synthetic biology's first malaria drug meets market resistance. Nature.
530, 389-90.
Pereira, S. C., et al., 2015. 2G ethanol from the whole sugarcane lignocellulosic biomass.
Biotechnol Biofuels. 8, 44.
Pfaffl, M. W., et al., 2004. Determination of stable housekeeping genes, differentially
regulated target genes and sample integrity: BestKeeper – Excel-based tool using
pair-wise correlations. Biotechnol. Lett. 26, 509-515.
Pham, T. H., et al., 2008. Metabolites produced by Pseudomonas sp. enable a Gram-
positive bacterium to achieve extracellular electron transfer. Appl. Microbiol.
Biotechnol. 77, 1119-29.
Pilarek, M., et al., 2011. Enhanced growth and recombinant protein production of
Escherichia coli by a perfluorinated oxygen carrier in miniaturized fed-batch cultures.
Microb Cell Fact. 10, 50.
Pirbadian, S., et al., 2014. Shewanella oneidensis MR-1 nanowires are outer membrane
and periplasmic extensions of the extracellular electron transport components. Proc.
Natl. Acad. Sci. U. S. A. 111, 12883-12888.
Pitts, K. E., et al., 2003. Characterization of the Shewanella oneidensis MR-1 decaheme
cytochrome MtrA: expression in Escherichia coli confeers the ability to reduce
soluble Fe(III) chelates. J. Biol. Chem. 278, 27758-27765.
Poblete-Castro, I., et al., 2012. Industrial biotechnology of Pseudomonas putida and
related species. Appl. Microbiol. Biotechnol. 93, 2279-2290.
Poblete-Castro, I., et al., 2013. In-silico-driven metabolic engineering of Pseudomonas
putida for enhanced production of poly-hydroxyalkanoates. Metab. Eng. 15, 113-
123.
Pocaznoi, D., et al., 2012. Stainless steel is a promising electrode material for anodes of
microbial fuel cells. Energy Environ. Sci. 5, 9645-9652.
Prakash, D., et al., 2010. A process optimization for bio-catalytic production of substituted
catechols (3-nitrocatechol and 3-methylcatechol. BMC Biotechnol. 10, 49-49.
106
Pramanik, J., Keasling, J. D., 1997. Stoichiometric model of Escherichia coli metabolism:
Incorporation of growth-rate dependent biomass composition and mechanistic
energy requirements. Biotechnol. Bioeng. 56, 398-421.
Qiao, K., et al., 2017. Lipid production in Yarrowia lipolytica is maximized by engineering
cytosolic redox metabolism. Nat Biotech. 35, 173-177.
Quay, S. C., et al., 1972. Gluconate regulation of glucose catabolism in Pseudomonas
fluorescens. J. Bacteriol. 112, 291-298.
Queener, S. F., Gunsalus, I. C., 1970. Anthranilate synthase enzyme system and
complementation in Pseudomonas species. Proc. Natl. Acad. Sci. U. S. A. 67,
1225-32.
Rabaey, K., et al., 2004. Biofuel cells select for microbial consortia that self-mediate
electron transfer. Appl. Environ. Microbiol. 70, 5373-5382.
Rabaey, K., et al., 2011. Metabolic and practical considerations on microbial
electrosynthesis. Curr. Opin. Biotechnol. 22, 371-377.
Rabaey, K., Rozendal, R. A., 2010. Microbial electrosynthesis - revisiting the electrical
route for microbial production. Nature Rev. Microbiol. 8, 706-716.
Rabilloud, T., 1998. Use of thiourea to increase the solubility of membrane proteins in two-
dimensional electrophoresis. Electrophoresis. 19, 758-760.
Ramos, J.-L., 2004. Pseudomonas, Volume 3 : Biosynthesis of macromolecules and
molecular metabolism. Boston, MA, USA: Springer US, Boston.
Reguera, G., et al., 2005. Extracellular electron transfer via microbial nanowires. Nature.
435, 1098-101.
Rice, R. J., McCreery, R. L., 1989. Quantitative relationship between electron transfer rate
and surface microstructure of laser-modified graphite electrodes. Anal. Chem. 61,
1637-1641.
Rojo, F., 2010. Carbon catabolite repression in Pseudomonas: optimizing metabolic
versatility and interactions with the environment. FEMS Microbiol. Rev. 34, 658-684.
Rols, J. L., et al., 1990. Mechanism of enhanced oxygen transfer in fermentation using
emulsified oxygen-vectors. Biotechnol. Bioeng. 35, 427-435.
Rosenbaum, M. A., Franks, A. E., 2014. Microbial catalysis in bioelectrochemical
technologies: status quo, challenges and perspectives. Appl. Microbiol. Biotechnol.
98, 509-518.
Rosenbaum, M. A., Henrich, A. W., 2014. Engineering microbial electrocatalysis for
chemical and fuel production. Curr. Opin. Biotechnol. 29C, 93-98.
107
Rosenberger, G., et al., 2014. A repository of assays to quantify 10,000 human proteins by
SWATH-MS. Sci Data. 1, 140031.
Rumbold, K., et al., 2009. Microbial production host selection for converting second-
generation feedstocks into bioproducts. Microb Cell Fact. 8, 64.
Salehmin, M. N. I., et al., 2013. High cell density fed-batch fermentations for lipase
production: feeding strategies and oxygen transfer. Bioprocess Biosystems Eng. 36,
1527-1543.
Salis, H. M., 2011. Chapter two - The ribosome binding site calculator. In: Christopher, V.,
(Ed.), Methods Enzymol. vol. Volume 498. Academic Press, pp. 19-42.
Salis, H. M., et al., 2009. Automated design of synthetic ribosome binding sites to precisely
control protein expression. Nat. Biotechnol. 27, 946-950.
Schlegel, S., et al., 2010. Revolutionizing membrane protein overexpression in bacteria.
Microb Biotechnol. 3, 403-411.
Schluesener, D., et al., 2005. Mapping the membrane proteome of Corynebacterium
glutamicum. Proteomics. 5, 1317-30.
Schmitz, S., et al., 2015. Engineering mediator-based electroactivity in the obligate aerobic
bacterium Pseudomonas putida KT2440. Front. Microbiol. 6, 284.
Schobert, M., Jahn, D., 2002. Regulation of heme biosynthesis in non-phototrophic
bacteria. J. Mol. Microbiol. Biotechnol. 4, 287-94.
Schottek, J., Liquid crystal polymers (LCPs). Kunststoffe international, 2007.
Selevsek, N., et al., 2015. Reproducible and consistent quantification of the
Saccharomyces cerevisiae proteome by SWATH-mass spectrometry. Mol. Cell.
Proteomics. 14, 739-49.
Shimizu, K., 2013. Metabolic regulation of a bacterial cell system with emphasis on
Escherichia coli metabolism. ISRN Biochem. 2013, 645983.
Siebert, M., et al., 1994. Formation of 4-hydroxybenzoate in Escherichia coli:
characterization of the ubiC gene and its encoded enzyme chorismate pyruvate-
lyase. Microbiology-Uk. 140, 897-904.
Silva-Rocha, R., et al., 2013. The Standard European Vector Architecture (SEVA): a
coherent platform for the analysis and deployment of complex prokaryotic
phenotypes. Nucleates Res. 41, D666-D675.
Singh, P. B., et al., 2016a. Pseudomonas: the versatile and adaptive metabolic network. In:
Kahlon, R. S., (Ed.), Pseudomonas: Molecular and Applied Biology. Springer
International Publishing, Cham, pp. 81-126.
108
Singh, V., et al., 2016b. Strategies for fermentation medium optimization: An In-Depth
Review. Front. Microbiol. 7, 2087.
Smolke, C. D., 2010. The metabolic pathway engineering handbook tools and applications.
Boca Raton : CRC Press, Boca Raton.
Spaans, S., et al., 2015. NADPH-generating systems in bacteria and archaea. Front.
Microbiol. 6.
Steen, A., et al., 2013. Construction and characterization of nitrate and nitrite respiring
Pseudomonas putida KT2440 strains for anoxic biotechnical applications. J.
Biotechnol. 163, 155-165.
Stevens, J. M., et al., 2011. Cytochrome c biogenesis system I. The Febs Journal. 278,
4170-4178.
Stover, C., et al., 2000. Crystallization and 1.1-Å diffraction of chorismate lyase from
Escherichia coli. J. Struct. Biol. 129, 96-99.
Sun, Z., et al., 2006. Automated feeding strategies for high-cell-density fed-batch
cultivation of Pseudomonas putida KT2440. Appl. Microbiol. Biotechnol. 71, 423-
431.
Sydow, A., et al., 2014. Electroactive bacteria—molecular mechanisms and genetic tools.
Appl. Microbiol. Biotechnol. 98, 8481-8495.
Thakker, C., et al., 2012. Succinate production in Escherichia coli. ‎ J. Biotechnol. 7, 213-
224.
Thöny-Meyer, L., 1997. Biogenesis of respiratory cytochromes in bacteria. Microbiol. Mol.
Biol. Rev. 61, 337-376.
Thöny-Meyer, L., 2002. Cytochrome c maturation: a complex pathway for a simple task?
Biochem. Soc. Trans. 30, 633-638.
Tommassen, J., 2010. Assembly of outer-membrane proteins in bacteria and mitochondria.
Microbiology. 156, 2587-96.
Toyama, H., et al., 1995. Three distinct quinoprotein alcohol dehydrogenases are
expressed when Pseudomonas putida is grown on different alcohols. J. Bacteriol.
177, 2442-50.
Trachootham, D., et al., 2008. Redox regulation of cell survival. Antioxid Redox Signal. 10,
1343-1374.
Troeschel, S. C., et al., 2012. Novel broad host range shuttle vectors for expression in
Escherichia coli, Bacillus subtilis and Pseudomonas putida. J. Biotechnol. 161, 71-
79.
Utagawa, T., 2004. Production of arginine by fermentation. J. Nutr.. 134, 2854S-2857S.
109
Ütkür, F. Ö., et al., 2011. Regioselective aromatic hydroxylation of quinaldine by water
using quinaldine 4-oxidase in recombinant Pseudomonas putida. J. Ind. Microbiol.
Biotechnol. 38, 1067-1077.
Vaisar, T., 2009. Thematic review series: proteomics. proteomic analysis of lipid-protein
complexes. J. Lipid Res. 50, 781-786.
The Journal of Nutrition Vallon, T., et al., 2015. Applying systems biology tools to study n-
butanol degradation in Pseudomonas putida KT2440. Eng. Life Sci. 15, 760-771.
Van Duijn, M. M., et al., 1998. Ascorbate stimulates ferricyanide reduction in HL-60 cells
through a mechanism distinct from the NADH-dependent plasma membrane
reductase. J. Biol. Chem. 273, 13415-13420.
van Duuren, J. B., et al., 2013. Reconciling in vivo and in silico key biological parameters
of Pseudomonas putida KT2440 during growth on glucose under carbon-limited
condition. BMC Biotechnol. 13, 1-13.
van Hoek, M. J., Merks, R. M., 2012. Redox balance is key to explaining full vs. partial
switching to low-yield metabolism. BMC Syst. Biol. 6, 22.
Vee Aune, T. E., et al., 2010. Directed evolution of the transcription factor XylS for
development of improved expression systems. Microb Biotechnol. 3, 38-47.
Venkataraman, A., et al., 2010. Quorum sensing regulates electric current generation of
Pseudomonas aeruginosa PA14 in bioelectrochemical systems. Electrochem.
Commun. 12, 459-462.
Verhoef, S., et al., 2014. Crude glycerol as feedstock for the sustainable production of p-
hydroxybenzoate by Pseudomonas putida S12. N. Biotechnol. 31, 114-119.
Verhoef, S., et al., 2007. Bioproduction of p-hydroxybenzoate from renewable feedstock by
solvent-tolerant Pseudomonas putida S12. J. Biotechnol. 132, 49-56.
Verhoef, S., et al., 2009. Bioproduction of p-hydroxystyrene from glucose by the solvent-
tolerant bacterium Pseudomonas putida S12 in a two-phase water-decanol
fermentation. Appl. Environ. Microbiol. 75, 931-936.
Wagner, S., et al., 2007. Consequences of membrane protein overexpression in
Escherichia coli. Mol. Cell. Proteomics. 6, 1527-1550.
Waltz, E., 2008. Do biomaterials really mean business? Nat Biotech. 26, 851-853.
Wang, S., et al., 2013. Clostridium acidurici electron-bifurcating formate dehydrogenase.
Appl. Environ. Microbiol. 79, 6176-9.
Warnecke, T., Gill, R. T., 2005. Organate toxicity, tolerance, and production in Escherichia
coli biorefining applications. Microb Cell Fact. 4, 25.
110
Wessels, H. J. C. T., et al., 2016. Chapter Six - Bacterial electron transfer chains primed
by proteomics. In: Robert, K. P., (Ed.), Adv. Microb. Physiol. vol. Volume 68.
Academic Press, pp. 219-352.
Whitaker, R. J., et al., 1982. Pseudomonas aeruginosa possesses two novel regulatory
isozymes of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase. J. Biol. Chem.
257, 12789-12794.
Whiting, P. H., et al., 1976. The regulation of transport of glucose, gluconate and 2-
oxogluconate and of glucose catabolism in Pseudomonas aeruginosa. Biochem. J.
154, 659-668.
Wi, S. G., et al., 2015. Lignocellulose conversion for biofuel: a new pretreatment greatly
improves downstream biocatalytic hydrolysis of various lignocellulosic materials.
Biotechnol Biofuels. 8, 228.
Wierckx, N. J. P., et al., 2005. Engineering of solvent-tolerant Pseudomonas putida S12
for bioproduction of phenol from glucose. Appl. Environ. Microbiol. 71, 8221-8227.
Wilson, A. C., Pardee, A. B., 1962. Regulation of flavin synthesis by Escherichia coli. J.
Gen. Microbiol. 28, 283-303.
Wisniewski, J. R., et al., 2009. Universal sample preparation method for proteome analysis.
Nat Meth. 6, 359-362.
Wittgens, A., et al., 2011. Growth independent rhamnolipid production from glucose using
the non-pathogenic Pseudomonas putida KT2440. Microb Cell Fact. 10, 80.
Wu, G., et al., 2016. Metabolic burden: cornerstones in synthetic biology and metabolic
engineering applications. Trends Biotechnol. 34, 652-64.
Yamane, Y., et al., 1997. Influence of oxygen and glucose on primary metabolism and
astaxanthin production by Phaffia rhodozyma in batch and fed-batch cultures:
kinetic and stoichiometric analysis. Appl. Environ. Microbiol. 63, 4471-8.
Ye, X., et al., 2009. (18)O stable isotope labeling in MS-based proteomics. Brief Funct
Genomic Proteomic. 8, 136-144.
Yoshida, T., Nagasawa, T., 2007. Biological Kolbe-Schmitt carboxylation: Possible use of
enzymes for the direct carboxylation of organic substrates A2 In: Matsuda, T., (Ed.),
Future Directions in Biocatalysis. Elsevier Science B.V., Amsterdam, pp. 83-105.
Yuan, J., et al., 2011. Functional assessment of EnvZ/OmpR two-component system in
Shewanella oneidensis. PLoS One. 6, e23701.
Yuste, L., et al., 1998. Carbon-source-dependent expression of the PalkB promoter from
the Pseudomonas oleovorans alkane degradation pathway. J. Bacteriol. 180, 5218-
5226.
111
Zerbs, S., et al., 2009. Chapter 12 Bacterial systems for production of heterologous
proteins. In: Richard, R. B., Murray, P. D., Eds.), Methods Enzymol. vol. Volume
463. Academic Press, pp. 149-168.
Zhang, H., Stephanopoulos, G., 2013. Engineering E. coli for caffeate biosynthesis from
renewable sugars. Appl. Microbiol. Biotechnol. 97, 3333-3341.
Zhang, T., et al., 2013. Improved cathode materials for microbial electrosynthesis. Energy
Environ. Sci. 6, 217-224.
Zoski Cynthia, G., 2007. Chemically Modified Electrodes. Elsevier.
Zwick, F., et al., 2013. Regulation of the expression level of transcription factor XylS
reveals new functional insight into its induction mechanism at the Pm promoter.
BMC Microbiol. 13, 262.
112
Appendicx I Publications
1. Balancing redox metabolism using bio-electrochemical systems – a chance for
metabolic engineering? Kracke, F., Bin, L., Yu, S., Krömer, J. O. A review paper was
submitted to Metab. Eng. (under revision)
2. Metabolic Engineering of Pseudomonas putida KT2440 for the Production of para-
Hydroxy benzoate. Yu, S., Plan, M. R., Winter, G., Krömer, J. O., 2016. Front Bioeng
Biotechnol. 4, 90.
3. Anodic respiration of Pseudomonas putida KT2440 in a stirred-tank bioreactor.
Hintermayer, S., Yu, S., Krömer, J. O., Weuster-Botz, D., 2016. Biochem Eng J. 115, 1-13.
4. Anoxic metabolism and biochemical production in Pseudomonas putida F1 driven by a
bioelectrochemical system. Lai, B., Yu, S., Bernhardt, P. V., Rabaey, K., Virdis, B., Krömer,
J. O., 2016. Biotechnol Biofuels. 9, 39.
5. Quantitative analysis of aromatics for synthetic biology using liquid chromatography. Lai,
B., Plan, M. R., Averesch, N. J. H., Yu, S., Kracke, F., Lekieffre, N., Bydder, S., Hodson, M.
P., Winter, G., Krömer, J. O., 2016. Quantitative analysis of aromatics for synthetic biology
using liquid chromatography. J. Biotechnol.
6. Improved performance of Pseudomonas putida in a bioelectrochemical system through
overexpression of periplasmic glucose dehydrogenase. Biotechnol Bioeng. Yu, S., Bin, L.,
Plan, M. P., Hodson, M.P., Lestari E.A., Song H., Krömer. J.O. Biotechnol. Bioeng
(accepted)
7. The effects of aerobic growth conditions on electrochemical production by P. putida
KT2440/644D-GK during aerobic-anaerobic dual-phase fermentation. Yu, S., Bin, L.,
Winter, G., Krömer, J. O., - Manuscript to be submitted.
113
Appendicx II Supplementary materials
Supplementary material for chapter 2
Figure S2-1. Molecular tools for strain development. (A) The design of nested fusion
PCR for the construction of pEMG-TS1TS2. (B) The procedure for gene deletion
from genome.
A
B
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Table S2-1. Comparison of soluble fraction and whole cell expression of wild type
UbiC
Culture conditions ratio of soluble fraction to the whole extraction
fraction
25℃, 2h 87.9%
30℃, 2h 93.5%
25℃, 6h 91.4%
30℃, 6h 96.3%
Note: The expression level of UbiCwere quantified using the software of Quantity One
(Bio-rad).
Figure S2-2 Feed rate control for P. putida KT∆pobA∆pheA∆trpE∆hexR/UA in fed-
batch fermentation. ●, feed rate (ml h-1)
Codon optimized ubiC gene:
ATGAGCCATCCGGCCCTGACCCAGCTGCGTGCCCTGCGCTACTGCAAAGAGATCCC
GGCCCTGGACCCGCAGCTGCTGGATTGGCTGCTGCTGGAAGATAGCATGACCAAGC
GCTTCGAGCAGCAGGGCAAGACCGTGAGCGTGACCATGATCCGCGAGGGCTTCGTG
GAACAGAACGAGATCCCGGAAGAACTGCCGCTGCTGCCGAAAGAGAGCCGCTACTG
GCTGCGCGAGATCCTGCTGTGCGCCGACGGCGAACCGTGGCTGGCGGGTCGTACC
GTGGTGCCGGTGAGCACCCTGAGCGGTCCGGAACTGGCCCTGCAGAAGCTGGGCA
AGACCCCGCTGGGCCGTTACCTGTTCACCAGCAGCACCCTGACCCGTGACTTCATCG
AGATCGGCCGTGATGCCGGCCTGTGGGGCCGTCGTAGCCGTCTGCGCCTGAGCGG
CAAGCCGCTGCTGCTGACCGAACTGTTCCTGCCGGCCAGCCCGCTGTACTGA
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Codon optimized aroGD146N gene:
ATGAACTACCAGAACGACGACCTGCGTATCAAGGAGATCAAGGAGCTGTTGCCACCG
GTCGCGCTCCTGGAGAAGTTCCCGGCGACCGAGAACGCGGCAAATACCGTCGCGCA
TGCCCGCAAAGCCATCCACAAGATTTTGAAGGGCAACGATGACCGTCTGCTGGTCGT
CATCGGGCCCTGCTCGATCCACGACCCGGTGGCCGCCAAAGAGTACGCCACCCGCC
TGCTGGCCCTCCGCGAAGAACTGAAGGACGAGCTGGAGATCGTCATGCGCGTGTAC
TTCGAAAAACCCCGCACCACCGTAGGCTGGAAGGGTTTGATTAACGACCCGCACATG
GATAACAGCTTTCAGATCAACGACGGTCTGCGCATCGCCCGCAAACTCCTCCTGGAC
ATCAACGACAGCGGCCTGCCGGCCGCCGGTGAATTTTTGAACATGATCACCCCGCA
GTACCTGGCGGACCTGATGAGCTGGGGTGCCATTGGCGCCCGCACCACCGAGAGC
CAGGTGCATCGCGAACTGGCGTCCGGTCTGTCGTGCCCGGTAGGCTTTAAGAACGG
CACCGATGGGACCATCAAGGTGGCTATCGACGCGATCAACGCTGCGGGGGCTCCGC
ACTGCTTCCTGTCCGTGACCAAGTGGGGTCATTCGGCCATCGTCAACACCTCCGGCA
ACGGTGACTGCCACATCATCCTCCGCGGTGGGAAAGAGCCCAACTATTCCGCTAAGC
ACGTGGCAGAGGTCAAGGAGGGGCTGAACAAGGCCGGCCTCCCGGCGCAAGTCAT
GATCGACTTCAGCCACGCCAACTCGAGCAAGCAGTTCAAGAAGCAAATGGACGTGTG
CGCGGACGTGTGCCAGCAGATCGCTGGTGGGGAGAAGGCCATCATCGGCGTGATG
GTCGAGTCGCATCTGGTGGAGGGCAACCAATCGCTCGAGTCCGGCGAACCGCTCGC
ATACGGTAAGAGCATCACCGACGCGTGCATCGGTTGGGAGGATACGGATGCGCTGC
TGCGTCAACTGGCGAACGCCGTCAAGGCCCGcCGCGGCTGA
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F(A)FliS
(B) mGCD
(C)GADH
Figure S3-2 Melting curve analysis for the realtime RT-qPCR
Only one amplicon was amplified when using the designed primer sets for the
amplification of genes mgcd, gadh and fliS.
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Figure S4-2 Enzymes in central carbon metabolism in Pseudomonas putida KT2440
influenced by growth on glycerol compared with the growth on glucose. Enzymes
involved in these biochemical reactions are highlighted in different colours based on their
differentiated expression levels: down-regulated expression (blue); up-regulated
expression (red); unaffected expression (black). Note: the colour grey indicated the
undetected enzymes or subunits.
Table S4-1 Expression change in cells grown on glycerol (Vs glucose)
glycerol vs glucose glycerol vs glucose
strain: 644D-GK Vs 644D-GK strain: 644D-GK Vs wild type
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Compound Name
fold
change log1.3 p-value
fold
change log1.3
p-
value
Aspartate kinase GN=PP_4473 0.8164 -0.7734 0.0298 0.7879 -0.9086 0.0087
Fatty acid oxidation complex subunit alpha GN=fadB 0.4037 -3.4575 0.0515 0.7905 -0.8958 0.2887
Acetylornithine aminotransferase GN=argD 0.6259 -1.7858 0.0333 0.6192 -1.8270 0.0022
ATP synthase subunit b GN=atpF 0.6595 -1.5864 0.1122 0.7313 -1.1928 0.0045
ATP synthase subunit alpha GN=atpA 0.5665 -2.1658 0.0130 0.9306 -0.2742 0.5364
ATP synthase subunit beta GN=atpD 0.5462 -2.3054 0.0100 0.7742 -0.9755 0.0003
Carbamoyl-phosphate synthase large chain GN=carB 0.5208 -2.4865 0.0124 1.4720 1.4737 0.0006
Chemotaxis response regulator protein-glutamate methylesterase of group 1 operon GN=cheB1 0.7925 -0.8862 0.2924 0.8391 -0.6688 0.3313
60 kDa chaperonin GN=groL 0.6523 -1.6282 0.0177 0.9283 -0.2836 0.1084
10 kDa chaperonin GN=groS 0.7839 -0.9281 0.0636 1.0052 0.0196 0.8931
Elongation factor G 1 GN=fusA 0.6118 -1.8725 0.0180 0.7512 -1.0905 0.0017
Elongation factor Tu-B GN=tufB 0.6232 -1.8026 0.0017 0.7885 -0.9055 0.0001
Elongation factor Tu-A GN=tufA 0.7973 -0.8635 0.0641 0.9322 -0.2677 0.0487
ATP-dependent Clp protease ATP-binding subunit ClpX GN=clpX 0.6030 -1.9282 0.0230 1.3698 1.1994 0.0032
Chaperone protein ClpB GN=clpB 0.9860 -0.0539 0.9722 1.4987 1.5422 0.2521
Chaperone protein DnaK GN=dnaK 0.5919 -1.9989 0.0308 1.1435 0.5110 0.0131
Enolase GN=eno 0.5944 -1.9830 0.0028 1.0486 0.1809 0.0944
Elongation factor Ts GN=tsf 0.5299 -2.4204 0.0010 1.1827 0.6397 0.0009
Bifunctional protein FolD 2 GN=folD2 0.6398 -1.7024 0.0421 0.7627 -1.0323 0.0071
Ribosome hibernation promoting factor GN=hpf 1.0151 0.0573 0.9462 1.8433 2.3309 0.0478
Chaperone protein HtpG GN=htpG 0.4987 -2.6521 0.0049 1.0111 0.0422 0.9226
Translation initiation factor IF-2 GN=infB 0.6548 -1.6136 0.0386 0.8258 -0.7297 0.0048
ATP-dependent protease ATPase subunit HslU GN=hslU 0.6019 -1.9350 0.0469 0.8670 -0.5440 0.0212
Dihydroxy-acid dehydratase GN=ilvD 1.7775 2.1925 0.0236 1.1578 0.5585 0.1247
Ketol-acid reductoisomerase (NADP(+)) GN=ilvC 0.7590 -1.0510 0.0455 0.9038 -0.3853 0.1241
Peptidoglycan-associated lipoprotein GN=pal 0.6079 -1.8973 0.0400 0.6939 -1.3931 0.0079
Ribose-phosphate pyrophosphokinase GN=prs 0.4710 -2.8697 0.0108 0.6538 -1.6199 0.0001
2-isopropylmalate synthase GN=leuA 1.2688 0.9075 0.5543 0.9773 -0.0874 0.8027
3-isopropylmalate dehydrogenase GN=leuB 0.5142 -2.5354 0.0001 0.6312 -1.7539 0.0000
3-isopropylmalate dehydratase large subunit GN=leuC 0.6857 -1.4383 0.2981 0.6649 -1.5557 0.0138
S-adenosylmethionine synthase GN=metK 0.5843 -2.0481 0.0037 1.3799 1.2274 0.0001
Malate synthase G GN=glcB 0.6209 -1.8165 0.1529 0.9615 -0.1497 0.0311
Probable malate:quinone oxidoreductase 1 GN=mqo1 0.3955 -3.5354 0.0222 0.7237 -1.2325 0.0347
UDP-N-acetylglucosamine 1-carboxyvinyltransferase GN=murA 0.8158 -0.7762 0.1366 0.6977 -1.3718 0.0066
NADH-quinone oxidoreductase subunit C/D GN=nuoC 0.7488 -1.1024 0.0057 0.6456 -1.6677 0.0047
Phosphoglycerate kinase GN=pgk 0.7169 -1.2685 0.0326 0.8390 -0.6689 0.0020
Polyribonucleotide nucleotidyltransferase GN=pnp 0.7256 -1.2227 0.0505 0.9013 -0.3961 0.0426
Phosphoribosylformylglycinamidine synthase GN=purL 0.6068 -1.9042 0.0037 1.0708 0.2608 0.2651
Bifunctional purine biosynthesis protein PurH GN=purH 0.6392 -1.7060 0.1914 0.6541 -1.6178 0.0158
Phosphoribosylaminoimidazole-succinocarboxamide synthase GN=purC 0.4686 -2.8889 0.1073 0.6349 -1.7315 0.0002
CTP synthase GN=pyrG 0.6894 -1.4175 0.0310 0.9838 -0.0624 0.7382
Recombination-associated protein RdgC GN=rdgC 1.7272 2.0831 0.6238 1.5201 1.5962 0.4657
Protein RecA GN=recA 0.8789 -0.4922 0.3874 4.0115 5.2948 0.0000
50S ribosomal protein L14 GN=rplN 0.7167 -1.2694 0.0423 0.7230 -1.2360 0.0080
50S ribosomal protein L16 GN=rplP 0.6458 -1.6665 0.0465 0.6202 -1.8209 0.0002
50S ribosomal protein L17 GN=rplQ 0.6450 -1.6711 0.0109 0.8710 -0.5262 0.0286
50S ribosomal protein L25 GN=rplY 0.5879 -2.0248 0.0354 1.3275 1.0798 0.0539
50S ribosomal protein L2 GN=rplB 0.6313 -1.7530 0.0034 0.6955 -1.3841 0.0019
50S ribosomal protein L11 GN=rplK 0.5802 -2.0747 0.0447 2.5274 3.5339 0.0020
50S ribosomal protein L22 GN=rplV 0.6619 -1.5728 0.0383 0.9836 -0.0631 0.7367
50S ribosomal protein L10 GN=rplJ 0.6068 -1.9038 0.0225 0.6441 -1.6764 0.0006
50S ribosomal protein L1 GN=rplA 0.5736 -2.1188 0.0039 1.1776 0.6230 0.0004
50S ribosomal protein L21 GN=rplU 0.6805 -1.4673 0.0640 0.7648 -1.0222 0.0089
50S ribosomal protein L19 GN=rplS 0.6749 -1.4986 0.0183 0.9313 -0.2711 0.1433
50S ribosomal protein L18 GN=rplR 0.6513 -1.6341 0.0509 0.8589 -0.5800 0.0864
50S ribosomal protein L20 GN=rplT 0.6848 -1.4432 0.0089 0.8262 -0.7275 0.0092
50S ribosomal protein L3 GN=rplC 0.6300 -1.7610 0.0067 1.8738 2.3934 0.0000
50S ribosomal protein L7/L12 GN=rplL 0.8046 -0.8286 0.7085 0.0816 -9.5517 0.1724
50S ribosomal protein L5 GN=rplE 0.7166 -1.2699 0.0432 0.6960 -1.3812 0.0008
50S ribosomal protein L9 GN=rplI 0.6388 -1.7083 0.0410 0.8203 -0.7551 0.0000
50S ribosomal protein L4 GN=rplD 0.7477 -1.1082 0.0009 0.7476 -1.1087 0.0021
50S ribosomal protein L6 GN=rplF 0.6445 -1.6746 0.0174 0.9800 -0.0768 0.6849
50S ribosomal protein L23 GN=rplW 0.7049 -1.3329 0.0156 0.8261 -0.7282 0.0002
DNA-directed RNA polymerase subunit alpha GN=rpoA 0.7441 -1.1267 0.0490 0.9737 -0.1015 0.5522
DNA-directed RNA polymerase subunit beta GN=rpoB 0.7127 -1.2912 0.0188 1.0131 0.0498 0.5809
DNA-directed RNA polymerase subunit beta' GN=rpoC 0.6246 -1.7937 0.0056 1.1709 0.6014 0.0263
30S ribosomal protein S10 GN=rpsJ 0.6138 -1.8601 0.0325 1.7396 2.1102 0.0079
30S ribosomal protein S7 GN=rpsG 0.7121 -1.2939 0.0345 0.7199 -1.2525 0.0010
30S ribosomal protein S8 GN=rpsH 0.7532 -1.0805 0.0979 0.6397 -1.7028 0.0022
30S ribosomal protein S9 GN=rpsI 0.7502 -1.0955 0.0001 0.6456 -1.6679 0.0043
30S ribosomal protein S5 GN=rpsE 0.6269 -1.7798 0.0139 0.8233 -0.7412 0.0166
30S ribosomal protein S3 GN=rpsC 0.8508 -0.6160 0.6599 0.8095 -0.8053 0.2801
30S ribosomal protein S2 GN=rpsB 0.6695 -1.5291 0.0026 0.7369 -1.1639 0.0007
30S ribosomal protein S4 GN=rpsD 0.7788 -0.9529 0.0815 0.7542 -1.0754 0.0053
Protein-export protein SecB GN=secB 0.5409 -2.3426 0.0173 0.5959 -1.9731 0.0002
Succinate--CoA ligase [ADP-forming] subunit beta GN=sucC 0.4987 -2.6516 0.0015 0.7519 -1.0868 0.0001
Alanine--tRNA ligase GN=alaS 0.6220 -1.8099 0.0414 0.7022 -1.3476 0.0000
Aspartate--tRNA(Asp/Asn) ligase GN=aspS 0.6667 -1.5454 0.0131 0.8051 -0.8265 0.0008
Isoleucine--tRNA ligase GN=ileS 0.7219 -1.2419 0.0011 0.7768 -0.9625 0.0081
Methionine--tRNA ligase GN=metG 0.5267 -2.4438 0.0025 0.6971 -1.3751 0.0007
Leucine--tRNA ligase GN=leuS 0.4246 -3.2651 0.1685 0.6414 -1.6930 0.0001
Tryptophan--tRNA ligase GN=trpS 0.5721 -2.1284 0.1977 0.9180 -0.3263 0.7296
Glycine--tRNA ligase alpha subunit GN=glyQ 0.6690 -1.5319 0.0057 0.8153 -0.7781 0.0012
Glycine--tRNA ligase beta subunit GN=glyS 0.6671 -1.5429 0.0428 0.5680 -2.1558 0.0131
Proline--tRNA ligase GN=proS 0.8106 -0.8004 0.5100 0.7200 -1.2522 0.0008
Valine--tRNA ligase GN=valS 0.7013 -1.3523 0.0194 0.9411 -0.2315 0.1816
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Serine--tRNA ligase GN=serS 0.5850 -2.0438 0.0057 0.8394 -0.6672 0.0156
Trigger factor GN=tig 0.5201 -2.4920 0.0105 1.3568 1.1631 0.0002
Protein TolB GN=tolB 0.6412 -1.6940 0.0053 0.6404 -1.6983 0.0006
Uracil phosphoribosyltransferase GN=upp 1.2890 0.9675 0.7454 1.0887 0.3238 0.6270
Membrane protein insertase YidC GN=yidC 0.5140 -2.5365 0.0026 0.9035 -0.3867 0.4500
Cell division protein ZipA GN=zipA 1.1560 0.5525 0.3018 0.9181 -0.3257 0.0147
RNA polymerase sigma factor RpoS OS=Pseudomonas putida GN=rpoS 0.9795 -0.0789 0.7889 3.9716 5.2567 0.0000
2-oxoglutarate decarboxylase, thiamine-requiring E1 subunit GN=sucA 0.5700 -2.1427 0.0069 0.7981 -0.8595 0.0023
Transketolase GN=tktA 0.5895 -2.0144 0.0514 0.7711 -0.9908 0.0030
Glyceraldehyde-3-phosphate dehydrogenase GN=gapB 0.4819 -2.7823 0.0002 0.8896 -0.4459 0.0193
AMP nucleosidase GN=amn 0.7350 -1.1734 0.0932 0.7381 -1.1573 0.0022
Transcription termination/antitermination protein NusA GN=nusA 0.7108 -1.3011 0.1115 0.9567 -0.1686 0.2041
Aldehyde dehydrogenase GN=aldB-II 2.8911 4.0464 0.0133 3.9063 5.1935 0.0001
Chemotaxis histidine kinase CheA GN=cheA 0.8675 -0.5419 0.2539 0.8925 -0.4336 0.2588
Transcription termination factor Rho GN=rho 0.7067 -1.3231 0.0696 0.7410 -1.1425 0.0950
D-alanyl-D-alanine carboxypeptidase GN=dacA 0.7780 -0.9567 0.4612 0.8518 -0.6113 0.2084
Electron transfer flavoprotein subunit alpha GN=etfA 0.5327 -2.4003 0.0014 0.9498 -0.1961 0.4744
Outer-membrane porin E GN=oprE 0.4660 -2.9103 0.3663 0.3897 -3.5920 0.0094
Signal recognition particle protein GN=ffh 1.2129 0.7357 0.8023 0.8441 -0.6461 0.0967
Glucose-6-phosphate 1-dehydrogenase GN=zwfA 0.3377 -4.1380 0.0015 0.6040 -1.9217 0.0003
Outer membrane protein H1 GN=oprH 0.9316 -0.2699 0.5059 0.8218 -0.7482 0.0290
Glucose-1-phosphate thymidylyltransferase GN=rfbA 0.5498 -2.2802 0.0290 0.5326 -2.4015 0.0018
Cbb3-type cytochrome c oxidase subunit GN=ccoP-I 3.7676 5.0557 0.0035 0.5429 -2.3283 0.0008
Acetyltransferase component of pyruvate dehydrogenase complex GN=aceF 0.6520 -1.6302 0.0093 0.6823 -1.4573 0.0000
DNA binding regulator, beta subunit B GN=hupB 0.5942 -1.9843 0.0045 18.0700 11.0314 0.0000
Pyruvate dehydrogenase E1 component GN=aceE 0.6410 -1.6951 0.0553 1.4808 1.4963 0.0157
Methylenetetrahydrofolate reductase GN=metF 0.5287 -2.4290 0.0652 0.6271 -1.7784 0.0258
Glutamine synthetase GN=glnA 0.5716 -2.1319 0.0350 0.3081 -4.4870 0.0000
Saccharopine dehydrogenase GN=PP_2928 0.4421 -3.1107 0.0018 0.5583 -2.2214 0.0012
Uncharacterized protein GN=PP_0913 0.4282 -3.2325 0.0172 1.1926 0.6714 0.0021
Pyruvate carboxylase subunit A GN=pycA 0.6153 -1.8513 0.0147 1.0152 0.0575 0.7951
Malic enzyme B GN=maeB 0.6560 -1.6066 0.0094 0.7985 -0.8577 0.0178
Dihydrolipoyl dehydrogenase GN=lpdG 0.5149 -2.5299 0.0200 0.8178 -0.7667 0.0722
Uncharacterized protein GN=PP_3106 0.6620 -1.5721 0.0908 1.9166 2.4795 0.0001
Adenylosuccinate lyase GN=purB 0.5234 -2.4677 0.0007 0.7596 -1.0482 0.0105
Non-ribosomal peptide synthetase (Subunit of ferribactin synthase) GN=pvdJ 0.6064 -1.9068 0.0161 0.8123 -0.7925 0.0249
Homoserine dehydrogenase GN=hom 0.6260 -1.7851 0.0222 0.8705 -0.5286 0.0747
Cell division protein FtsA GN=ftsA 0.6201 -1.8213 0.0629 1.2460 0.8382 0.2588
Site-determining protein GN=minD 0.7989 -0.8559 0.3249 0.9903 -0.0373 0.4806
LPS-assembly lipoprotein LptE GN=lptE 0.4883 -2.7321 0.0077 0.6480 -1.6540 0.0026
Protein kinase GN=yeaG 1.0615 0.2275 0.0011 0.3380 -4.1342 0.0000
Outer membrane porin F GN=oprF 0.5400 -2.3487 0.0299 1.2666 0.9009 0.1770
Non-ribosomal peptide synthetase GN=pvdD 1.1856 0.6487 0.7823 0.8332 -0.6957 0.6760
Agglutination protein GN=tolC 0.3764 -3.7244 0.0026 0.8599 -0.5753 0.0517
TonB-dependent receptor GN=PP_1446 0.3256 -4.2768 0.3194 0.9564 -0.1700 0.6034
Outer membrane protein assembly factor BamA GN=bamA 0.5873 -2.0284 0.0512 0.7016 -1.3506 0.0019
Lon protease GN=lon-II PE=2 SV=1 0.6453 -1.6695 0.0124 1.0815 0.2986 0.0085
Diaminobutyrate-2-oxoglutarate transaminase GN=pvdH 0.1174 -8.1652 0.0046 2.7725 3.8868 0.0007
Uncharacterized protein GN=PP_1309 2.1682 2.9497 0.0208 8.7175 8.2531 0.0000
PhoH family protein GN=PP_1291 0.7085 -1.3137 0.2081 0.2101 -5.9464 0.0001
DNA gyrase subunit B GN=gyrB 0.7426 -1.1341 0.0927 0.7399 -1.1480 0.0215
NAD-specific glutamate dehydrogenase GN=gdhB 0.7997 -0.8518 0.2170 0.5860 -2.0372 0.0021
Uncharacterized protein GN=PP_1230 0.4920 -2.7034 0.5117 0.7921 -0.8885 0.4987
Outer membrane protein OprG GN=oprG 1.4859 1.5094 0.6205 5.4237 6.4444 0.0644
D-gluconate transporter GN=gntT 0.6834 -1.4508 0.2147 0.7609 -1.0416 0.1104
RNA polymerase sigma factor RpoS GN=rpoS 0.7936 -0.8809 0.0014 2.8554 3.9991 0.0000
Pyruvate kinase GN=pykA 0.8702 -0.5300 0.2073 0.7050 -1.3322 0.0000
Putative Outer membrane ferric siderophore receptor GN=PP_3325 0.3406 -4.1048 0.0089 0.3152 -4.4011 0.0001
Cytochrome c oxidase subunit, cbb3-type GN=ccoO-I 2.6040 3.6478 0.0055 3.0175 4.2095 0.0001
Uncharacterized protein GN=PP_2331 0.5650 -2.1759 0.0052 0.8321 -0.7007 0.0886
Phosphoenolpyruvate synthase GN=ppsA 0.6147 -1.8550 0.0109 0.9462 -0.2108 0.4674
Succinate dehydrogenase flavoprotein subunit GN=sdhA 0.8625 -0.5639 0.0499 0.8601 -0.5743 0.0492
Integral membrane ATP-dependent zinc metallopeptidase / HflK-HflC complex GN=hflK 0.6910 -1.4085 0.0139 1.0161 0.0607 0.7374
Gluconate 2-dehydrogenase flavoprotein subunit GN=PP_3383 0.5387 -2.3577 0.0143 46.8596 14.6634 0.0000
Succinate--CoA ligase [ADP-forming] subunit alpha GN=sucD 0.4985 -2.6531 0.0132 1.4067 1.3007 0.0060
Gluconate 2-dehydrogenase gamma subunit GN=PP_3384 0.6564 -1.6045 0.0014 12.8497 9.7320 0.0000
Succinate dehydrogenase iron-sulfur subunit GN=sdhB 1.0237 0.0893 0.6736 0.7872 -0.9120 0.0003
Ribosome associated GTPase GN=typA 0.6368 -1.7203 0.0217 0.8283 -0.7178 0.0105
Outer membrane lipoprotein GN=slyB 0.3401 -4.1106 0.0067 1.6374 1.8796 0.0005
Non-ribosomal peptide synthase (Subunit of ferribactin synthase) GN=pvdL 0.5073 -2.5869 0.0114 0.8966 -0.4160 0.6341
Outer membrane ferripyoverdine receptor FpvA, TonB-dependent GN=fpvA 0.1308 -7.7517 0.0012 0.5861 -2.0361 0.0101
Aminomethyltransferase GN=gcvT-I 0.7589 -1.0518 0.0142 0.4737 -2.8480 0.0000
Phosphogluconate dehydratase GN=edd 0.7082 -1.3152 0.0147 0.7110 -1.3001 0.0012
ADP/ATP ratio sensor and inhibitor of translation GN=ettA 0.8380 -0.6736 0.0444 0.9903 -0.0373 0.7934
Inosine-5'-monophosphate dehydrogenase GN=guaB 0.6216 -1.8123 0.0278 0.9014 -0.3958 0.1321
Glyceraldehyde-3-phosphate dehydrogenase GN=gapA 0.7247 -1.2272 0.1290 2.2319 3.0601 0.0000
ATP:GTP 3'-pyrophosphotransferase GN=relA 0.2001 -6.1330 0.1374 0.2516 -5.2593 0.0000
Cytochrome bo terminal oxidase subunit I GN=cyoB 0.3477 -4.0270 0.0132 1.1502 0.5334 0.4881
Outer-membrane porin D GN=oprQ 1.5699 1.7190 0.4093 0.9384 -0.2422 0.7754
Electron transfer flavoprotein subunit beta GN=etfB 0.4686 -2.8891 0.0017 0.9572 -0.1666 0.3472
Ribonucleoside-diphosphate reductase GN=nrdA 0.6557 -1.6089 0.0078 1.2923 0.9773 0.0014
Polyhydroxyalkanoate granule-associated protein GA2 GN=PP_5007 0.9910 -0.0343 0.9482 0.4206 -3.3007 0.0000
Putative epimerase GN=kguE 0.1676 -6.8086 0.0584 0.2561 -5.1924 0.0004
Pyruvate carboxylase subunit B GN=pycB 0.6914 -1.4066 0.0307 1.3348 1.1008 0.0056
OmpA/MotB domain-containing protein GN=yiaD 0.6670 -1.5436 0.0781 1.0567 0.2101 0.4938
L-glutamate synthase(NADPH) alpha subunit GN=gltB 0.7098 -1.3067 0.0505 1.1920 0.6693 0.2514
4-hydroxy-tetrahydrodipicolinate synthase GN=dapA 0.6750 -1.4980 0.0445 0.6710 -1.5205 0.0001
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D-3-phosphoglycerate dehydrogenase / alpha-ketoglutarate reductase GN=serA 0.7796 -0.9489 0.1670 0.8714 -0.5247 0.0946
3-oxoacyl-[acyl-carrier-protein] reductase subunit GN=fabG 0.6139 -1.8597 0.0259 0.9712 -0.1115 0.5196
30S ribosomal protein S1 GN=rpsA 0.6019 -1.9348 0.0027 1.2933 0.9804 0.0030
NADH-quinone oxidoreductase subunit F GN=nuoF 0.8713 -0.5250 0.1060 1.0199 0.0749 0.5879
Uncharacterized protein GN=PP_3777 1.2405 0.8215 0.0669 1.0701 0.2582 0.0680
Non-ribosomal peptide synthetase (Subunit of ferribactin synthase) GN=pvdI 0.3999 -3.4931 0.0450 0.6706 -1.5231 0.0616
Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
GN=sucB 0.5765 -2.0993 0.0067 0.6185 -1.8312 0.0003
Basic-amino-acid specific porin OprD GN=oprD 2.1835 2.9765 0.0805 0.8739 -0.5139 0.2726
ATP-dependent zinc metalloprotease FtsH GN=ftsH 0.5595 -2.2137 0.0823 0.9106 -0.3568 0.1193
Putative sarcosine oxidase GN=PP_3775 0.7973 -0.8636 0.0079 1.5026 1.5520 0.0000
Aldehyde dehydrogenase GN=aldB-I 0.8421 -0.6551 0.3019 0.7829 -0.9328 0.1022
Polyamine-transporting ATPase GN=spuF 0.9620 -0.1475 0.7240 1.0400 0.1494 0.4762
Putative Glycosyl transferase GN=PP_1786 0.5112 -2.5572 0.0204 0.6629 -1.5669 0.0030
Oxygen-independent Coproporphyrinogen III oxidase family protein GN=PP_3781 0.9316 -0.2701 0.0854 3.3145 4.5674 0.0000
Porin GN=oprB-I 0.7150 -1.2789 0.4376 0.5859 -2.0378 0.0001
Syringomycin biosynthesis enzyme 2 GN=syrB 0.6256 -1.7878 0.0147 8.8765 8.3220 0.0000
Malonyl CoA-acyl carrier protein transacylase GN=fabD 0.6788 -1.4764 0.1908 6.7985 7.3055 0.0031
Putative peroxiredoxin GN=tsaA 0.5762 -2.1016 0.0108 0.9101 -0.3589 0.0012
Isocitrate dehydrogenase GN=idh 0.2506 -5.2752 0.0006 0.6074 -1.9003 0.0011
Enoyl-CoA hydratase GN=PP_2217 0.7062 -1.3257 0.0182 1.9627 2.5702 0.0000
Threonine synthase GN=thrC 0.5163 -2.5193 0.0033 0.6632 -1.5655 0.0008
Ribonuclease E GN=rne 0.8505 -0.6171 0.0621 0.9346 -0.2579 0.1942
Protein translocase subunit SecD GN=secD 0.7567 -1.0624 0.0259 0.8129 -0.7893 0.0057
Uricase/urate oxidase GN=puuD 0.4438 -3.0965 0.2372 3.4560 4.7267 0.0017
Uncharacterized protein GN=PP_3784 0.6509 -1.6365 0.0161 2.0167 2.6736 0.0000
Pyrroline-5-carboxylate reductase GN=proC 0.8944 -0.4254 0.1857 1.6355 1.8752 0.0008
ATP-dependent RNA helicase DeaD GN=deaD 0.8244 -0.7359 0.2247 1.1557 0.5516 0.0032
Uncharacterized protein GN=PP_2105 0.8333 -0.6952 0.1741 1.4355 1.3780 0.0000
Pyridoxal-phosphate dependent enzyme family protein GN=PP_1113 0.6890 -1.4197 0.4302 0.7759 -0.9670 0.3106
dTDP-4-dehydrorhamnose 3,5-epimerase GN=rfbC 0.3755 -3.7338 0.0619 1.4993 1.5437 0.0326
Branched-chain-amino-acid aminotransferase GN=ilvE 0.6352 -1.7298 0.0035 1.3113 1.0329 0.0029
Uncharacterized protein GN=PP_3089 0.4287 -3.2284 0.0033 0.7796 -0.9489 0.0013
Citrate synthase GN=gltA 0.8151 -0.7793 0.1296 0.8930 -0.4313 0.0255
Flagellin GN=fliC 0.6338 -1.7383 0.0679 0.9111 -0.3548 0.1324
Protein HflC GN=hflC 0.8907 -0.4410 0.6422 1.2281 0.7830 0.2968
GDP-mannose 4,6-dehydratase GN=gmd 0.5407 -2.3440 0.0019 0.8996 -0.4033 0.0070
Ubiquinol oxidase subunit 2 GN=cyoA 0.4154 -3.3484 0.0095 0.4619 -2.9441 0.0003
Aconitate hydratase B GN=acnB 0.5979 -1.9603 0.0312 0.6622 -1.5713 0.0000
47 kDa protein GN=PP_5361 0.3966 -3.5249 0.0229 0.5535 -2.2548 0.0001
Peptidyl-prolyl cis-trans isomerase GN=fklB-II 0.7090 -1.3108 0.0043 1.0789 0.2896 0.2426
LPS-assembly protein LptD GN=lptD 1.0445 0.1660 0.9576 0.8320 -0.7010 0.6105
Putative lipoprotein GN=PP_5661 0.3851 -3.6376 0.1408 6.0271 6.8464 0.0578
Sec translocation complex-SecG subunit GN=secG 0.2116 -5.9192 0.0057 0.5661 -2.1689 0.0006
Adenosylhomocysteinase GN=ahcY 0.5683 -2.1540 0.0177 0.6868 -1.4318 0.0005
Flagellar brake protein YcgR GN=ycgR 0.9154 -0.3370 0.3104 0.9689 -0.1203 0.6698
Methyl-accepting chemotaxis protein McpS GN=mcpS 0.8121 -0.7935 0.5567 0.7654 -1.0191 0.0615
Chromate reductase GN=PP_4138 1.0147 0.0557 0.9249 0.7677 -1.0078 0.0009
5-aminovalerate aminotransferase DavT GN=davT 0.4658 -2.9120 0.0036 1.5557 1.6844 0.0004
UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase GN=murE 0.6498 -1.6432 0.0064 1.2641 0.8932 0.0097
Acyl carrier protein GN=acpP 0.6831 -1.4526 0.3353 0.7353 -1.1720 0.0001
Acetyl-coenzyme A synthetase 1 GN=acsA1 5.5198 6.5113 0.0071 10.5462 8.9790 0.0000
Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta GN=accD 1.4705 1.4698 0.6195 1.1880 0.6568 0.7283
Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha GN=accA 0.5915 -2.0014 0.0294 0.7555 -1.0685 0.0034
Probable cytosol aminopeptidase GN=pepA 0.7418 -1.1385 0.0980 2.0052 2.6519 0.0021
Phosphomannomutase/phosphoglucomutase GN=algC 0.4923 -2.7010 0.0471 0.7884 -0.9061 0.2004
Argininosuccinate lyase GN=argH 0.4373 -3.1528 0.0101 0.6677 -1.5394 0.0042
Acetylglutamate kinase GN=argB 0.7108 -1.3013 0.0571 0.9210 -0.3137 0.1253
N-acetyl-gamma-glutamyl-phosphate reductase 1 GN=argC1 0.6365 -1.7217 0.0087 0.8631 -0.5610 0.0211
Chorismate synthase GN=aroC 0.5525 -2.2612 0.0045 1.1393 0.4971 0.0603
Arginine deiminase GN=arcA 0.7718 -0.9871 0.2706 0.3973 -3.5182 0.0096
Arginine biosynthesis bifunctional protein ArgJ GN=argJ 0.5799 -2.0771 0.0909 1.3714 1.2039 0.0137
Glutaminase-asparaginase GN=ansB 0.2009 -6.1180 0.0017 0.3819 -3.6693 0.0000
3-dehydroquinate synthase GN=aroB 0.6607 -1.5796 0.0903 0.7733 -0.9798 0.0001
Argininosuccinate synthase GN=argG 0.5693 -2.1475 0.0136 0.6103 -1.8824 0.0014
N-succinylarginine dihydrolase GN=astB 1.3812 1.2308 0.1130 14.2311 10.1212 0.0001
ATP synthase subunit delta GN=atpH 0.5951 -1.9782 0.0113 0.9216 -0.3114 0.2374
ATP synthase epsilon chain GN=atpC 0.9760 -0.0926 0.9274 1.0299 0.1123 0.8611
ATP synthase gamma chain GN=atpG 0.6870 -1.4311 0.2214 0.4822 -2.7802 0.0063
Biotin synthase GN=bioB 0.2104 -5.9404 0.0085 0.8947 -0.4240 0.3563
Carbamoyl-phosphate synthase small chain GN=carA 1.1518 0.5387 0.1636 0.9508 -0.1922 0.2479
Sulfate adenylyltransferase subunit 2 GN=cysD 1.0501 0.1865 0.7941 0.5910 -2.0044 0.0004
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase GN=dapD 0.3665 -3.8253 0.0050 0.7112 -1.2992 0.0233
4-hydroxy-tetrahydrodipicolinate reductase GN=dapB 0.6018 -1.9354 0.0028 1.0975 0.3547 0.0087
Ecotin GN=eco 0.5456 -2.3093 0.0086 0.4966 -2.6679 0.0000
Glucose-6-phosphate isomerase 2 GN=pgi2 0.6141 -1.8587 0.0225 0.7803 -0.9455 0.0026
Glutamyl-tRNA(Gln) amidotransferase subunit A GN=gatA 4.9992 6.1337 0.0009 6.0548 6.8640 0.0000
Cell division protein FtsZ GN=ftsZ PE=3 SV=3 1.2116 0.7316 0.2104 1.0442 0.1647 0.0832
Serine hydroxymethyltransferase 2 GN=glyA2 0.7329 -1.1846 0.0108 0.6870 -1.4311 0.0018
Glycerol-3-phosphate dehydrogenase [NAD(P)+] GN=gpsA 0.6670 -1.5438 0.0811 0.6881 -1.4246 0.3071
Phosphoglucosamine mutase GN=glmM 0.6253 -1.7895 0.1053 0.8675 -0.5416 0.0507
Transcription elongation factor GreA GN=greA 0.3622 -3.8707 0.0124 0.9253 -0.2959 0.7446
Protein GrpE GN=grpE 0.7721 -0.9856 0.3603 1.5339 1.6305 0.0038
Glutathione synthetase GN=gshB 0.4430 -3.1035 0.0818 1.1207 0.4342 0.5818
GMP synthase [glutamine-hydrolyzing] GN=guaA 0.5406 -2.3442 0.0295 0.7098 -1.3066 0.0280
0.6416 -1.6917 0.0081 1.8148 2.2715 0.0000
ATP-dependent Clp protease proteolytic subunit GN=clpP 0.5948 -1.9802 0.0140 1.0634 0.2345 0.8276
Protein phosphatase CheZ GN=cheZ 0.6492 -1.6467 0.0098 0.6402 -1.7000 0.0251
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Phosphopantetheine adenylyltransferase GN=coaD 0.7209 -1.2471 0.0203 0.8224 -0.7454 0.0057
Glutarate-semialdehyde dehydrogenase DavD GN=davD 0.5671 -2.1617 0.0263 1.1589 0.5619 0.0091
DNA polymerase III subunit beta GN=dnaN 0.5970 -1.9662 0.0108 0.8880 -0.4530 0.0018
Chaperone protein DnaJ GN=dnaJ 0.6499 -1.6424 0.2538 0.7466 -1.1139 0.1107
Elongation factor P GN=efp 0.6391 -1.7065 0.0059 0.7541 -1.0756 0.0003
tRNA-dihydrouridine(20/20a) synthase GN=dusA 0.9489 -0.1999 0.9346 0.8348 -0.6884 0.0086
Enoyl-[acyl-carrier-protein] reductase [NADH] GN=fabV 0.8645 -0.5551 0.1767 0.7607 -1.0424 0.0016
Fructose-1,6-bisphosphatase class 1 GN=fbp 0.7548 -1.0724 0.2148 0.8583 -0.5823 0.0304
3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase GN=fabA 0.7187 -1.2592 0.0853 0.7499 -1.0972 0.0117
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B GN=gatB 1.9003 2.4469 0.0078 0.3862 -3.6263 0.0756
GTP cyclohydrolase FolE2 GN=folE2 0.3418 -4.0912 0.0925 0.9165 -0.3324 0.8123
2,3-bisphosphoglycerate-independent phosphoglycerate mutase GN=gpmI 0.6308 -1.7561 0.0142 0.8800 -0.4872 0.0439
Glycine dehydrogenase (decarboxylating) 1 GN=gcvP1 0.8038 -0.8324 0.2894 2.7631 3.8738 0.0005
Oxygen-dependent coproporphyrinogen-III oxidase GN=hemF 0.5676 -2.1589 0.0241 0.5666 -2.1656 0.0028
Histidinol-phosphate aminotransferase GN=hisC 0.9374 -0.2463 0.6915 1.1435 0.5109 0.1010
ATP phosphoribosyltransferase regulatory subunit GN=hisZ 0.5080 -2.5813 0.0247 0.5924 -1.9955 0.0048
Bifunctional protein HldE GN=hldE 0.5845 -2.0466 0.0437 0.6396 -1.7036 0.0021
ATP phosphoribosyltransferase GN=hisG 0.6261 -1.7846 0.0043 0.7994 -0.8534 0.0791
Imidazoleglycerol-phosphate dehydratase GN=hisB 0.4724 -2.8582 0.1753 0.4067 -3.4294 0.0001
RNA-binding protein Hfq GN=hfq 0.5830 -2.0565 0.0125 0.8006 -0.8478 0.0078
Histidinol dehydrogenase GN=hisD 0.4904 -2.7162 0.0972 0.6124 -1.8691 0.0098
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide
isomerase GN=hisA 0.6574 -1.5985 0.0199 0.6218 -1.8108 0.0007
33 kDa chaperonin GN=hslO 0.6032 -1.9270 0.0234 0.6924 -1.4011 0.0034
ATP-dependent protease subunit HslV GN=hslV PE=3 SV=3 0.5351 -2.3830 0.0452 0.8576 -0.5855 0.2424
Translation initiation factor IF-1 GN=infA 0.6936 -1.3943 0.0729 1.1537 0.5448 0.2088
Translation initiation factor IF-3 GN=infC 0.5423 -2.3321 0.0102 0.8408 -0.6608 0.0002
Inorganic pyrophosphatase GN=ppa 0.7784 -0.9548 0.0008 0.8402 -0.6635 0.0062
4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (flavodoxin) GN=ispG 0.6623 -1.5704 0.0224 0.9466 -0.2091 0.1988
Cell division topological specificity factor GN=minE 1.0935 0.3406 0.8960 0.6661 -1.5484 0.0321
Cyclic pyranopterin monophosphate synthase accessory protein GN=moaC 0.6342 -1.7357 0.0099 0.7741 -0.9758 0.0458
NADH-quinone oxidoreductase subunit G GN=nuoG 0.9304 -0.2748 0.2397 0.9433 -0.2225 0.1605
GTPase Obg GN=obg 0.8561 -0.5920 0.2890 1.2800 0.9409 0.0299
NADH-quinone oxidoreductase subunit H GN=nuoH 1.0148 0.0560 0.9087 0.4920 -2.7031 0.0011
Glucans biosynthesis protein G GN=opgG 0.9695 -0.1181 0.8479 0.9996 -0.0015 0.9968
N utilization substance protein B homolog GN=nusB 0.6269 -1.7797 0.2197 1.1310 0.4694 0.3548
Ornithine carbamoyltransferase, catabolic GN=arcB PE=3 SV=3 0.6542 -1.6174 0.1251 0.2975 -4.6211 0.0007
Pantothenate synthetase GN=panC 0.8576 -0.5855 0.7418 0.7227 -1.2380 0.2067
2-dehydro-3-deoxyphosphooctonate aldolase 2 GN=kdsA2 0.5314 -2.4099 0.0135 0.9703 -0.1151 0.5680
Cysteine desulfurase IscS GN=iscS 0.6163 -1.8450 0.0003 1.5362 1.6363 0.0001
Catalase-peroxidase GN=katG 0.6585 -1.5925 0.0988 0.6765 -1.4896 0.0246
Cytidylate kinase GN=cmk 0.5804 -2.0738 0.0075 0.8482 -0.6275 0.0695
Adenylate kinase GN=adk 0.7750 -0.9713 0.0873 0.9834 -0.0636 0.5161
3-isopropylmalate dehydratase small subunit GN=leuD 0.8023 -0.8397 0.0208 0.8811 -0.4823 0.0499
UDP-3-O-acyl-N-acetylglucosamine deacetylase GN=lpxC 0.7258 -1.2214 0.0827 0.8458 -0.6382 0.0164
UDP-3-O-acylglucosamine N-acyltransferase GN=lpxD 0.4590 -2.9681 0.1128 2.1327 2.8867 0.0431
tRNA-specific 2-thiouridylase MnmA GN=mnmA 0.6014 -1.9380 0.0009 0.7448 -1.1228 0.0143
NH(3)-dependent NAD(+) synthetase GN=nadE 0.5321 -2.4044 0.0130 0.8240 -0.7378 0.0002
Nucleoside diphosphate kinase GN=ndk 0.9004 -0.4000 0.6989 0.9636 -0.1414 0.8134
Fe/S biogenesis protein NfuA GN=nfuA 0.6566 -1.6032 0.0473 3.5506 4.8297 0.0015
NADH-quinone oxidoreductase subunit B GN=nuoB 0.5294 -2.4245 0.3952 0.3510 -3.9910 0.0001
Phosphoribosylformylglycinamidine cyclo-ligase GN=purM 0.7261 -1.2200 0.1239 1.0451 0.1680 0.3872
Gamma-glutamyl phosphate reductase GN=proA 0.6429 -1.6838 0.0384 0.9854 -0.0560 0.8120
Phosphoribosylamine--glycine ligase GN=purD 0.5171 -2.5139 0.0135 0.8376 -0.6756 0.0564
Dihydroorotase GN=pyrC 0.2941 -4.6642 0.0164 0.3336 -4.1840 0.0004
Dihydroorotate dehydrogenase (quinone) GN=pyrD 0.6497 -1.6439 0.0008 0.8865 -0.4591 0.0974
Phosphoribosylglycinamide formyltransferase 2 GN=purT 0.9679 -0.1243 0.8187 0.8181 -0.7650 0.1075
Adenylosuccinate synthetase GN=purA 0.6320 -1.7491 0.0147 0.8463 -0.6362 0.0223
Orotate phosphoribosyltransferase GN=pyrE 0.6275 -1.7764 0.0138 0.5778 -2.0909 0.0006
Aspartate carbamoyltransferase GN=pyrB 0.6056 -1.9116 0.0121 0.6741 -1.5033 0.0003
Selenide, water dikinase GN=selD 0.8813 -0.4815 0.6547 0.8545 -0.5994 0.4850
Nucleoid-associated protein PP_4268 GN=PP_4268 0.5782 -2.0878 0.0011 0.7294 -1.2028 0.0086
UPF0312 protein PP_4981 GN=PP_4981 0.6136 -1.8617 0.0133 0.6973 -1.3743 0.0000
RNA polymerase-associated protein RapA GN=rapA 1.2730 0.9201 0.0330 0.1336 -7.6730 0.0000
Uridylate kinase GN=pyrH 0.6115 -1.8748 0.0375 0.4225 -3.2838 0.0012
Peptide chain release factor 3 GN=prfC 0.4670 -2.9023 0.0053 0.6952 -1.3856 0.0299
Ribosome maturation factor RimM GN=rimM 0.6002 -1.9459 0.0304 0.8204 -0.7547 0.0458
6,7-dimethyl-8-ribityllumazine synthase GN=ribH 0.5811 -2.0691 0.0043 0.5675 -2.1595 0.0013
50S ribosomal protein L13 GN=rplM 0.6354 -1.7284 0.0075 0.7485 -1.1043 0.0227
50S ribosomal protein L30 GN=rpmD 0.8608 -0.5713 0.7821 1.0978 0.3555 0.7369
50S ribosomal protein L15 GN=rplO 0.6014 -1.9383 0.0363 0.7548 -1.0722 0.0051
50S ribosomal protein L24 GN=rplX 0.7186 -1.2598 0.0034 0.7307 -1.1960 0.0009
50S ribosomal protein L33 GN=rpmG 0.6505 -1.6391 0.0123 0.6330 -1.7429 0.0013
Ribosomal RNA large subunit methyltransferase E GN=rlmE 0.8454 -0.6399 0.3116 1.1576 0.5578 0.0291
50S ribosomal protein L29 GN=rpmC 0.6220 -1.8096 0.0012 1.0346 0.1296 0.4834
50S ribosomal protein L28 GN=rpmB 0.7399 -1.1484 0.0022 0.7746 -0.9735 0.0028
50S ribosomal protein L32 GN=rpmF PE=3 SV=3 0.5737 -2.1176 0.1103 9.1859 8.4526 0.0005
Ribose-5-phosphate isomerase A GN=rpiA 0.7281 -1.2095 0.0334 0.7440 -1.1273 0.0008
RNA polymerase sigma-54 factor GN=rpoN 0.8009 -0.8464 0.0317 0.7370 -1.1633 0.0067
Ribosome-recycling factor GN=frr 0.7052 -1.3315 0.0377 1.1710 0.6017 0.0003
30S ribosomal protein S17 GN=rpsQ 0.6640 -1.5608 0.0136 0.7022 -1.3473 0.0016
30S ribosomal protein S13 GN=rpsM 0.4615 -2.9475 0.0438 2.1766 2.9645 0.0440
30S ribosomal protein S16 GN=rpsP 0.6185 -1.8311 0.0063 0.8143 -0.7830 0.0034
DNA-directed RNA polymerase subunit omega GN=rpoZ 0.6392 -1.7059 0.1314 0.7265 -1.2180 0.0014
30S ribosomal protein S18 GN=rpsR 0.4903 -2.7168 0.0202 0.5724 -2.1265 0.0021
30S ribosomal protein S11 GN=rpsK 0.6057 -1.9109 0.0421 0.6346 -1.7335 0.0000
30S ribosomal protein S19 GN=rpsS 0.5767 -2.0981 0.0267 0.6341 -1.7361 0.0014
30S ribosomal protein S15 GN=rpsO 0.6155 -1.8496 0.0094 0.7655 -1.0185 0.0885
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30S ribosomal protein S14 GN=rpsN 0.9628 -0.1444 0.8265 0.8519 -0.6111 0.1461
30S ribosomal protein S6 GN=rpsF 0.6605 -1.5809 0.0102 1.0093 0.0351 0.9336
30S ribosomal protein S20 GN=rpsT 0.5834 -2.0536 0.0466 0.6740 -1.5036 0.0014
Protein translocase subunit SecA GN=secA 0.6208 -1.8174 0.0237 0.8698 -0.5315 0.0183
Phosphoserine aminotransferase GN=serC 0.5854 -2.0411 0.0246 0.7019 -1.3494 0.0207
Superoxide dismutase [Fe] GN=sodB PE=3 SV=3 2.9230 4.0883 0.0318 0.8568 -0.5890 0.1209
Single-stranded DNA-binding protein GN=ssb 0.7976 -0.8618 0.1715 1.1405 0.5011 0.1031
Chaperone SurA GN=surA 0.4715 -2.8659 0.0095 0.8124 -0.7917 0.0674
Cysteine--tRNA ligase GN=cysS 0.6711 -1.5203 0.0752 1.3167 1.0485 0.0459
Soluble pyridine nucleotide transhydrogenase GN=sthA PE=3 SV=3 0.8489 -0.6242 0.6598 0.2982 -4.6117 0.0252
Glutamate--tRNA ligase GN=gltX 0.7175 -1.2652 0.2891 0.5987 -1.9554 0.0010
Lysine--tRNA ligase GN=lysS 0.5586 -2.2198 0.0065 0.6756 -1.4949 0.0001
Histidine--tRNA ligase GN=hisS 0.7139 -1.2843 0.0072 0.6511 -1.6357 0.0013
Glutamine--tRNA ligase GN=glnS 0.5530 -2.2577 0.3026 0.8264 -0.7269 0.2399
Arginine--tRNA ligase GN=argS 0.6476 -1.6558 0.0471 0.8622 -0.5649 0.3919
Phenylalanine--tRNA ligase alpha subunit GN=pheS 0.6533 -1.6225 0.0261 1.8296 2.3026 0.0015
Threonine--tRNA ligase GN=thrS 0.6683 -1.5361 0.0814 1.1111 0.4017 0.3719
Transaldolase GN=tal 0.7727 -0.9827 0.0069 0.9030 -0.3887 0.0802
Phenylalanine--tRNA ligase beta subunit GN=pheT 0.6605 -1.5806 0.0225 0.6833 -1.4516 0.0000
Tyrosine--tRNA ligase GN=tyrS 0.5280 -2.4341 0.0004 0.5020 -2.6268 0.0004
Thiazole synthase GN=thiG 0.7831 -0.9319 0.0371 1.0886 0.3235 0.1657
Phosphomethylpyrimidine synthase GN=thiC 0.4581 -2.9757 0.0029 0.8977 -0.4114 0.0445
Triosephosphate isomerase GN=tpiA 0.5871 -2.0299 0.0089 0.7853 -0.9214 0.0063
Tryptophan synthase beta chain GN=trpB 0.6443 -1.6752 0.0165 0.7317 -1.1905 0.0001
Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE GN=ubiE 0.3328 -4.1936 0.2845 0.8036 -0.8333 0.0020
Tryptophan synthase alpha chain GN=trpA 0.5981 -1.9592 0.0021 0.6824 -1.4567 0.0006
Xanthine phosphoribosyltransferase GN=xpt 0.5739 -2.1164 0.0184 0.7659 -1.0166 0.0056
UPF0234 protein PP_1352 GN=PP_1352 3.5748 4.8555 0.0033 1.4205 1.3379 0.1848
UPF0345 protein PP_4248 GN=PP_4248 0.4929 -2.6966 0.0147 0.5900 -2.0109 0.0000
Acetolactate synthase GN=PP_1157 0.4827 -2.7759 0.0259 0.4216 -3.2920 0.0008
Glutathione reductase (NADPH) GN=gor 0.6265 -1.7821 0.0583 0.7850 -0.9227 0.0000
Putative type IV piliation protein GN=ycgB 1.2651 0.8964 0.1557 0.3062 -4.5115 0.0000
Mannose/glucose ABC transporter, permease protein GN=gtsC 0.9314 -0.2707 0.8513 1.0355 0.1330 0.6912
Uncharacterized protein GN=PP_4633 0.5701 -2.1421 0.0231 0.5857 -2.0390 0.0002
Branched-chain amino acid ABC transporter, periplasmic amino acid-binding protein (BraC-like)
GN=PP_4867 3.2459 4.4877 0.0254 0.7526 -1.0831 0.0002
Nuclease SbcCD subunit C GN=sbcC 0.7556 -1.0684 0.1535 0.7610 -1.0410 0.0036
Fructose-bisphosphate aldolase GN=fba 0.6742 -1.5025 0.0409 0.7990 -0.8551 0.0206
Uncharacterized protein GN=PP_1246 0.4153 -3.3496 0.0024 0.4852 -2.7564 0.0000
Uncharacterized protein GN=PP_0766 1.0926 0.3375 0.5335 0.6631 -1.5659 0.0013
Inositol monophosphatase / glycerol-2-phosphatase GN=suhB 0.6115 -1.8746 0.1192 1.0450 0.1679 0.4111
Long-chain-fatty-acid/CoA ligase GN=fadD-I 0.6404 -1.6987 0.1774 0.7781 -0.9563 0.0364
DNA-binding protein HU-alpha GN=hupA 1.8675 2.3806 0.0067 0.8902 -0.4432 0.3714
Thioredoxin GN=trx 0.5537 -2.2529 0.0269 0.7757 -0.9682 0.0231
Periplasmic cystine-binding protein GN=fliY 0.8988 -0.4067 0.1259 0.7804 -0.9449 0.0006
Protein CobW GN=cobW 0.5464 -2.3039 0.0305 0.7595 -1.0484 0.0017
Putative Lipoprotein GN=PP_1238 0.7307 -1.1958 0.4032 1.0925 0.3373 0.6899
Mannose/glucose ABC transporter-ATP binding subunit GN=gtsD 0.1716 -6.7191 0.0016 0.2547 -5.2130 0.0001
Ornithine decarboxylase GN=speC 0.6863 -1.4348 0.0798 0.4192 -3.3136 0.0001
Ribosomal RNA large subunit methyltransferase I GN=rlmI 0.8993 -0.4044 0.4504 0.8308 -0.7064 0.1470
Putative SyrP protein GN=PP_4222 0.6567 -1.6031 0.0435 0.6246 -1.7940 0.0311
Amidophosphoribosyltransferase GN=purF 0.6027 -1.9300 0.0156 0.7803 -0.9454 0.0442
Pimeloyl-[acp] methyl ester esterase GN=bioH 0.9259 -0.2933 0.5180 0.4857 -2.7522 0.0010
Cytochrome c4 GN=cc 0.7202 -1.2508 0.0201 0.7946 -0.8764 0.1454
Glutamate / aspartate ABC transporter-periplasmic binding protein GN=gltI 0.9801 -0.0767 0.6998 0.8789 -0.4921 0.0238
Glutaredoxin GN=grxD 0.7045 -1.3348 0.1109 0.8722 -0.5213 0.0128
Cobalamin-dependent methionine synthase GN=metH 0.5812 -2.0683 0.2277 0.6256 -1.7879 0.0711
Mannose-6-phosphate isomerase/mannose-1-phosphate guanylyltransferase GN=PP_1776 0.6303 -1.7590 0.0615 0.7628 -1.0320 0.0003
Uncharacterized protein GN=PP_3321 0.2306 -5.5921 0.0098 0.1335 -7.6750 0.0000
Putative transporter GN=yjiY 0.7162 -1.2725 0.0576 1.4897 1.5191 0.0053
Aminotransferase GN=tyrB 0.4824 -2.7789 0.0089 0.6404 -1.6989 0.0007
Putative Acyl-CoA dehydrogenase GN=PP_0368 0.9632 -0.1430 0.8042 0.8925 -0.4334 0.1595
Histidine kinase GN=gacS 0.5151 -2.5287 0.0264 0.8017 -0.8426 0.1666
Skp-like protein GN=PP_1600 0.7155 -1.2761 0.0140 0.7680 -1.0062 0.0005
Aminotransferase GN=amaC 0.5808 -2.0709 0.0081 0.8151 -0.7793 0.0325
Putative DNA-binding protein HU, form N GN=hupN 0.6956 -1.3835 0.0053 2.7523 3.8589 0.0000
3,4-dihydroxy-2-butanone 4-phosphate synthase GN=ribAB-I 0.3031 -4.5497 0.0218 0.5666 -2.1652 0.0052
Uncharacterized protein GN=PP_5232 0.6317 -1.7507 0.2400 0.8773 -0.4988 0.0104
Cell wall structural actin-like protein MreB GN=mreB 0.7589 -1.0515 0.1761 0.7394 -1.1507 0.0001
Alcohol dehydrogenase, zinc-containing GN=PP_1720 0.6787 -1.4770 0.0379 0.9303 -0.2754 0.1597
ATP-dependent serine protease GN=clpA 0.5502 -2.2776 0.0335 1.0783 0.2874 0.3553
Nucleate cold-shock chaperone GN=cspA-II 0.6894 -1.4178 0.0220 0.7517 -1.0878 0.0013
Uncharacterized protein GN=PP_0909 0.4420 -3.1122 0.0174 0.7103 -1.3039 0.0070
Sulphite reductase hemoprotein, beta subunit GN=cysI 0.6534 -1.6223 0.0349 0.7014 -1.3520 0.0000
Acetyl-CoA carboxylase-biotin carboxyl carrier subunit GN=accB 0.6070 -1.9027 0.0226 1.3233 1.0676 0.0132
Glucokinase GN=glk 0.7108 -1.3009 0.2051 0.6228 -1.8051 0.0283
DNA helicase GN=uvrD 0.9340 -0.2603 0.7114 1.0902 0.3293 0.5011
Small heat shock protein IbpA GN=ibpA 0.8552 -0.5964 0.3384 2.6049 3.6490 0.0002
Bifunctional protein PutA GN=putA 0.7856 -0.9199 0.1278 1.0094 0.0357 0.8681
Oligopeptidase A GN=prlC 0.5120 -2.5517 0.0376 0.7287 -1.2063 0.0466
Thiol:disulfide interchange protein GN=dsbA 0.7216 -1.2435 0.0028 0.7436 -1.1289 0.0050
Outer membrane protein assembly factor BamE GN=bamE 0.6572 -1.6000 0.0233 0.7062 -1.3260 0.0347
Organic hydroperoxide resistance protein GN=ohr 0.7007 -1.3556 0.2229 0.8871 -0.4566 0.0337
6-phosphogluconolactonase GN=pgl 0.4267 -3.2458 0.0571 0.4555 -2.9968 0.0000
Regulator of murein cross-linking GN=ygaU 1.1096 0.3963 0.3085 1.0497 0.1847 0.1775
Putative Lipoprotein GN=PP_0753 0.5053 -2.6017 0.0033 0.5570 -2.2307 0.0008
Putative mannosyltransferase GN=PP_1780 PE=4 SV=2 0.5616 -2.1991 0.0366 0.6592 -1.5881 0.0162
Putative transcriptional regulator GN=PP_0017 1.0656 0.2422 0.5235 2.6878 3.7685 0.0001
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Delta-aminolevulinate dehydratase GN=hemB 0.3670 -3.8204 0.2542 0.7204 -1.2500 0.0176
Sulfate adenylyltransferase subunit 1 GN=cysNC 0.8489 -0.6242 0.1340 0.7415 -1.1401 0.0002
H-NS family protein MvaT GN=PP_3765 0.8410 -0.6602 0.3715 0.4635 -2.9308 0.0000
Spermidine/putrescine ABC transporter-periplasmic subunit GN=spuD 0.7915 -0.8914 0.0700 0.7139 -1.2847 0.0001
Oxidative and nitrosative stress transcriptional dual regulator GN=oxyR 0.7835 -0.9301 0.1371 0.7405 -1.1450 0.0022
NLPA lipoprotein GN=plpB 0.7618 -1.0372 0.0824 1.3360 1.1040 0.0137
Uncharacterized protein GN=PP_3804 0.4505 -3.0393 0.0613 1.2669 0.9017 0.3064
Acetyl-CoA carboxylase-biotin carboxylase subunit GN=accC 0.9814 -0.0714 0.9251 0.9401 -0.2355 0.1788
Transcriptional dual regulator / CysB-O-acetyl-L-serine GN=cysB 1.1186 0.4272 0.3149 1.2735 0.9215 0.0023
Phospho-2-dehydro-3-deoxyheptonate aldolase GN=aroF-I 0.6540 -1.6186 0.0393 0.9341 -0.2599 0.4183
Phosphoglucomutase GN=pgm 0.5712 -2.1342 0.0539 0.8188 -0.7621 0.1037
Tail-specific protease prc GN=prc 0.6309 -1.7553 0.0032 0.5259 -2.4496 0.0000
Thioredoxin reductase GN=trxB 0.9220 -0.3096 0.2252 1.0911 0.3322 0.0805
KHG/KDPG aldolase GN=eda 0.2575 -5.1718 0.0037 0.3351 -4.1671 0.0000
Glutamate dehydrogenase GN=gdhA 0.2432 -5.3896 0.0107 1.3389 1.1122 0.0023
Aspartate ammonia-lyase GN=aspA 0.3352 -4.1657 0.0027 0.5096 -2.5698 0.0798
Hydroxyproline acetylase GN=pvdY PE=4 SV=2 0.1352 -7.6275 0.0000 1.4692 1.4663 0.0015
Aminotransferase GN=aspC 1.2388 0.8162 0.3406 1.1027 0.3727 0.4587
Lon protease GN=lon-I PE=2 SV=1 0.4375 -3.1511 0.0115 0.7934 -0.8823 0.0253
Hydrolase, isochorismatase family GN=PP_1826 0.4789 -2.8063 0.0882 0.6573 -1.5993 0.0028
RNA polymerase-binding transcription factor DksA GN=dksA 0.5904 -2.0083 0.0456 1.3048 1.0140 0.1582
Uncharacterized protein GN=PP_0640 0.9308 -0.2735 0.5927 0.7218 -1.2426 0.0182
Glutamate-pyruvate aminotransferase GN=alaA 0.6279 -1.7739 0.0002 0.7805 -0.9444 0.0307
Lipopolysaccharide ABC transporter, subunit LptB GN=lptB 0.7141 -1.2833 0.0421 0.7078 -1.3174 0.0032
Polyamine:pyruvate transaminase GN=spuC-I 0.5938 -1.9868 0.0249 0.7953 -0.8728 0.0125
Glutamate / aspartate ABC transporter-permease subunit GN=gltJ 0.6451 -1.6710 0.0591 0.6218 -1.8110 0.0006
Uncharacterized protein GN=PP_2370 0.7866 -0.9150 0.3169 0.8616 -0.5678 0.1737
Dienelactone hydrolase family protein GN=PP_4178 0.5025 -2.6232 0.0752 1.5965 1.7831 0.0646
Aminopeptidase N GN=pepN 0.7089 -1.3113 0.0397 1.2393 0.8176 0.0205
Uncharacterized protein GN=PP_1518 0.5177 -2.5091 0.0189 0.6587 -1.5913 0.0017
Cysteine synthase GN=cysK 0.6848 -1.4429 0.0061 0.7064 -1.3249 0.0088
Sulfate ABC transporter GN=sbp-I 0.7026 -1.3456 0.1039 0.7903 -0.8968 0.0336
Probable thiol peroxidase GN=tpx 0.4142 -3.3599 0.0071 1.0381 0.1423 0.4778
NADP-dependent dihydropyrimidine dehydrogenase subunit GN=pydX 2.0413 2.7199 0.0149 0.5099 -2.5675 0.0002
Fumarate hydratase class II GN=fumC-I 0.0916 -9.1108 0.0021 1.2124 0.7340 0.0230
Fumarate hydratase, class I GN=PP_0897 2.0776 2.7871 0.0013 0.6290 -1.7672 0.0026
Inositol monophosphatase family protein GN=PP_3157 0.4221 -3.2873 0.0106 0.6062 -1.9081 0.0028
Transcription-repair-coupling factor GN=mfd 0.6337 -1.7385 0.0453 0.5933 -1.9896 0.0000
Response regulator for chemotactic signal transduction GN=cheY 0.6745 -1.5007 0.0578 0.5851 -2.0426 0.0001
Uncharacterized protein GN=PP_2189 0.9537 -0.1805 0.4278 0.8155 -0.7775 0.0450
RNA polymerase sigma factor RpoD GN=rpoD 0.7285 -1.2075 0.0183 1.2097 0.7256 0.0202
DNA replication inhibitor GN=cspD 0.6899 -1.4151 0.0637 0.6394 -1.7045 0.0009
Phosphomethylpyrimidine kinase GN=thiD 0.5614 -2.2006 0.0877 0.7211 -1.2460 0.0013
Ferric iron uptake global transcriptional repressor Fur-Fe+2 GN=fur 0.5941 -1.9844 0.0430 0.7323 -1.1878 0.1352
Short-chain alcohol dehydrogenase GN=adhP 0.9180 -0.3261 0.4403 0.5202 -2.4908 0.0461
Putative enzyme GN=PP_4315 1.3961 1.2717 0.1902 1.5079 1.5654 0.0302
Transcriptional regulator, LysR family GN=PP_3779 1.5536 1.6793 0.0009 0.7334 -1.1818 0.0274
Formyltetrahydrofolate deformylase GN=purU-II 0.8703 -0.5297 0.4721 0.8552 -0.5964 0.0889
Ubiquinol--cytochrome c reductase, cytochrome c1 GN=petC 0.8596 -0.5764 0.3295 0.8801 -0.4867 0.0467
Uncharacterized protein GN=PP_5360 0.2267 -5.6571 0.0023 0.3023 -4.5594 0.0006
OmpA family protein GN=PP_1121 0.8319 -0.7013 0.3872 0.3428 -4.0810 0.0000
Peptidyl-prolyl cis-trans isomerase GN=ppiB 0.5291 -2.4260 0.0100 0.6390 -1.7071 0.0022
Uncharacterized protein GN=PP_3662 0.5671 -2.1619 0.0034 0.8803 -0.4861 0.0184
Uncharacterized protein GN=PP_0765 0.8586 -0.5810 0.1739 0.6403 -1.6990 0.0020
Uncharacterized protein GN=PP_3787 0.7103 -1.3035 0.0108 1.0927 0.3378 0.0703
Ribosomal silencing factor RsfS GN=rsfS 0.5832 -2.0552 0.0019 0.9383 -0.2429 0.5146
Branched-chain amino acids ABC transporter-periplasmic leucine binding subunit GN=livK 2.1679 2.9491 0.0040 1.6416 1.8893 0.0001
Transcription termination/antitermination protein NusG GN=nusG 0.6181 -1.8337 0.0465 0.6795 -1.4729 0.0004
Flagellar protein FliS GN=fliS 0.8691 -0.5348 0.3983 0.7640 -1.0262 0.0001
Transcriptional regulatory protein AlgP GN=algP 0.7688 -1.0020 0.0032 0.8116 -0.7958 0.0019
Ferroxidase GN=bfr-I 0.6236 -1.7999 0.0000 0.7006 -1.3561 0.0069
Ribonucleoside-diphosphate reductase subunit beta GN=nrdB 0.5883 -2.0220 0.0363 1.3731 1.2085 0.0516
Quinolinate phosphoribosyltransferase (Decarboxylating) monomer GN=nadC 0.8397 -0.6658 0.6043 0.6415 -1.6922 0.0070
Ferredoxin--NADP(+) reductase GN=fpr-I 0.2319 -5.5700 0.0062 0.4381 -3.1459 0.0006
Gluconate 2-dehydrogenase cytochrome c subunit GN=PP_3382 1.2670 0.9020 0.1498 3.5821 4.8632 0.0000
Uncharacterized protein GN=PP_4684 PE=4 SV=2 0.7436 -1.1294 0.0381 0.8139 -0.7846 0.0005
Phosphoenolpyruvate-dependent regulator (With NPR and NTR proteins) GN=ptsP 0.8696 -0.5324 0.4508 1.1619 0.5720 0.6202
Putative metallopeptidase GN=PP_2238 0.8048 -0.8275 0.0125 0.8019 -0.8414 0.0100
Carboxynorspermidine/carboxyspermidine decarboxylase GN=nspC 0.5107 -2.5613 0.0141 0.7368 -1.1641 0.0105
Aspartate-semialdehyde dehydrogenase GN=asd 0.4893 -2.7247 0.0059 0.8889 -0.4489 0.0279
Peptidyl-prolyl cis-trans isomerase GN=fkpB 0.6454 -1.6687 0.0824 #DIV/0! #DIV/0! 0.0000
Uncharacterized protein GN=PP_1787 0.5438 -2.3217 0.0475 1.0664 0.2449 0.2300
3-oxoacyl-[acyl-carrier-protein] synthase 1 GN=fabB 0.5416 -2.3372 0.0209 0.8872 -0.4562 0.0514
Activator of NRII(GlnL/NtrB) phosphatase GN=glnK 0.8145 -0.7823 0.3844 0.3460 -4.0448 0.0002
Ribosome-binding ATPase YchF GN=ychF 0.6196 -1.8246 0.0624 1.0222 0.0838 0.0805
dTDP-glucose 4,6-dehydratase GN=rffG 0.4300 -3.2168 0.0035 0.5740 -2.1158 0.0001
Peptidyl-prolyl cis-trans isomerase GN=fklB-I 0.4007 -3.4856 0.0771 0.4737 -2.8478 0.0011
ATP-dependent RNA helicase RhlE GN=rhlE 0.6871 -1.4302 0.2757 0.5865 -2.0337 0.0135
Isocitrate lyase GN=aceA 2.7587 3.8677 0.0052 3.1436 4.3655 0.0000
Photosynthetic apparatus regulatory protein RegA GN=regA 1.1805 0.6325 0.2505 0.4861 -2.7494 0.0000
Chemotaxis protein CheW GN=PP_4332 0.5951 -1.9784 0.0219 0.5879 -2.0250 0.0058
Carbonic anhydrase GN=cynT 0.7918 -0.8898 0.0534 2.1175 2.8595 0.0002
UTP--glucose-1-phosphate uridylyltransferase GN=galU 0.6068 -1.9042 0.0275 1.1237 0.4447 0.0405
Aldose-ketose isomerase GN=yihS 0.0531
-
11.1882 0.0009 0.0721
-
10.0209 0.0000
Gluconokinase GN=gnuK 0.0744 -9.9041 0.0150 0.4288 -3.2273 0.1033
Aminotransferase GN=alaC 0.5865 -2.0339 0.0153 0.9139 -0.3432 0.4573
Uncharacterized protein GN=PP_5353 0.9804 -0.0755 0.8709 1.5198 1.5954 0.0005
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Uncharacterized protein GN=PP_0508 0.4132 -3.3687 0.0135 0.3141 -4.4141 0.0000
Catabolite repression control protein GN=PP_5292 0.6343 -1.7354 0.0126 0.6892 -1.4188 0.0007
Uncharacterized protein GN=PP_1663 0.8473 -0.6315 0.0902 0.8775 -0.4979 0.1264
Cold shock protein CapB GN=capB 0.6514 -1.6338 0.0266 1.3827 1.2349 0.0009
Thioredoxin GN=trxA 0.5895 -2.0145 0.0571 0.9723 -0.1070 0.6568
Uncharacterized protein GN=PP_0998 0.9327 -0.2654 0.7461 0.3209 -4.3327 0.0003
Uncharacterized protein GN=PP_0750 0.5984 -1.9573 0.0145 0.8257 -0.7298 0.4386
Putative 2-ketogluconokinase GN=kguK 0.0574 ##### 0.0328 0.1333 -7.6806 0.0158
Putative methyl-accepting chemotaxis protein GN=PP_5020 1.2514 0.8548 0.0509 0.5223 -2.4758 0.0001
Cold-shock protein GN=PP_1209 PE=4 SV=2 0.7441 -1.1268 0.1330 0.9102 -0.3586 0.2014
Lysine / arginine / ornithine ABC transporter-periplasmic binding protein GN=argT 1.3537 1.1542 0.1477 0.9433 -0.2225 0.4286
Cysteine synthase GN=cysM 0.6855 -1.4393 0.0448 1.1966 0.6840 0.0262
Outer membrane protein assembly factor BamB GN=bamB 0.6933 -1.3962 0.0411 0.7288 -1.2055 0.0057
ThiJ/PfpI family protein GN=PP_3431 0.8500 -0.6193 0.3818 0.6437 -1.6789 0.0024
Uncharacterized protein GN=PP_4017 0.6652 -1.5540 0.1591 0.8777 -0.4970 0.6106
Anthranilate synthase component 1 GN=trpE 0.5856 -2.0399 0.0385 0.8135 -0.7867 0.0725
Uncharacterized protein GN=PP_4448 0.5838 -2.0511 0.0010 0.8966 -0.4162 0.1325
Peptidyl-prolyl cis-trans isomerase C (Rotamase C) GN=ppiC-II 0.4919 -2.7042 0.1272 0.9404 -0.2341 0.5269
Peroxiredoxin, alkylhydroperoxide reductase-small subunit GN=ahpC 0.4451 -3.0853 0.0031 1.3663 1.1895 0.0166
Amino acid ABC transporter, periplasmic amino acid-binding protein GN=PP_5024 0.8953 -0.4217 0.3979 0.7386 -1.1548 0.1208
3-hydroxy acid dehydrogenase, NADP-dependent / malonic semialdehyde reductase GN=ydfG 0.5916 -2.0005 0.0440 0.7288 -1.2057 0.0003
N5-carboxyaminoimidazole ribonucleotide mutase GN=purE 0.9656 -0.1335 0.0802 0.9124 -0.3493 0.0690
Uncharacterized protein GN=PP_3924 0.7140 -1.2837 0.1373 0.5573 -2.2286 0.0588
Uncharacterized protein GN=PP_5395 0.9395 -0.2380 0.6108 0.8359 -0.6834 0.0213
Diaminopimelate epimerase GN=dapF 0.5414 -2.3384 0.0009 0.6096 -1.8865 0.0000
NADP-dependent dihydropyrimidine dehydrogenase subunit PreA GN=pydA 4.3057 5.5646 0.0149 0.3532 -3.9669 0.0000
DNA-binding response regulator GN=colR 0.6915 -1.4060 0.0045 0.7148 -1.2795 0.0158
Uncharacterized protein GN=PP_3785 0.7497 -1.0978 0.1726 0.8489 -0.6243 0.0843
Putative Acyl-CoA dehydrogenase GN=PP_3638 0.4769 -2.8220 0.0077 0.6291 -1.7662 0.2906
Carboxy-terminal-processing protease GN=ctpA 0.6012 -1.9395 0.0066 0.9764 -0.0909 0.8261
O-acetylhomoserine (Thiol)-lyase GN=PP_2528 0.5680 -2.1561 0.0129 0.8964 -0.4167 0.1241
Putative ABC efflux transporter, ATP-binding protein GN=PP_0507 0.5703 -2.1403 0.0256 0.5002 -2.6404 0.0001
Putative Transcriptional regulator MvaT, P16 subunit GN=PP_3693 0.5796 -2.0787 0.0623 1.7973 2.2347 0.0001
Glutamate synthase (NADPH) beta subunit GN=gltD 3.4618 4.7331 0.0027 2.4790 3.4602 0.0000
Glycerophosphoryl diester phosphodiesterase GN=ugpQ 0.8118 -0.7948 0.2176 0.9510 -0.1916 0.3873
N-succinyl-L,L-diaminopimelate aminotransferase alternative GN=dapC 1.1816 0.6361 0.4695 0.8269 -0.7247 0.0873
Peptidylprolyl isomerase GN=PP_2304 0.5811 -2.0689 0.0000 0.8764 -0.5027 0.0136
Methionine aminopeptidase GN=map 0.6128 -1.8663 0.0024 0.5822 -2.0615 0.0008
Putative Xenobiotic reductase GN=PP_1478 0.9896 -0.0398 0.9204 0.3221 -4.3184 0.0001
Peptidyl-prolyl cis-trans isomerase GN=slyD 0.4301 -3.2162 0.0001 0.8411 -0.6595 0.0427
Putative heme biosynthesis protein GN=PP_0189 0.8729 -0.5180 0.1790 0.9599 -0.1562 0.8276
ATP-dependent protease-like protein GN=PP_0680 0.4023 -3.4708 0.0050 0.4341 -3.1808 0.0013
Exodeoxyribonuclease III / apurinic/apyrimidinic endodeoxyribonuclease VI GN=xthA 0.5852 -2.0425 0.0134 1.0239 0.0902 0.6648
Putative Glycine cleavage system transcriptional repressor GN=PP_1236 0.6703 -1.5250 0.0460 0.5812 -2.0681 0.0029
Ferroxidase GN=bfr-II 0.4675 -2.8981 0.0098 0.5389 -2.3561 0.0021
Uncharacterized protein GN=PP_1795 0.6582 -1.5941 0.0247 2.6368 3.6956 0.0000
Carbamate kinase GN=arcC 0.5980 -1.9598 0.2879 0.2912 -4.7024 0.0015
Glutamylpolyamine synthetase GN=spuI 0.8205 -0.7540 0.1004 0.7258 -1.2217 0.0050
Isocitrate dehydrogenase [NADP] GN=icd 0.8869 -0.4574 0.3919 0.7884 -0.9063 0.0498
tRNA-modifying protein YgfZ GN=PP_1423 0.4918 -2.7051 0.0195 0.6892 -1.4188 0.0116
Coproporphyrinogen-III oxidase GN=hemN 1.1636 0.5774 0.0525 0.8957 -0.4197 0.2856
Quinoprotein ethanol dehydrogenase GN=qedH-I 1.6400 1.8856 0.0046 0.2019 -6.0977 0.0006
Putative phosphonate dehydrogenase GN=ptxD 0.0434
-
11.9543 0.0085 0.0950 -8.9728 0.0000
Uncharacterized protein GN=PP_2364 0.8557 -0.5939 0.5822 0.8754 -0.5072 0.2305
ParA family protein GN=PP_5070 0.5904 -2.0087 0.0852 1.0425 0.1586 0.5815
DNA gyrase subunit A GN=gyrA 0.5784 -2.0867 0.1259 0.8165 -0.7729 0.0122
Transcriptional regulator MvaT, P16 subunit GN=PP_1366 0.6927 -1.3994 0.0202 1.3698 1.1994 0.0795
Mannose/glucose ABC transporter, glucose-binding periplasmic protein GN=gtsA 0.1036 -8.6427 0.0005 0.0918 -9.1028 0.0000
Two-component system DNA-binding transcriptional dual regulator GlnL/GlnG GN=glnG 1.1621 0.5726 0.3442 0.3114 -4.4470 0.0024
Medium-chain-fatty-acid CoA ligase GN=PP_0763 0.6391 -1.7064 0.0038 0.3396 -4.1164 0.0001
Putative Aldolase/synthase GN=PP_1791 0.6310 -1.7552 0.0051 1.5825 1.7495 0.0030
Uncharacterized protein GN=PP_0181 1.0408 0.1526 0.8741 0.6907 -1.4103 0.0067
Uncharacterized protein GN=PP_0693 0.5594 -2.2137 0.0304 0.5635 -2.1864 0.0017
Uncharacterized protein GN=PP_3326 0.4271 -3.2422 0.0530 0.4805 -2.7932 0.0005
Putative glyceraldehyde-3-phosphate dehydrogenase GN=PP_3443 0.8684 -0.5378 0.0017 1.1527 0.5417 0.0000
Uncharacterized protein GN=PP_5711 0.5744 -2.1132 0.0077 0.6159 -1.8474 0.0004
Uncharacterized protein GN=PP_5737 1.0269 0.1011 0.8546 0.7608 -1.0419 0.0117
Uncharacterized protein GN=PP_5576 0.5196 -2.4952 0.0243 1.2686 0.9069 0.1575
Pseudouridine synthase GN=rluB 0.6204 -1.8198 0.0111 0.7554 -1.0689 0.0118
Uncharacterized protein GN=PP_5426 1.1129 0.4078 0.2709 2.5504 3.5685 0.0001
